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Abstract 
 
 
Nutraceuticals provide protection against several diseases included cardiovascular 
diseases, cancer and neurodegenerative disorders. The use of phytochemicals in daily 
dietary products determines several beneficial effects on human health. Curcumin, 
quercetin, carotenoids, resveratrol are only few examples of molecules with beneficial 
action on our body. However, these benefits are often limited by a low solubility in 
water, a poor absorption in the gastro-intestinal tract, a low stability and an easy 
oxidation of these molecules. In order to overcome these problems several efforts are 
addressed in the formulation of successful delivery systems able to protect and 
efficiently deliver nutraceuticals and, in particular, nanotechnology holds great 
promises in this field. The possibility of an efficient delivery of nutraceuticals 
incrementing their biological activity represents a current relevant challenge for 
researchers. In this Thesis biopolymers are explored as potential materials to obtain 
nanostructured delivery systems capable to improve water solubility of hydrophobic 
molecules. In particular, within the class of biopolymers, the interest has been focused 
on alginate and chitosan. These polymers show characteristics of non toxicity, 
biocompatibility, mucoadhesion that make them very attracting for the formulation of 
new carriers for oral administration of nutraceuticals. Despite literature reports are 
usually addressed in the development of new delivery systems based on a ionic 
attraction between the two polymers, in this Thesis  the possibility to form  a covalent 
linkage between the carboxyl functions of alginate and the amine groups of chitosan 
using EDC/NHS as zero-length cross-linking agents was investigated in order to obtain 
stable nanocarriers. Covalent interactions are indeed stronger than ionic ones and can 
improve stability and resistance of the nanoparticles. Moreover they should confer 
rigidity to the polymeric network limiting the leakage of the entrapped molecules. In 
literature this type of covalently crosslinked network is not widely studied, and only 
few articles describe a covalent alginate-chitosan linkage. Different methodologies of 
crosslinked alginate-chitosan nanoparticles preparation have been explored in the 
Thesis: from reaction in water to reaction in macroemulsion with food grade 
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components, to nanoemulsion using pure chemical solvents. In our approach, the W/O 
emulsions represent an instrument to confine the reaction between the two polymers 
in a small environment in order to avoid aggregation and the uncontrolled formation 
of large insoluble networks of polymers. In this context the inner water droplets of the 
W/O emulsion represent a nanoreactor in which the reaction between the two 
polymers takes place. Stability of the emulsion and sizes of the water droplets have a 
great influence on the final dimensions and stability of the polymer nanoparticles. 
According to that, better results in term of sizes and stability of the nanoparticles have 
been reached when polymers are included in W/O nanoemulsion rather than 
macroemulsion. Specifically, two different types of nanoemulsions  have been 
optimized in this Thesis, using cyclohexane as oil phase and hexanol/Triton X-100 as 
cosurfactant/surfactant or a mixture of Tween80-Span80 as surfactants. Once 
nanoemulsions have been optimized, a reproducible methodology to isolate and purify 
the polymer nanoparticles from toxic residues has been defined. The obtained 
nanoparticles have been characterized with different techniques (FT-IR, NTA, DLS, 
TEM, SEM, UV-Vis, etc.). In particular they have been analyzed in term of polymer 
composition, sizes and size stability during time, shape and morphology, 
biocompatibility, entrapping ability of nutraceuticals and antioxidant properties of 
nutraceuticals after the encapsulation in the carriers. The average diameter of the 
nanoparticles is 180 nm with a monodisperse and homogenous particle population 
despite the presence of few larger aggregates. Analysis of the evolution of particle size 
during time confirms the presence of aggregates that precipitate during time. The 
precipitation of these aggregates can be accelerated by centrifugation of the fresh 
samples. A characterization of pure polymers and nanoparticles by spectroscopic 
methods has been performed using FT-IR spectroscopy. Results show the  presence of 
both alginate and chitosan in the final composition, although  a direct evidence of the 
formation of the covalent amide bond between alginate and chitosan was not 
obtained. However, relevant indirect information about the differences between 
covalent and ionic nanoparticles has been obtained from a comparison of 
nanoparticles synthesized with and without covalent crosslinkers. An in vitro assay  
(MTT) confirmed the safety of the nanoparticles revealing a good biocompatibility. The 
morphological investigation using transmission and scanning microscopy (TEM/SEM) 
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shows well defined and spherical nanoparticles. Entrapping abilities of the 
nanoparticles were explored using molecules of interest in nutraceuticals such as 
resveratrol and quercetin. Nanoparticles show good loading capacity and the bioactive 
compounds are stably retained in the network after the optimization of the system. 
The nutraceuticals tested, preserve their scavenging ability after the entrapment in the 
carriers. Therefore, the goals achieved in the Thesis represent an important result in 
the development of nanodelivery systems for uses both in food and pharmaceutical 
field. 
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Sommario 
 
 
I nutraceutici rappresentano un valido aiuto nella prevenzione di diverse patologie, 
malattie cardiovascolari, cancro e malattie neurodegenerative in primis. L’uso di 
molecole bioattive di origine vegetale nella dieta quotidiana, infatti determina effetti 
benefici sulla salute umana. La curcumina, la quercetina,  i carotenoidi e il resveratrolo 
sono solo alcuni esempi di una classe  di composti con attività benefica sul nostro 
organismo. Spesso i benefici di queste molecole sono limitati dalla scarsa solubilità in 
acqua, dallo scarso assorbimento nel tratto gastro-intestinale unitamente a una certa 
instabilità e tendenza ad ossidarsi facilmente. Nel tentativo di superare tali criticità, 
sono stati destinati diversi sforzi nella formulazione di sistemi di rilascio capaci di 
proteggere in modo efficace i nutraceutici e in particolare è nel campo della 
nanotecnologia che si riversano grandi promesse.  La formulazione di un sistema di 
rilascio efficiente capace di aumentare l’attività biologica dei nutraceutici rappresenta 
una sfida attuale nella ricerca scientifica. In questa Tesi, sono stati utilizzati biopolimeri 
come potenziali materiali di partenza per ottenere sistemi di rilascio nano strutturati 
capaci di aumentare la solubilità in acqua di molecole idrofobiche. L’interesse  si è 
focalizzato  soprattutto sull’impiego di  alginato e chitosano come potenziali carriers. 
Tali polimeri mostrano caratteristiche di non tossicità, biocompatibilità, e muco 
adesione che li rendono attraenti nella formulazione di nuovi carriers per la 
somministrazione orale di nutraceutici. Mentre in letteratura abbondano esempi di 
interazioni ioniche tra i due polimeri, in questa Tesi è stata studiata la possibilità di 
formare un legame covalente tra le funzioni carbossiliche dell’alginato  e i gruppi 
amminici del chitosano grazie all’impiego di EDC/NHS, crosslinker di zero ordine, con lo 
scopo di ottenere nanoparticelle stabili. Le interazioni covalenti infatti sono più forti 
rispetto a quelle ioniche e possono aumentare la stabilità e la resistenza delle 
nanoparticelle. In più potrebbero determinare una maggiore rigidità del network 
polimerico finale limitando la perdita delle molecole incapsulate. In letteratura questo 
tipo di legame covalente tra alginato e chitosano è stato poco studiato  e solo qualche 
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articolo descrive studi in questo senso. In questa Tesi sono state impiegate diverse 
metodologie di preparazione di nanoparticelle di alginato e chitosano nel tentativo di 
legare i due polimeri: da reazioni in acqua, a reazioni in macroemulsione con l’utilizzo 
di componenti di grado alimentare, fino a nanoemulsioni in cui sono stati impiegati 
solventi chimici. In quest’ottica l’uso di emulsioni A/O è un valido strumento per 
confinare la reazione tra i due polimeri in un ambiente ridotto così da impedire 
l’aggregazione e la formazione incontrollata di un network insolubile tra i due polimeri. 
Le gocce interne dell’emulsione A/O rappresentano infatti dei nano reattori in cui far 
reagire alginato e chitosano. La stabilità  dell’emulsione e le dimensioni delle gocce 
hanno una grande influenza sulle dimensioni finali e sulla stabilità delle nanoparticelle. 
Di conseguenza i risultati migliori in termini di dimensioni e  stabilità sono stati ottenuti 
nel caso in cui i polimeri sono stati inclusi in nanoemulsioni A/O piuttosto che in 
macroemulsioni. Nello specifico, sono state ottimizzate due tipologie di 
nanoemulsioni, una impiegando cicloesano come fase continua ed esanolo/Triton X-
100 come cosurfattante/emulsionante, l’altra in presenza di Tween 80 e Span 80 come 
miscela di emulsionanti. Dopo aver ottimizzato l’emulsione si è messa a punto una 
metodologia riproducibile per isolare e purificare le nano particelle polimeriche dai 
residui tossici. Le nanoparticelle sono state poi caratterizzate con l’ausilio di diverse 
tecniche (FT-IR, NTA, DLS, TEM, SEM, UV-Vis, ecc.). In particolare si sono determinate 
la composizione, le dimensioni e la stabilità nel tempo, la forma e la morfologia, la 
biocompatibilità, la potenziale capacità di incapsulare nutraceutici e l’eventuale azione 
antiossidante dei nutraceutici una volta incapsulati. Il diametro medio delle 
nanoparticelle risulta essere di 180 nm con una popolazione di particelle monodispersa 
nonostante la presenza di qualche aggregato. L’evoluzione del diametro medio  nel 
tempo di tali nanoparticelle conferma la presenza di questi aggregati che precipitano e 
può essere accelerata dalla centrifugazione del campione appena preparato. I risultati 
della caratterizzazione spettroscopica ottenuta tramite spettroscopia FT-IR mostrano 
la chiara presenza di alginato e chitosano nella composizione finale nonostante non sia 
stato possibile convalidare la formazione del legame covalente. Si è perciò ricorso a 
prove indirette basate sull’analisi di alcune importanti differenze derivanti da un 
confronto diretto tra nanoparticelle covalenti sintetizzate in presenza dei crosslinker e 
nanoparticelle ioniche sintetizzate senza i crosslinker covalenti. La  valutazione della 
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biocompatibilità misurata  con un saggio in vitro (MTT) ha dato ottimi risultati nel 
profilo della sicurezza delle nanoparticelle. L’analisi morfologica eseguita con 
microscopia elettronica a trasmissione e scansione (TEM/SEM) mostra particelle 
sferiche e ben definite. La capacità delle nanoparticelle di incapsulare molecole di 
interesse in nutraceutica come resveratrolo e quercetina è stata altresì valutata. Le 
nanoparticelle mostrano una buona capacità di loading e i composti sono stabilmente 
trattenuti nella matrice polimerica. I nutraceutici testati, inoltre, preservano la loro 
attività di scavenger anche dopo l’incapsulamento nei carrier.  Gli obiettivi raggiunti 
nella Tesi pertanto rappresentano un importante risultato nel campo dei sistemi di 
rilascio per uso farmaceutico ed alimentare. 
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1.1 Food, health, diet  
 
Rapid modifications in diet and lifestyle as a consequence of industrialization, 
urbanization and market globalization have had a considerable impact on health and 
nutrition of population. All these changes have determined an improvement in living 
standard , food bioavailability and access to services but with negative effects on the 
diffusion of improper dietary models.1 For example, the revolution in mobility and 
technologies has favored a sedentary lifestyle that combined with an increased intake 
of food rich in saturated fats and poor in unrefined carbohydrates, has dangerous 
repercussions on public health. Epidemiological studies evidenced the role of diet in 
preventing and controlling mortality. Some nutrients in fact may retard or avoid the 
onset of illness, while others increase the probability to develop diseases. Although  it 
is known that healthy food is vital for our wellbeing, many people do not follow a 
balanced  diet, increasing the incidence of serious metabolic imbalances, responsible 
of the increment of disease risk factors as obesity, hypertension, food intolerance, 
allergy, etc.. Being  universally recognized that dietary adjustments  represent a valid 
help in fighting several diseases it is important to spread a correct pattern of nutrition 
to follow in daily life. 
The Mediterranean diet represents a model of the correlation between food and 
wellbeing. Several studies underline the improvements in life quality of populations 
bordering the Mediterranean sea due to contributions of diet  in promoting health 
benefits. In particular, Mediterranean dietary model is related to a defense from 
cardiovascular mortality and reduction in incidence of cancer and cardiovascular 
diseases.2 This became evident when several data were published regarding  the low 
or very low rate of heart diseases among the inhabitants of the Mediterranean basin 
despite a normal high consumption of fats (although with regional differences). The 
lower incidence in hearth diseases produced a longer life expectation  respect to other 
populations. The fundamental sources of food, in Mediterranean diet, are plants foods 
i.e. vegetables, fresh and dried fruits, nuts, legumes, and grain cereals. The principal 
source of fats is represented by olive oil followed by fish, egg, cheese, yoghurt and 
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white meat, while fats of red meat, saturated fats and trans fatty acids are present in 
limited amounts.3 Also a moderate consumption of wine represents part of daily diet. 
 
 
1.1.1 Polyphenols: an example of dietary source of wellbeing 
 
All the typical foods of Mediterranean diet contain significant amounts of healthy 
nutrients as polyphenols. These compounds and their derivatives represent a class of 
food constituents with the ability to regulate metabolic processes and  to determine a 
positive impact on health and wellbeing.4 They abound in different food sources, 
generally fruits, vegetables, cereals, beverages. For example fresh fruits as apples are 
rich in polyphenols: a variable fraction between 60-120 mg/100 g is made of 
polyphenols. Also red wine, tea, coffee, chocolate, cereals and dry legumes are rich in 
polyphenols. In the plants, polyphenols are produced as secondary metabolites acting 
in the defense  from UV radiations and pathogen injury.5  
During the time several articles and epidemiological studies confirmed the important 
role of a daily dose consumption of polyphenols in the protection of human 
healthiness. The action of polyphenols is basically due to a strong antioxidant activity 
in human body against  the reactive oxygen/nitrogen species (ROS, RNS) formed as 
byproducts in the normal metabolic processes. In particular, in case of stress or 
alteration, ROS and RNS are produced in excessive amounts and the body is not able to 
detoxify them. Figure 1.1 illustrates all the injuries in which polyphenols are involved 
with a protective rule. 
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Fig.1.1 Health effects of polyphenols in human body (adapted from reference 
5
). 
 
 
Several hundreds of different compounds have been recognized to belong to the class 
of polyphenols.  The most useful classification is based on the number of phenol rings 
and on the structural elements connecting phenols between them. Figure 1.2 
illustrates a schematic classification of polyphenols. 
 
 
Fig.1.2 Schematic classification of polyphenols present in nature. 
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Bioavailability of polyphenols varies depending on the class considered and is not 
related to the amounts present in food. The aglycone form is usually absorbed in the 
small intestine, but most polyphenols are taken up in complexes with esters, 
glycosides or polymers. Intestinal enzymes and colonic microflora provide to the 
hydrolysis of the conjugated form before the absorption. During absorption, the  
molecules undergo processes of modification and they finally enter in the blood 
stream in a modified form making complicated to identify all metabolites originating 
from a class of molecules and to monitor their biological activity.5 For this purpose, a 
Phenol-Explorer web database has been created that counts 383 different polyphenol 
metabolites identified up to date.6 These data represent the starting point to 
characterize the metabolome, the set of all components originating from a class of 
compounds, in this case polyphenols. Following the schematic resume in figure 1.2, 
polyphenols are divided in five principal classes: stilbenes, lignans, hydroxycinnamic 
acids, hydrobenzoic acids and flavonoids. 
Among these classes, stilbenes are present only in little amounts in the human diet. 
Within the group of stilbenes, resveratrol, was extensively investigated for its 
anticarcinogenic effects.7 Resveratrol is found mostly in grape and in derived products 
such  as wine. However, being present in a very low quantity in the diet, the  protective 
role of this compound is improbable in a normal diet dose.8 
In nature, resveratrol exists in two structural isomers, but only the trans form is active 
in scavenging free radicals.9 Its active role in preventing diseases such as 
neurodegenerative injuries, cardiovascular diseases, cancers and viral infections, has 
been sustained by in vitro and in vivo studies.10  
Another important class of polyphenols is the class of flavonoids. Flavonoid derivatives 
represent the most ubiquitous polyphenols in nature and are divided in seven sub-
classes. The basic structure of flavonoids presents a carbon skeleton formed by two 
benzene rings (A and B) bonded via a heterocyclic pyrane ring (C), as shown in figure 
1.2. The most common sub classes are: isoflavones, flavonols, flavanones, flavanols, 
anthocyanidinis and flavones. 
Studies in absorption spectroscopy showed that flavones and flavonols display two 
absorption bands in different wavelength ranges. Band in the interval between 320-
385 nm due to B ring absorption and Band  in the range from 250 to 285 nm 
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corresponding to A ring absorption, with the position of the maxima influenced by the  
substituents on the two aromatic rings. The presence of different functional groups 
gives to every class of flavonoids exclusive physicochemical properties and biological 
activities. For example, the antioxidant activity depends on the number and position of 
the hydroxyl groups in the structure. Systems in which the B-ring contains two 
hydroxyl moieties and the C ring has a double bond and a 4-oxo function seem to have 
improved antioxidant ability.11 Aglycone form or glycoside derivatives are the common 
forms in which flavonoids are present in nature.12 The aglycone form is easily absorbed 
in the small intestine, while glycoside flavonoids must be first hydrolyzed to the 
aglycones before to be absorbed. The hydrolysis may occur by action of digestive 
enzymes and, in this case, once the aglycones are formed, they are absorbed in the 
small intestine, too. Glycosides that are not substrates of enzymes are transported in 
the colon, whose capacity of absorption is lower than that of small intestine and where 
bacteria provide to the hydrolysis. After the absorption step, different enzymes 
promote the conjugation of flavonoids in the liver producing glucuronidated, 
sulphated and methylated derivatives or small metabolized molecules. These 
modifications make difficult to control pharmacokinetic parameters. The solubility of 
flavonoids has a significant action in the therapeutic efficacy of these molecules. 
Indeed, the relative low residence time and low absorption exclude toxic effects 
derived from ingestion of flavonoids. However low solubility  represents a limit for 
medicinal applications.13  
Among the class of flavonols, quercetin represents the most intensively bioactive 
molecule studied. It has a formidable antioxidant activity, and in the flavonoids family 
quercetin is the most effective scavenger of ROS and RNS as reported from Hanasaki et 
al..14 Quercetin structure is responsible of its strong antioxidant activity: the presence 
of two antioxidant pharmacophores (catechol group in B ring and hydroxyl group in 
position 3 of AC ring) in the molecule offers an ideal configuration for the scavenger 
activity. Quercetin exhibits different biological actions from antiatherogenic to 
antiproliferative or anticoagulative ones. This molecule is also able to regulate  
expression of enzymes and to inhibit cell proliferation. On the other hand, the 
consequence of the antioxidative activity of quercetin  is the formation of its oxidized 
quinoid form, named QQ which exists in many tautomeric isomers. These oxidized 
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derivatives display a toxic action for their capacity of arylation of protein thiols present 
in the body. Moreover, the strong reactivity of QQ leads to the formation of an adduct 
with GSH, the most abundant endogenous thiol.15  
 
 
1.1.2 Functional food and nutraceuticals 
 
An increasing number of consumers is becoming aware  of the role of food in health.  
The attention toward diet and food correlated diseases has modified the perception  
of food which is now often intended not only to satisfy hunger and to provide the 
necessary nutrients, but also to prevent chronic diseases and to increase longevity. The 
rapid diffusion of healthy products obtained from natural sources has determined a 
growing interest in modified food, enriched in bioactive molecules. The modified food 
is generally defined as functional food. As was expressed by Shibamoto and al.16 in 
accordance with the International Food Information Council, a functional food is a food 
that “provides health benefits beyond basic nutrition”. A report on functional food 
published by the European Commission defines which are the main requirements  for a 
food to be considered as functional:  
 the basic constituent has to be a food, which contains or is enriched with an 
ingredient, a micronutrient or a naturally bioactive molecule with a beneficial role in 
health, well-being or disease prevention, 
 the beneficial activity has to go beyond normal nutrition, 
 the functional action has to be “illustrated” or declared and communicated to 
consumers, 
 the effect is expected to occur when the food is ingested in normal amounts. 
 In the functional food market, dairy products are the most widespread, followed by 
drinks, cereals, and snack food. In the dairy market, company advertisings offering 
“daily dosage” bottle to consumers, seem to be an appreciated strategy to increase 
the diffusion of functional dairy products. In the beverages class it is complicated to 
distinguish between energy drinks, tonic drinks and functional beverages, but the good 
results in term of sale of these products indicate that drinks are well perceived by 
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consumers in promotion of functional products. Regarding ingredients, probiotic 
bacteria cultures seem to be the principal bioactive nutrients, followed by dietary 
fibres, plant extracts based on polyphenols with anti-oxidative action or anti-age 
function.17 Functional food belongs to the large category of nutraceuticals that 
includes also food supplements, usually presented in form of pills and tablets. 
All kinds of nutraceuticals are considered as dietary products linking nutrition with 
health and having a key role in promoting wellness. Some researchers have defined 
also nutraceuticals as potent adjuvants in clinical therapy.18 It is not possible to identify 
a specific mechanism of action of nutraceuticals but it can be understood that their 
addition to food matrixes decreases disease risk. This experimental evidence 
represents a starting point  to develop  functional food potentially able to produce 
physiological benefits or to reduce the risk to develop disorder and prevent chronic 
diseases.19 In fact, apart from the actual medical treatments based on fast reduction of 
symptoms, dietary regulation promotes a moderate long term process for illness 
prevention or treatment.20 Summarizing cancer, diabetes, cardiovascular diseases and  
other correlated diseases are the main pathologies affecting patients, and several 
investigations have demonstrated that nutraceuticals maintain or control physiological 
functions correlated to the pathologies mentioned above. Therefore, the current 
tendency is to regard nutraceuticals as a valid instrument for prevention and a 
complementary tool for the treatment of diseases. Their beneficial action in 
preventing diseases is associated in part to the production of secondary phytochemical 
metabolites that was demonstrated to have several biological effects. In general, drugs 
have a more potent action in the treatment of illness thanks to the higher 
concentration in bioactive components, but if natural substances become part of daily 
diet, they may have long term effects on health.21 Moreover, nutraceuticals are 
expected to produce relative low toxicity and less side effects compared to drugs.20 
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1.1.2.1 Oral administration route of nutraceuticals 
 
In order to be taken as daily dietary products, and being the oral administration the  
most preferred route for its non-invasive character, the actual studies are exploring 
new delivery mechanisms to optimize the oral intake. In fact oral administration is 
influenced by  several factors  that can enhance or reduce the absorption of the active 
ingredients. In particular, the hard and different conditions to which bio-molecules are 
exposed in the body, the presence of degradative and metabolic enzymes, the 
susceptibility to first pass metabolism, may determine a modification of the chemical 
structure of the nutraceuticals and a loss in bioavailability. The oral cavity is the first 
site of the body in which food mass  is chopped in small pieces by enzymes present in 
the mouth, producing the so called bolus. The process is fast and the pH ranges from 
5,6 to 7,6. The changes due to temperature and  ionic strength are considered as the 
first step of the digestion, preparing food for the next step in the stomach. Here the pH 
is regulated, with the production of hydrochloric acid to values ranging from 1 to 3, 
depending on the characteristics of the bolus, to ensure an optimal activity of the 
digestive enzymes. The gastric environment is a crucial step for stability of bioactive 
molecules, in fact, most of them lose their activity because of important 
physicochemical modifications. Stomach  permanence time of the various components 
depends on their physiological and individual characteristics, and it is a predictive 
factor of the consequent bioavailability of molecules. For example, an insufficient time 
of residence in the stomach reduces the primary absorption of many polyphenols and 
of other poorly soluble bioactive molecules. A short permanence in stomach reduces 
also oral bioavailability for molecules absorbed in the upper section of small intestine. 
The small intestine receives the partly digested food, chyme, from stomach. Gut is 
divided in three different segments: duodenum jejunum and ileum. The mucosa is 
protected from  injury of the acidic chyme by the secretion of alkaline pancreatic juice 
that mixed to enzymes, phospholipids, bile salts and sodium bicarbonate continues to 
process food. In the intestine, food undergoes the conversion in simple nutrients ready 
to be absorbed. The composition of ingested food has a role in the type of nutrients 
absorbed, for example lipids enhance the absorption of lipophilic molecules, which 
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being not soluble in the water intestinal environment, tend to precipitate and to be 
excreted in absence of lipids. Instead, ingesting  fatty molecules along with food, leads 
to the formation of micelles made of lipase degraded fatty acids in which the lipophilic 
nutrients are incorporated and made available to pass through intestinal villi. Active 
and passive transport are  the mechanisms that allow the absorption of nutrients. In 
active transport cells use their own energy to internalize nutrients exploiting channels  
on the surface. In passive transport nutrients are internalized without spending energy 
following a simple diffusion mechanism. The rate of absorption and the consequence 
availability depend from the physicochemical characteristics of the molecules as 
stability to different pH, resistance to ionic strength, enzymatic transformations, 
hydrolysis. The last tract of GI apparatus is represented by the colon, here, the last 
nutrients and water are absorbed. 
Moreover some nutrients undergo a first pass metabolism which causes a reduction in 
the amount available to be absorbed in the site of action. Liver and intestinal cells are 
the common  responsible of first pass metabolism for  molecules administered orally.22 
The fraction of bioactive molecules that undergoes first metabolism is variable in each 
individual, so it is difficult to forecast the effect of a standard dose of a drug. 
 
 
1.1.2.2 Other administration routes of nutraceuticals 
 
Being absorption of nutrients in many cases compromised in the gastro-intestinal tract, 
recent studies illustrate the possibility for lipophilic drugs to penetrate the dermis. 
Dermal administration represents an innovative solution for systemic delivery with a 
reduced toxicity. In some cases the concomitant use of oral and dermal products 
enhances the antioxidants  action of nutraceuticals18 as reported by  Palombo et al.23 
in  the case of consumption of some carotenoids. There is an increasing demand of 
products incorporating nutraceuticals with a function in retarding aging too. Bioactive 
compounds can also be released transdermally as coadjuvants in the treatment of 
dermatitis, psoriases, skin cancer and other skin pathologies.  
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In the case of ocular related therapies, the ophthalmic route remains the principal 
route of administration in the clinical practice despite oral route presents a major 
acceptability by consumers. In ophthalmic route, nutraceuticals rapidly reach the 
target   explicating a fast anti-inflammatory and antioxidant action.  
 
 
1.2 Encapsulation technology 
 
Encapsulation is an effective way  to regulate  the delivery of bioactive molecules. 
Using encapsulation technology, bioactive drugs are included in a matrix acting as a 
barrier, protecting and preserving sensitive molecules from degradation during  
processing and  digestion.24 In the  modeling of a delivery system, it is of primary 
importance to formulate the best system considering the type of instability of the 
encapsulated agent, the final application of the system and the properties (protection, 
degradation, etc.) that one need to improve. The following criteria are the parameters 
to evaluate during formulation of delivery systems: 
Loading capacity  represents the amount, expressed as percentage, of encapsulated 
drug/bioactive molecule per unit of carrier matrix. In the formulation of a delivery 
system is important to obtain a high final loading capacity. The value ranges from 0% 
to 100% depending on the nature of the bioactive drug, the structure of the matrix and 
the mutual interactions between them. 
Loading efficiency evaluates  the capacity of the matrix to retain the bioactive 
molecules during time. This factor is important to be controlled  for instance in the 
case in which the carrier  matrix has to resist to the acidic conditions  of the  stomach 
enabling the nutrients to cross the gastro environment. This property has also 
particular importance for systems that require a long period of storage. Ideally a 
loading efficiency of 100% corresponds to a complete preservation of the  
encapsulated material.  
Encapsulation efficiency is defined as the percentage of bioactive molecules entrapped 
in the carrier respect to their initial concentration. The value can be calculated 
indirectly by subtracting the amount of non encapsulated  molecules  to the total mass 
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of bioactive molecules used, or with a direct measure of the encapsulated 
compound.25 
Delivery mechanism is related to the release of the bioactive molecules from the 
carrier in a controlled rate in response  to different stimuli  i.e. pH variations, ionic 
strength, temperature, once the carrier arrives in the target site.  For example,  in a 
delivery system formed by polymers having swelling properties, swelling is the 
principal mechanism of delivery of bioactive compounds.  
Delivery efficiency is the ability of the carrier to deliver the drug in the desired site of 
action. Drugs have affinity for certain organs or tissue exerting their action in a specific 
area defined as target site. In order to ensure a high delivery efficiency, the matrix has 
to arrive intact to the target site where the drug is delivered in response to stimuli. 
There is also the possibility to modify  the carrier, making it able to be recognized by 
specific receptors of the target site cells thus facilitating cell internalization. 
Protection of the bioactive represents the starting factor in the stabilization of a 
bioactive component. In fact usually molecules need to be encapsulated to resist to 
the action of oxygen, heat, light, contact with other substances promoting 
degradation,26 and strong value of pH. 
Bioavailability is a crucial factor in the action of a bioactive molecule. It is a 
pharmacokinetic property regarding the fraction of bioactive molecules that reaches in 
a unchanged state the systemic circulation. When the route of administration of a drug 
is intravenous, the bioavailability has a percentage of 100%. If other routes are used, 
the bioavailability decreases considerably. Orally administered drugs present a 
reduced absorption and a possible first pass metabolism.27 Encapsulation of the drug 
may strongly affect its bioavailability. 
During the production of enriched food systems,  encapsulation technology  is a useful 
method for different reasons that are listed below: 
o increased release of bioactive molecules, 
o protection from oxidation, light, degradation, hydrolysis, 
o limited susceptibility to gastro-intestinal environment, 
o protection from first pass metabolism, 
o limited interaction with food matrix, 
o preservation of stability during processing and storage, 
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o creation of a barrier toward other components, 
o masking bitter taste and astringency (as for polyphenols), 
o increased bioavailability, 
o prevention of reactions with other components, 
o providing a sufficient amount, 
o uniforming dispersion of a compound, 
o control of the rate of release, 
o delivery in a target site. 
 
 
1.2.1 From “micro to nano” encapsulation 
 
Encapsulation technologies have been extensively explored for the delivery of 
bioactive compounds of low and high molecular weight. In this field the use of 
microspheres or microparticles is largely diffuse and, in general, the presence of a 
micrometric matrix ensures a controlled release of entrapped bioactive molecules. 
Food biopolymers are receiving great interest in the formulation of microsphere 
delivery systems, thanks to their natural origin, edible nature, stability and 
processability. Biopolymers include a large number of different polymers, from protein 
to carbohydrates. Among proteins,  the widespread  types  are: whey protein, gluten, 
gelatin. Among carbohydrates, polymers as starch, maltodextrins, chitosan, celluloses, 
alginates are usually adopted in fabrication of micro and nano structures for 
pharmaceutical, food and cosmetic applications. Also poly(lactic acid) (PLA) having 
good biocompatibility is frequently used as material in microencapsulation technology. 
The requirements  for a technology in the manufacturing of carriers deal with  aspects 
such as safety, economicity, reproducibility and  high controlled methodology.  
Several procedures are available to encapsulate food bioactive molecules. Since the 
compounds to be entrapped are normally in a solution, various technologies of 
encapsulation include drying processes and, for example, spray drying is one of the 
oldest method used in food sector. Also gelling techniques enable the formation of 
microparticles. Other common adopted methodologies  originate from modification of 
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the basic methods: solvent extraction/evaporation, phase separation (coacervation), 
ionic gelation.28 This field has grown and diversified in few years and in the last period 
the principal efforts are concentrated in the exploration of nano delivery systems thus 
moving from micro- to nanoparticles. Nanotechnology has a growing role in 
agriculture, pharmaceutical and food systems. Concerning food and agriculture, the 
control at a nanoscale level of the material characteristics may modify features as 
texture, flavor, solubility, stability, processability with strong impact on final 
applicability. Several studies are also focused on the development of new materials for 
detection of pathogen, tools for protecting food, methodology to increase safety and 
efficacy and smart packaging.29 
The novel interest in nutraceuticals and the consequent need of new designed delivery 
systems  to encapsulate functional food  make attractive the investigation in the area 
of nanotechnology too. The last trend in encapsulation and stabilization 
methodologies is to adopt novel strategies  to ensure targeted delivery and good 
bioavailability of nutrients. Nanotechnology offers  some advantages in the design and 
optimization of delivery systems to overcome drawbacks  of conventional carriers. In 
fact, active intracellular delivery of nutrients and modification of pharmacokinetic and 
pharmacodynamic properties depend  from the sizes and surface properties of the 
carriers30 with the nano-structured systems usually more effective in promoting the 
uptake of nutrients.  A scientific review published by Acosta 31 compares data collected 
by five different research groups on the influence of the particle sizes on 
bioavailability/uptake properties. The results  show that the size of carriers affects the 
process, in fact nano-particles below 500 nm of sizes increase the uptake of the 
carriers and the absorption of encapsulated nutrients. The equation of Ostwald-
Freundlich well describes the dependence of solubility  of spherical nanoparticles from 
their sizes and represents a good way to predict solubility of small particles: 
 
ln  
 
  
  = 
      
      
 × 
 
 
                                                                                   (1) 
 
where S  is the solubility of the nanoparticles  at a given particle size and     is the 
value of solubility of the nanoparticles for big   values,    is the molecular weight of 
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the nanoparticle,   is  the surface tension or  interfacial tension as in this case between 
solvent and nanoparticle,   is the density of nanoparticle,   the Universal gas 
constant,   is temperature expressed in Kelvin,    is the radius of the nanoparticle. 
A simulation based on the Ostwald-Freundlich equation for a hypothetic compound 
shows a large influence of the size of the nanocarriers on bioavailability for carriers 
below 100 nm of diameter (where  solubility is the limiting factor for bioavailability). 
Instead for nanoparticles ranging from 100 nm to 500 nm different mechanisms are 
hypothesized to act: the increase of solubility of active ingredients, the increment of 
the gastro residence time,  the consequent enhancement of the absorption favoring 
the direct uptake.32 
This result implies that absorption is strongly influenced by uptake of the carrier, and 
uptake of the carrier is influenced by its  size. This observation is also confirmed by 
other studies describing for example how particles with a size of 100 nm generally 
increase the absorption by 2,5 times compared to 1 m particles in CaCo-2 33 cells and  
that nanoparticles are able to cross the submucosal layer in a rat model.34 These 
scientific evidences of increased  uptake of nanoparticles justify the strong interest  in 
the potentiality of nanocarriers.35 
 
1.2.2 Delivery systems based on nanocarriers 
 
Nanoencapsulated systems are formed by entrapping one or more different molecules 
in a structured matrix. In the development of nanocarriers, the most explored matrices 
are lipid components and polymeric materials. 
In the family of lipids, liposomes represent the major investigated nanocarriers in agro-
food and pharmaceutical areas. The structure of a liposome derives from the self-
aggregation of phospholipids once they are exposed to a water environment. 
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Fig. 1.3  Schematic structure of phospholipids and rearrangement  in aqueous system. 
 
In fact to minimize the hydrophobic area exposed to water, phospholipids self-
aggregate forming a bilayer in which hydrophobic tails are in the internal layer and 
hydrophilic heads are exposed to water (see figure 1.3) both in the internal  and in the 
external compartment. The procedure of formation needs some necessary steps and 
often involves the use of toxic solvents that may remain in traces. Carriers obtained 
after hydration in water are multi lamellar vesicles (MLV), with several double layers of 
phospholipids arranged in a concentric way and an usually large size distribution. Multi 
lamellar vesicles are able to entrap both hydrophilic (in the internal compartment and 
in the compartments between different bilayers) and hydrophobic molecules (in the 
bilayers). A further step of extrusion of MLV through filters with a controlled pore sizes 
(see figure 1.4) gives a narrow distribution of unilamellar vesicles (LUV).  
 
 
Fig.1.4 Schematic representation of LUV obtained by  extrusion process. 
 
Liposomes are excellent carriers to increase the bioavailability and stability  of 
polyphenols. In vitro studies of liposomes internalized polyphenols show an 
incremented efficacy compared to polyphenols alone. In a work of Tonnesen et al. 36 it 
was demonstrated an increase of 20-fold for the uptake of curcumin by red blood cells 
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after encapsulation in liposomes respect to curcumin in solution. Also encapsulation of 
resveratrol resulted in a more effective protection against UVB radiation. Liposomal 
formulations of trans-resveratrol determined also an increment in bioavailability due 
to a prolonged exposure of the cells to the molecule. Several articles show the same 
results on advantages of polyphenols encapsulated in liposomes. Table 1.1 shows a 
resume of the literature available about inclusion  of polyphenols in different type of 
liposomes: 
 
 
Tab.1.1 Different examples of inclusion of polyphenols in liposomes (adapted from reference 
37
). 
 
Thus, liposomes have several advantages in the protection and delivery of the 
bioactive molecules  and in the relatively easy way of preparation which ensures high 
control of the size and size uniformity. However they present some several limitations 
mainly related to problems in long-term storage and rapid excretion.  
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Other carriers originating from lipids are micelles which are formed by amphipathic 
molecules and which structure depends on the solvent they are exposed. If the 
surrounding medium is water, the polar portion of the surfactant is exposed to the 
aqueous environment and the hydrophobic tails organize in clusters in the core, 
avoiding the contact with water. The micelles originating from this interaction are 
known as regular micelles. If the surrounding medium is of hydrophobic nature, the 
orientation of molecules changes, and the hydrophobic tails are exposed to the solvent 
while the hydrophilic heads are in the core of the structure usually embedded in a 
small water pool. Micelles of this kind are known as reverse micelles.38 Studies 
concerning encapsulation of  artemisinin 39 and curcumin 40 in sodium dodecyl sulfate 
(SDS) micelles suggest an increment in stability against oxidation. Micelles made of SDS 
seem also able to protect green tea polyphenols extracts.41 
Polymers are also able to form micelles, in particular the self assembling of amphiphilic 
block copolymers forms polymeric micelles. This kind of micelles  show a great ability 
to solubilize relevant amounts of hydrophobic drugs, and enable the modification of 
the surface with targeting ligands. Usually such micelles present a hydrophilic blocks  
formed by PEG and a core including  various structures.42 For example, curcumin 
loaded polymeric micelles formed by monomethoxy poly(ethylene glycol)-
poly(epsilon-caprolactone) (MPEG-PCL) have been investigated.43 
Cyclodextrins (CD) represent also a model of molecular inclusion. They are formed 
from enzymatic modifications of starch and present a cavity in which the hydrophobic 
molecules are incorporated. The CD family consists of glucopyranose subunits bonded 
with (1-4) links.  Based on the number of sugars forming the ring, cyclodextrins are 
distinguished in cyclodextrins (see figure 1.5). In literature there are several 
examples of polyphenols as resveratrol,44 olive leaf extracts,45 flavonoid rich 
Hipericum,46 quercetin,47 rutin,48 rosmarinic acid 49 and polyphenol extract 50 included 
in cyclodextrins. In general inclusion increases aqueous solubility and antioxidant 
capacity.  
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Fig.1.5 Structures of  - - -cyclodextrins. 
 
 
1.3 Polymers 
 
The term polymer designs a large molecule constituted of smaller repeating units 
known as monomers which are connected through covalent bonds. 
A monomer is thus a fragment that combines with other fragments of the same or 
different type. A homopolymer derives from the repetition of a single monomer, 
instead a copolymer (in addition to the need of specifying the monomeric 
composition) is formed by two or more structurally different monomers. Another 
useful distinction is between random copolymers in which monomers are randomly 
arranged in the chain, alternating copolymers in which the different monomers are 
arranged in an alternating sequence and block copolymers which are made up of 
blocks of different polymerized monomers. The final conformation of the chain 
depends from the modality in which monomers are joined to each others: in linear 
polymers the units are linked together end to end in a single flexible chain, in  
branched  polymers, side or branch chains are connected to the principal ones, in 
crosslinked polymers several branches connect different polymer chains (see figure 
1.6). 
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Fig.1.6 Schematic representation of different types of polymers. 
  
One important characteristic of polymers is that the polymeric chains may establish a 
large number of contact interactions between each other thus leading to the 
formation of higher level structures (fiber, particles, etc.) with important 
physicochemical and mechanical properties. The force of these intermolecular 
attractions is more important respect to the molecular weight of the polymer, and 
consequently to the number of repeating units, in determining the final properties of 
the system. In fact polymers with a low molecular weight but strongly interacting  have 
better mechanical properties of high molecular weight polymers with weaker 
interactions.51 
 
 
1.3.1 Polyelectrolytes 
 
In the case in which the repeating units of a polymer bear a charged group, the 
polymer is identified as a polyelectrolyte. This class of polymers has several 
applications in all fields related to human uses. It is surprising, indeed, that many of 
biopolymers of living systems are polyelectrolytes, as nucleic acids, proteins, and 
glycosaminoglycans. Thanks to their hydrosolubility, the attention about possible 
applications is continuous. For example, in the oldest food technology the 
polyelectrolytes themselves are not only involved in the formation of the proper 
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texture but have been also used as thickening or gelling agents in juices, chocolate and 
other foods. Nowadays, potential applications in food industry are based on 
exploitation of polyelectrolytes and polyampholytes in mixed systems such as phase 
separated nanogels or multilayered membranes to improve stability of food emulsion. 
As explained above, a polyelectrolyte is a polymer carrying  ionizable groups with 
positive or negative charge. The fraction of dissociated ionic groups strongly affects the 
behavior of polyelectrolytes in solution. Solubility of the polymer in the solvent and 
presence of salt are other parameters influencing the final  properties. 
Dispersion of polyelectrolytes in polar solvents can determine a dissociation of the 
ionic groups leading to a charged polymer chain. The interactions between the charges 
confer to the polyelectrolyte characteristics strongly different from uncharged 
polymers. The main effects about electrostatic interactions on the chain are visible in: 
 Short radius effect, due to the repulsion between sequent charges on the 
chain, these interactions cause a local stiffening of the chain, that can be 
characterized by the value of the persistence length. 
 Long radius effect, in which different segments of the chain can interact  and 
repulse. Repulsion affects both segments of the same chain (expansion) and 
segments of different chains, a phenomenon that generates an increase of the 
so-called “excluded volume”. 
The addition of a salt to the solution, i.e. an increase of the ionic strength,  results in a 
general shielding of polymer charges, with a decrease of polyelectrolyte dimensions. 
Charges are organized in clusters on the polymer chain with elevated  local electric 
potential. The model used to interpret properties of polyelectrolyte solution refers to 
the idea of a molecule as an impenetrable sphere made of low dielectric constant 
material. This model is similar to that expressed by Debye  and Huckel in theorization 
of simple electrolytes. The model provides that electric charge is uniformly distributed 
on the surface of the sphere and that charge density  can be calculated by Poisson-
Boltzmann equation. In many cases this model is not sufficient and leads to serious 
error, as an example in the count of electrostatic free energies of polyelectrolytes. The 
theory was improved replacing the assumption of a uniform surface charge density 
with the introduction of the concept of well defined arrangement of the charged 
groups (clusters).52 
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The viscosity of a normal polymer solution is related to the nature of polymer and 
solvent, concentration of polymer, average molar mass, temperature etc.. If the 
solution is very diluted the  viscosity can be expressed  as:         
 
                                                                                                                                        (2) 
 
 
 
For several polyelectrolytes the equation (2) is applicable  only if the polymer is 
dissolved in aqueous salt solution,  otherwise, the ratio sp /c  does not approach to a 
constant value for c approaching to zero. 
Normally intrinsic viscosity depends from molecular weight as expressed from the 
Mark Houwink Sakurada (MHS) equation: 
 
[ = K ×                                                                                                                                   (3) 
 
and  from radius of gyration  Rg and end-to-end distance r: 
 
 
                                                                                                                                                                   (4) 
 
 
For polyelectrolytes, instead, intrinsic viscosity depends from charge density 
(calculated with the relation Ze/L in which Z is the number of charges (e) along the 
polymers and L is the length of the chain) and concentration of added salt.  At constant 
concentration of salt, the more is the charge density, the more is the viscosity. At fixed 
charge density an increment in the amount of salt results in a decrement of viscosity. 
Polyelectrolytes present some common behaviors such as, for example, the ability to 
form gel. 
Gelling properties confer the ability to swell and retain water thanks to the presence of 
a cross-linked polymer network. Hydrogel can reach a swollen status in response to 
different stimuli based on the type of polymer used in the formulation (see figure 1.7). 
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The ability to absorb water  depends on the characteristics of polymers and the type of 
crosslinking between the chains. The presence of large amounts of water confers 
properties of flexibility similar to the natural tissue and this represents an advantage 
for biomedical application also.53 
 
 
 
Fig.1.7 Gelling properties in response to different stimuli (adapted from reference 
53
). 
 
Moreover the exclusive opportunity to control the swelling makes these systems 
advantageous to be employed in drug delivery and food field as encapsulating agents 
for biomacromolecules including proteins, DNA and nutrients. The formation of the gel 
occurs at ambient temperature, without addition of toxic solvents.  
The polymers commonly used in the hydrogel formulations can have a natural or 
synthetic source. In food and pharmaceutical the use of natural polymers is preferred 
notwithstanding these materials have a poorer mechanical properties respect to 
synthetic ones.54 
 
1.3.1.1 An overview on chitosan and alginate 
 
Alginate and chitosan are biocompatible, biodegradable, safe and versatile 
polyelectrolytes of natural origin widely used in biotechnology and in the 
pharmaceutical sector. The principal application is as thickening agents in food field. 
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Their particular properties make them ideal matrices in cell immobilization or 
controlled release of proteins and other macromolecules. Chitosan derives from 
alkaline N-deacetylation of the chitin (see figure 1.8), the principal constituent  of  the 
outer shells of crustaceans and insects. Chitin is a structural polysaccharide, the most 
abundant after cellulose. 
Deriving usually from a partial deacetylation, chitosan  consists of a copolymer of 1-4 
linked 2-amino-2-deoxy--D-glucan (D-glucosamine) and N-acetyl-D-glucosamine with 
varying degree of deacetylation and molecular weights. 
Chitosan is a basic biopolymer and its properties of solubility and biodegradability 
depend on the degree of deacetylation and on the number of protonated amino 
groups which, in turn, depend on pH. The full protonation of the amino groups occurs 
in acidic medium with a pKa smaller than 6.2: in this condition  chitosan is water 
soluble.55 
 
 
 
Fig.1.8  Structure of  chitin a) and chitosan b). 
 
Alginates instead, derive from brown seaweed. The production of the polymer starts 
with a first step of grinding of the dried material, followed by acidic extraction to 
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remove residues of other polymers and to exchange alkaline cations with H+. At the 
end of these steps,  protonated alginate is converted in its sodium salt. Alginate is a 
linear copolymer with homopolymeric blocks of (1-4)-linked β-D-mannuronate (M) and 
its C-5 epimer α-L-guluronate (G) residues, respectively, covalently linked together in 
different sequences or blocks. The polymer belongs to the class of linear block 
copolymers (see figure 1.9). 
 
 
Fig.1.9  Structure of polymeric chains of Alginate: Guluronic and Mannuronic units. 
 
The typical arrangement of  blocks copolymer chain in alginate is characterized by the 
alternance in homopolymeric regions  and heteropolymeric regions. The former are 
composed by GG blocks alternated to MM blocks, the second instead are formed by 
sequence of mixed composition M-G blocks.56 M units give a flat aspect to chain, while 
G monomers confer a characteristic buckled aspect. These provide a certain flexibility 
in homopolimeric tracts of MM residues and minor flexibility in GG blocks due to the 
steric hindrance of the carboxyl groups. As a consequence, the more is the content of 
M units, the more is the flexibility of chains. The diaxial linkage in G blocks results in a 
difficult rotation around the glycosidic bond that gives reason for the stiff and 
extended nature of alginate chain. Considering that alginate belongs to the class of 
polyelectrolytes as referred before, the repulsion between the charged groups 
increases the expansion of chains enhancing intrinsic viscosity. In fact considering the 
MHS  relationship (3) a coefficient increases with chain extension, ionic strength and 
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alginate composition, having a direct role on intrinsic viscosity: low value of a is  
related to large fractions of MG region, high value of a is related to extended regions 
of G-blocks.57 
Due to their polyelectrolyte behavior, chitosan and alginate are able to interact 
ionically with several charged polyelectrolytes. The type of ionic interactions can be 
summarized in ionic crosslinking and polyelectrolyte complexation. 
The ionic crosslinking is a very appealing phenomenon: the presence of charged amino 
groups on chitosan in acidic conditions as an example, allows to crosslink the polymer 
by using negatively charged ions, such as triphosphate (usually reported in 
pharmaceutical literature as tripolyphosphate (TPP)), which is the most widely used. 
The interaction, commonly referred as ionotropic gelation, was extensively studied and 
described by Calvo,58 after that Bodmeier59 first reported the preparation of beads by 
dropping chitosan in a TPP solution. The ionic gelation takes place spontaneously via 
electrostatic interactions between chitosan chains and TPP.60 This methodology of 
nano-particles preparation allows to encapsulate several types of biomolecules, from 
protein,61,62,63 to small drugs64,65 and genes66 and because of its versatility it was 
extensively studied and optimized.67,68 
An interesting study published by Stoica69 shows encapsulation of a polyphenol 
complex extracted from Rosa canina with satisfactory results in term of efficiency. The 
article underlines the importance of Chitosan-TPP ratio in determining the 
characteristics of the nanoparticles. The capacity of chitosan to interact with TPP is 
translated in formation of inter and intra molecular crosslinking between amine groups 
of chitosan and phosphate groups of TPP. Operative parameters, such as stirring time 
and speed affect the properties of the nanoparticles and their yield70 thus becoming  
important too.  
TPP is not the only charged compound able to interact ionically with chitosan, and 
metallic ions as Mo (VI) and Pt (II) can also be used as cross-linkers. This metal ions give 
stronger crosslinking interaction respect to TPP. However, the use of TPP as 
crosslinker, has the advantage to give the possibility to check the crosslinking density 
by measuring the pH,  because as the reaction proceeds, OH- ions are released in the 
reaction media. With other crosslinking agent, at the moment, there are not applicable 
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methods to control the crosslinking density and to predict the final properties of the 
gel.71 
In alginate instead, the presence of G residues is responsible of  the gelling property. 
Water solution of alginate may form gel in presence of bivalent cations. In fact,  
guluronic residues72 may exchange Na+ ions with divalent cations such as Ca2+, Sr2+ and 
Ba2+, which act as bivalent linkers, promoting the formation of a strong network 
between GG blocks of different chains. The resulting network is known as egg-box 
structure (see figure 1.10).73 
 
 
 
Fig.1.10 Egg-box structure in presence of low (a) and high (b) concentration of bivalent ions. Red points represent 
ions between G sequences. 
 
The formation of alginate gel using Ca2+ is a widespread technology in the field of 
polyelectrolytes. A pioneering work by Rajaonarivony,74 involves the use of alginate 
and Ca2+ in such a concentration to form a pre-gel status with a lower level of 
crosslinking respect to a fully formed gel. In this  pre-gel status the G residues not 
involved in the network may be saturated using a different polycation such as poly-
Lysine. An example of this procedure is the encapsulation of doxorubicin in a 
alginate/Ca2+ pre-gel which has been then fully jellified by interaction with poly-
lysine.75 Since the beginning, such mild conditions of gelation appeared very attractive 
for the encapsulation of labile drugs, characterized by poor bioavailability upon oral 
administration, as polyphenols. Nevertheless, articles showing encapsulation of 
polyphenolic antioxidants in ionic crosslinked chitosan or alginate matrices are limited 
but  some examples  are available such as the works of Liang76 and Harris77 regarding 
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encapsulation of tea polyphenols and a natural extract of Illex Paraguariensis, 
respectively.  
Another very popular methodology for an easy formation of nanoparticles is through 
polyelectrolyte complexations  (PECs).  From this point of view, chitosan, is an 
attractive polymer, being the only natural polymer with a positive charge,78 and, 
therefore, having the possibility to complex with a wide range of negatively charged 
polysaccharides by electrostatic interactions, forming PECs.  
Since the early work published on PECs by Fuoss and Sadek (1949),79 different studies 
and reviews have been published on this topic. PEC complexes obtained using natural 
biopolymers with opposite charge have been previously formulated as protein 
carriers80 but represent also an ideal colloidal carrier for gene delivery81 and for a 
sustained release of bioactive molecules. Hyaluronian, a biocompatible polymer 
negatively charged can be used to form complexes with chitosan82,83,84, and has the 
ability to bind several receptors as CD44, once internalized in the body.85 It can also be 
used as coating for chitosan-TPP nanoparticles.67 
In literature there are not many reports on complex coacervation for the delivery of 
nutraceuticals, with some examples regarding interaction between chitosan and 
xanthan to deliver an oily seed rich86in lignans and physical interaction of alginate with 
polycaprolactone87 to encapsulate white tea  extract. On the other hand,  scientific 
works dealing  with nanoparticles preparation using coacervation methods to deliver 
polyphenols are lacking. 
A sub-category of complex coacervation is represented by polyelectrolyte-colloids 
coacervates that have some advantages respect to polyelectrolyte-polyelectrolyte 
coacervation in reducing the heterogeneity of the final system. In particular protein-
polymers coacervates belong to this category and represent an interesting system for 
preservation of bio-functionality and are particularly important in enzyme 
immobilization, protein purification, antigen delivery and stabilization of food.88 An 
interesting article regarding polyphenol encapsulation describes the formulation of a 
complex coacervate made of catechin loaded chitosan-pectin.89 Polyelectrolyte-
protein coacervation can also occurs between the ammonium function of chitosan and 
reactive group of heparin,90 BSA88 and casein.91 Also complexes between alginate and 
protein seem to act as potential carriers of nutraceuticals, in fact, nutraceuticals with 
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low solubility in water were successfully entrapped in -lactoglobulin-sodium alginate 
complex. 92 
Along with the preparation methods, it is worthy to stress that the achievement of 
nanoparticles with tailored characteristics requires a full knowledge of the 
physicochemical properties of the chitosan and alginate93 and various parameters 
affect the final properties.  
As an example, the increase in chitosan and alginate MW, has a consequent on both 
encapsulation efficiency and release of protein, deacetylation degree of the chitosan 
instead has an effect on hydrophobic interactions that can improve the retention of a 
lipophilic molecule and G/M ratio of alginate affects the final stiffness of the network. 
Ratio and concentration between components furthermore determine the amount of 
available hydroxyl groups that may be engaged in hydrogen bonding, influencing the 
results in terms of sizes and stability of nanoparticles.94 
Concentration and density charge of the crosslinking agent, Mw and reaction time 
instead influence the final crosslinking density, a determining factor in order to ensure 
swelling capacities, pH-dependance, acceptable mechanical properties and release of 
drug from gel. 
The control of all the variables affecting swelling behavior and network pore sizes, 
becomes a limiting factor reducing the field of application of these systems.95 
Furthermore, the possible lack of mechanical properties,96 the possibility of dissolution 
due to pH dependence, the strong dependence from external conditions after 
administration lead to weak systems. Nevertheless, improvements and modifications 
may  promise further progresses in pharmaceutical applications.97 
Chitosan and alginate can also interact each other’s forming a polyelectrolyte complex. 
The exact definition of the mechanism by which these complexes are formed is difficult 
mainly due to the complexity in following the multi-ionic interaction which are 
established at the interface of the macromolecules and which are strongly influenced  
by pH. Simsek and al.,98 gives a description of these interactions  based on a FT-IR 
characterization of the complex formed at different pH in extremely dilute solution of 
polymers. The complex is formed mainly thanks to Coulomb forces  with some 
participation of hydrogen and ionic bonding. As seen above the first ionic interaction 
studied between alginate and a polycation was with poly Lysine, but in several 
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subsequent research works, chitosan was used instead of poly-Lysine.72,73,99,100,101 
Alginate and chitosan are able to interact forming PECs as reported by Sarmento 102 in 
a comparative study on nanoparticulate systems prepared by coacervation and by 
ionotropic pre-gelation. The coacervation is due to interactions between the carboxyl 
functions of guluronic/mannuronic units of alginate and the positively charged amine 
groups of chitosan.103,104,105 Chitosan-alginate systems are usually obtained in the form 
of beads for a controlled release of high molecular weight drugs, whose release rate is 
strongly influenced by chitosan concentration and pH. The properties of low toxicity, 
high biocompatibility, biodegradability of alginate and chitosan make them attractive 
candidates for the development of nutraceuticals delivery systems, exploiting their 
polyelectrolytes behavior. For example, alginate and chitosan coacervates can  
preserve a polyphenolic plant extract.106 Other examples are microspheres formed by 
ionic attractions between the two polymers able to entrap tea polyphenols107 or 
crocin.108 The synergic action of alginate and chitosan improves the mechanical 
stability of the encapsulating systems while the presence of alginate improves 
impermeability and prevent rapid diffusion of bioactive molecules at  acidic pH. 
Moreover, the two polymers were shown to cooperate in the protection of bioactive 
molecules from degradation and in the increment of residence time of liphophilic 
molecules such as trans-cinnamaldehyide.101 
Apart from these and other few examples the use of systems made by alginate and 
chitosan interacting together for delivery of nutraceuticals to date remains largely 
unexplored, but potentially it should ensures the same results of delivery systems 
conceived for protein or antibiotics. 
Another interesting reaction is the covalent modification of  alginate and chitosan. For 
example glutaraldehyde has been used as covalent crosslinker for chitosan. The 
reaction occurs between the amine function of chitosan and the aldehyde group of the 
linker leading to an imine bond via a Schiff reaction linking the polymer to chain 
belonging to the same polymeric chain or to a different one.71 In literature several 
articles present the crosslinking of chitosan with itself in presence of glutaraldehyde.109 
The crosslink reaction with glutaraldehyde offers also the possibility to bind different 
polymers to chitosan and the synthesis of macroporous chitosan-gelatin scaffold110 is 
an example. 
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The main feature of such crosslinking is that it is irreversible and gives rise to rigid 
network structures.111 Drug release occurs mainly via diffusion and depends on chain 
relaxation characteristics of the crosslinked network after dissolution in the medium.  
The main drawbacks encountered are the high toxicity of the aldehydes and 
insufficient biocompatibility. These problems actually limit the use of this crosslinker. 
Similar considerations can be done for epichlorohydrin. A new crosslinking agent, 
genipin, which is found in gardenia fruit extract, is becoming an interesting alternative 
to glutaraldehyde.112,113,114,115 
Another suitable modification includes the use of ethyl-dimethyl-aminopropyl-
carbodiimide hydrochloride (EDC), a  more biocompatible agent compared to 
glutaraldehyde. EDC enables the formation of amide bonds  between the amino 
groups of chitosan and the carboxyl groups of different macromolecules. EDC is also 
known as zero length crosslinker. EDC is used to produce a great number of chemical 
derivatives. The mechanism involves the reaction of EDC with a carboxyl acid to 
produce a reactive o-acylisourea as intermediate. Reaction of this activated acid with a 
nucleophile such as a primary amine leads to the formation of an amide bond. 
Moreover, thanks to its water solubility, EDC is readily used in aqueous environment. 
The final structure results in a permanent network with high mechanical properties 
and high resistance to dissolution also in extreme conditions of pH. The use of a 
crosslinker zero length is a valid instrument to modify hydrophobically an hydrophilic 
polymer, as chitosan or alginate. Several articles show in fact the possibility to modify 
chitosan with cholesterol preventively conjugated with succinyl molecule 116 or to graft 
chitosan with linoleic acid.117 Alginate instead can be hydrophobically modified with 
octylamine using EDC as coupling agent.118 The coupling reaction is also a strategy to 
improve mucoadhesive property of alginate grafting the polymer with cystein.119 
Despite coupling reaction was explored to bind macromolecules to small molecules 
also macromolecules can be coupled as in the case of chitosan-hyaluronian120and 
chitosan-gelatin.121 Alginate is potentially able to interact covalently with chitosan 
through amide bond formation. A recent article122 describes an amide linkage between 
chitosan and alginate forming nanoparticles with high stability even  in acidic 
environment. 
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Nevertheless, the reaction between alginate and chitosan using EDC is still an 
unexplored route for production of nanoparticles but it may be a valid methodology to 
formulate stable nanoparticles as carriers. A central feature in the optimization of the 
reaction, regards the reaction conditions and in particular the medium in which the 
reactions is performed which can be water but also  more complex systems such as 
emulsions. The formulation of systems in emulsion can stabilize the polymers during 
the reaction and the formation of the nanoparticles will take place in the 
nanocompartments of the internal phase separated from each other by the continuous 
phase.123 The optimization of the reaction in emulsion requires an adequate 
knowledge of the emulsion formation. 
 
 
1.4 Emulsions 
 
Emulsions are thermodynamically unstable systems obtained by mixture of two 
immiscible liquids. Emulsions are generally classified as dispersed systems consisting of  
an internal phase forming droplets dispersed in a continuous, external phase. 
Emulsions can be distinguished in W/O if the continuous phase is water or O/W if oil is 
the external surrounding phase.124 The type of emulsion (W/O, O/W) depends on 
water-oil ratio, temperature and other parameters such as electrolyte concentration 
and type of emulsifying agent.  Any phase under agitation can be broken in droplets 
dispersed in a continuous immiscible phase but an emulsion formed in such way tends 
to a rapid coalescence of the droplets leading to phase separation.125 The predominant 
force for phase separation is the interfacial free energy of droplets, that increases after 
dispersing a phase into another one. The addition of surfactants,  molecules acting as 
“surface active” agent, can reduce the interfacial tension. A depth elucidation on what  
is intended as interfacial tension enables a full comprehension of the mechanism of 
action of surfactants. 
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1.4.1 Phenomenological description of theory of interfaces 
 
The interfacial tension is the event occurring at liquid-liquid interface, the same 
phenomenon happens in case of liquid-air contact and it is called surface tension. 
The phenomenon can be interpreted using two different models. From a mechanical 
point of view, in the bulk  of a liquid, molecules have  balanced cohesive forces acting 
in all directions with a resultant zero force. Instead molecules at the interface,  being 
not surrounded from other molecules in all sides, have a resultant force that is no zero, 
so they tend to reduce the area of contact with the other liquid to a minimum value, 
limiting the mixing. Based on these considerations, the interfacial tension is considered 
as the contractive force for unit length operating at the interface. It is mechanically 
quantifiable as the force needed to extend an interface of an infinitesimal amount. 
Considering the phenomenon with a thermodynamic approach, the interfacial tension 
is considered as the increase of Helmholtz or Gibbs energy after the increasing of the 
interfacial area of an infinitesimal quantity.126 The two approaches lead to equivalent 
dimensional units. The inclusion of a surfactant in the emulsion enables the reduction 
of the interfacial tension, promoting the mixing of the immiscible phases. Surfactants 
have an amphipathic molecular structure consisting of a hydrophilic group  with a good 
attraction for the water phase and a lipophilic portion with affinity for the oil phase.127 
When placed in an oil-water system, they orient to consent the interaction of the polar 
head with water and of the apolar tail with oil. The reduction of interfacial tension 
takes place by concentration of the surfactants at the oil-water interface,  preventing 
emulsion breaking due to the rapid coalescence of droplets.128 They usually are added 
during the emulsion formation to increase the process of dispersion and to ensure 
stability during time. The type of surfactant used is a very important aspect. In fact the 
phase in which the emulsifier is  better partitioned tends to be the external phase. This 
principle is summarized by Bancroft’s rule according to which the external phase of an 
emulsion tends to be the phase in which the emulsifier is more soluble.129 Following 
this theory is important to determine the contribution of hydrophilic and hydrophobic 
portions of the emulsifier introducing the concept of HLB. In fact, to reach a good 
predictability of emulsion stability, Griffin introduced in 1949 130 the so called HLB 
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number (Hydrophilic-Lipophilic Balance) that is a scalar numerical value which 
differentiates the emulsifiers. Davies, in 1963 optimized the original concept 
introducing  the HLB  group number based only on the structure of emulsifier. This 
methodology enables to calculate the HLB referring to the  functional groups present 
in the emulsifier and matching the value to the required  HLB value for  oil 
emulsification.131 Actually the HLB number  has been determined for each available 
emulsifier. For an easy choice of the right emulsifier is good to learn that a value of 
HLB lower than 9 corresponds to an emulsifier with a lipophilic character so it could be 
employed for W/O emulsions, on the contrary emulsifiers with HLB above 11-12 have  
hydrophilic characteristics and could be used to formulate an O/W emulsion. 
Emulsifiers with HLB value ranging from 9 to 11 have an intermediate behavior.132 This 
classification is sometimes not very rigid and depends also from the ratio between the 
continuous and internal phases. As a consequence, it is possible to formulate a good 
emulsion by using a single emulsifier  or a blend of emulsifiers having the same final 
HLB. An emulsifier has a multiplicity of roles in  emulsion which are related to: 
 lowering the interfacial energy between the two phases, 
 producing smaller droplet sizes, 
 improving stability of the dispersed phase, 
 determining the type of emulsion (W/O or O/W). 
 
 
1.4.2 Different types of surfactants 
 
Surfactants can be classified for their physical properties and functions. In relation to 
the chemical structure and the consequent hydrophobic and hydrophilic character, 
surfactants have different chemical properties and behavior. The most useful 
distinction of surfactants is based on the charge of the polar head. This leads to a 
classification of four classes of surfactants briefly described below: 
 Anionic surfactants, formed by a ionizable  head, dissociated in water generally 
in an anionic  amphiphilic portion associated to an alkaline metal cation and by 
a hydrophobic tail of different nature. This category includes  carboxylates (-
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CO2
-) e.g. sodium stearate, sulfonates (-SO3
-) e.g. sodium dodecyl benzene 
sulfonates, phosphate (-PO3
-2)  and sulfates (OSO3
-) e.g. sodium dodecyl 
sulfates (SDS), and alkylphenols. The hydrophobic chain can be of different 
typology as saturated, unsaturated, aromatic, or aliphatic. Anionic surfactants 
are widely employed as cleaning agents. 
 Cationic surfactants, of which the most common have a nitrogen atom 
positively charged. In the case of  amines the compound is pH sensitive,  acting  
as emulsifier only when the amine group is protonated e.g. laurylamine 
hydrochloride.  Ethoxylated amines, instead, can be considered cationic or non 
ionic depending on pH conditions. The properties of surfactants carrying a 
quaternary ammonium group are not pH dependent. Cationic surfactants 
usually are used for their adsorbing capacities at anionic surfaces of plastics, 
minerals etc. and as antiseptic agents. 
 Zwitterionic surfactants have opposite charged groups; generally the cationic 
function derives from the presence of a nitrogen atom and the anionic part is a 
carboxylic unit. Usually these surfactants are employed in shampoo and 
dermatological formulations for their low irritation properties. 
 Non ionic surfactants include polymerized derivatives of ethylene oxide in 
which the polyoxyethylene chain represents the polar head. The length of 
oxyethylene chain usually ranges from 5 to 10 units but in some cases can be 
longer. The reaction of ethoxylation is normally performed in alkaline condition 
in the presence of different type of nucleophiles. Indeed, fatty acids, fatty 
alcohols, fatty amines and alkylphenols are readily ethoxylated. 
Another important group of non ionic surfactants is constituted by hydroxyl 
derivatives. Poly-ol  based surfactants include sorbitan, sucrose, poly glycerol 
esters.  Alkyl glucoside compounds can be ethoxylated too. Spans are examples 
of sorbitan esters and Tweens are examples of ethoxylated sorbitan esters. Non 
ionic surfactants have an important role in emulsion formation for their 
peculiar characteristics such as low interaction with electrolytes, compatibility 
with other classes of surfactants and strong dependence of their behavior from 
temperature. This last aspect in particular is a characteristic of polyoxyethylene 
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derivatives that present a reverse behavior respect to sugar based ones: 
increasing temperature their solubility in water decreases.  
 
 
1.4.3 Instability of emulsions 
 
Emulsions have a natural predisposition to macroscopically separate in two different 
phases. In fact once emulsion has been formed several phenomena of instability may 
occur leading to the breakdown of the emulsion. Some of these processes are: 
Creaming: this phenomenon leads the dispersed globules to separate out forming a 
film on the top of the continuous phase. The internal phase remains in globular form 
so an intense agitation can restore the emulsion. The phenomenon is visible  on the 
top of the external phase when the internal phase is less dense than the external one 
such as in O/W emulsion. If the droplets are monodisperse, charged and coated they 
tend to repel so they don’t approach each other minimizing the tendency to cream.133 
Stock law well describes the rate of creaming of an emulsion at infinite dilution. 
Sedimentation: when internal  droplets have a density higher than external phase as in 
the case of W/O emulsion, particles fall, becoming visible at the bottom of the 
container. The process is called sedimentation, and is the same of creaming but in 
opposite direction. Creaming and sedimentation  represent a first  step towards phase 
separation.                            
Flocculation: is due to the aggregation of small droplets in big aggregated globules 
without coalescence. All droplets maintain integrity being totally separated from each 
other.   
Coalescence: this type of instability  occurs when droplets become gradually larger 
without no mechanical or physical barriers to prevent aggregation.134 It can be 
considered as a continuation of the flocculation process. 
Ostwald ripening: in addition to these events another mechanism of instability to be 
mentioned is Ostwald ripening. As time evolves, emulsion changes: the number of 
total particles decreases and particles diameter increases,135 in fact larger particles 
swallow the smaller ones with the total volume fraction remaining constant. This is 
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due to the fact that the larger particles having a higher volume to surface area ratio 
are thermodynamically more stable. 
 
 
1.4.4 Macro/micro/nano emulsions 
 
According to the sizes of the  droplets of the internal phase it is possible to distinguish 
different categories of emulsions:  
 
 macroemulsion: droplet size ranging from 0,5-100 m 
 microemulsion: droplet size from 50-500 nm  
 nanoemulsion: droplet size from 50-500 nm 
 
The main macroscopic difference between the different types of emulsions is the 
physical appearance of the system. In fact the aspect depends on the scattering of light 
by the droplets of the internal phase. The intensity of the light scattered is 
proportional to the sixth power of the radius of droplets. So macroemulsion scatters 
totally the spectrum of incident visible light owning an appearance of milky solution. 
As the droplets size decreases, the amount of scattered light decreases, so that the 
dispersion acquires the aspect of a translucent solution until to turn in transparent 
solution as in the case of micro and nanoemulsion. Emulsion is the term conventionally 
referred to macroemulsion. The relatively large droplet radius in macroemulsion  leads 
to an  increment of the droplet sizes with time that causes thermodynamic instability 
and phase separation. Macroemulsions are in fact kinetically stable but 
thermodynamically unstable. A microemulsion instead, once the right conditions of 
formulation are optimized, forms spontaneously so it is an example of  
thermodynamically stable and optically isotropic system.136 More subtle are the 
differences between microemulsion and nanoemulsion, such as that in literature these 
two terms are often confused. Indeed, there are many structural analogies between 
the micro- and nanoemulsions but also several differences, the main being the 
thermodynamic instability of nanoemulsions. 
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Fig.1.12 Difference in free energy involved in nanoemulsion and microemulsion formation (adapted from 
136
) 
 
To better understand the difference in thermodynamic stabilization is helpful to refer 
to a comparison between the free energy of the two systems (micro and 
nanoemulsion), considering for simplicity the case of oil in water emulsion (see figure 
1.12). As a premise is essential to highlight that thermodynamic stability of a specific 
state is calculated as the difference in free energy between this state and another one 
adopted as reference state. In nanoemulsion, the free energy of the non mixed phases 
is lower than the free energy of the oily droplets in water. This implies that 
nanoemulsion is thermodynamically not favored, so instable. The formation of 
nanoemulsion occurs thanks to energy input as mechanical shear. This means that a 
nanodispersed emulsion always evolves towards the breakdown. Giving a great barrier 
between the two states of energy is possible to confer a kinetic stability to the 
dispersion that will persist until the barrier will be overcome. In microemulsion 
instead, the free energy of the separated phases is higher than the free energy of the 
stabilized colloidal droplets which indicates that the dispersed state is 
thermodynamically favored, the system undergoes a spontaneous emulsification 
process governed by self assembly. Emulsion needs to receive energy for induction of 
the phase separation. Preserving unchanged the conditions of formulation (as 
temperature or chemical composition) a microemulsion will have unlimited stability.  
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1.4.5 Construction of a phase diagram 
 
The formulation of an emulsion requires the knowledge of the compatibility between 
solvents, cosolvents and amphiphilic components and of the effect of each component 
concentration on the final emulsion. A valid aid can be represented by the use of a 
phase diagram (see figure 1.13) as reference to explore stability of different regions of 
the mixtures. 
 
 
 
 
Fig 1.13 Example of phase diagram 
 
A phase diagram of a ternary system is represented by a triangle in which the vertexes 
of every angle represent one  of the three components (water, oil, surfactant).  
Moving inside the triangle is possible to explore different compositions and ratios 
between the three phases, staying within the same typology of emulsion (macro, micro 
or nano) or moving from one to others. For example considering the point A, three 
lines (red, violet, green) pass from here, so it is sufficient  to move on every line, 
toward the side represented by the  color (red for surfactant, green for  water, violet 
for oil), to know the proportion used of that component. In this way is easy to explore 
near regions and to  optimize the parameters. 
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1.4.6 Food grade emulsions in drug delivery and food 
  
The colloidal delivery systems obtained from micro and nano emulsification are rapidly 
spreading in food and pharmaceutical to protect, stabilize and deliver lipophilic 
compounds. Nanosized emulsions represent a vehicles for oil soluble drugs and the 
presence of aqueous environment can mask eventual strong taste of oil.134 
In the performing of a typical food-grade emulsion is of great importance to select 
ingredients approved in food industry. The use of corn oil olive oil, sunflower oil, castor 
oil 137 or other similar typologies of components founds application in several works. In 
particular the hydrophobicity of the oil phase and the chain extension of oil strongly 
affect the stability of emulsion. Also surfactants may undergo a critical evaluation of 
safety before to be selected.  Despite possibility to select food grade ingredients is 
limited, usually phospholipids (lecithin overall) are the principal investigated 
emulsifying agents.138 These systems present several limitation due to high viscosity 
and flocculation.139 
 
1.4.7 Technologies to produce  micro and nanocarriers from 
emulsions 
 
The transition from food-grade emulsions to emulsions involving chemical reagents 
enables the formation of smaller droplets and “pure” systems thus facilitating  a better 
analysis and a better understanding of the resulting systems. The field of nano-
formulated emulsions has not been widely explored for the formation of polymer 
nanoparticles, although it may give the advantage respect to other methodologies of a 
relatively easy preparation. The final stability of the nanoparticles over time, the 
narrow size distribution allowed by emulsion system and a good control of all the 
parameters concerning reaction are other reasons for consider interesting the 
investigation in this field. Moreover in literature not all combinations of polymers have 
been explored, despite they can represent a good starting point for new delivery 
systems. The employed technologies for the preparation of polymer nanoparticles in 
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emulsion can be resumed in a few basic techniques that can undergo changes and 
modifications. 
 Emulsification/solvent evaporation 
The drug or molecule to be encapsulated is dispersed or dissolved in an organic 
solvent in the presence of the encapsulating polymer matrix, then a second 
solvent (usually water), immiscible with the first one, is introduced to emulsify 
the organic phase. Finally the organic solvent is evaporated provoking the 
precipitation of the polymers in form of spheres in the continuous phase. 
Usually the use of O/W emulsions is preferred, giving the advantage of 
economic and safe process. The main limitation of this technology is the need 
to use polymers with a prevalent hydrophobic character as well as lipophilic 
drugs or bioactive molecules. The final sizes of spheres can be controlled acting 
on the viscosity of phases, stirring rate and temperature.140 Two possible 
mechanisms for particles formation has been proposed. The first regards the 
possibility that a single nanoparticle originates from a single droplet of 
emulsion and this is possible in the case in which the emulsion maintains stable 
during the evaporation of the solvent. The stabilization of the emulsion can be 
reached by the addition of a surfactant. The second possible mechanism 
instead considers every nanoparticle as originating from the merging of many 
different emulsion droplets. In this case the process is determined by the 
instability of droplets during evaporation of the solvent.141 Nanoparticles of 
poly-(lactic acid) (PLA) are usually obtained using this method of preparation. 
An adaptation of this methodology enables the preparation of nanocapsules of 
curcumin encapsulated in chitosan matrix. The technique includes a multiple 
emulsion O/W/O followed by the evaporation of the oil phase and the recovery 
of nanoparticles by centrifugation.142 An inversion of the typology of emulsion, 
W/O/W, was exploited to form alginate microparticles.143 
 Solvent displacement 
This method is a variant of the process just presented. It is known also  as 
nanoprecipitation and is a safe, reproducible and economic wide-spread 
method used to produce colloidal systems. The method is based on the 
solubilization of a non water soluble polymer in an amphiphilic solvent totally 
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water miscible, normally  acetone. Once polymer is solubilized, the solution is 
added to a water phase leading to the formation of the nanoparticles. The 
deposition of the polymer at the interface between the two solvents, 
determined by  a fast diffusion of the water phase,144 suggests that the 
formation of nanoparticles is based on interfacial phenomena.145 
 Interfacial deposition 
The mechanism is based on interfacial polymerization of a monomer at the 
interface between two immiscible phases. If the internal phase is a liquid the 
monomer can be  dissolved or dispersed in this phase and then the matrix can 
be emulsified  in the external phase until to reach the required size of droplets. 
It is also possible to add a crosslinking agent to the external phase.146 
 Emulsification/solvent diffusion 
This is a modified version of the emulsion/solvent evaporation, presented 
above. At first, a partially water soluble solvent is used to  dissolve the polymer, 
and then the mixture is saturated with water to ensure a thermodynamic 
equilibrium between the phases. Then the induction of precipitation of 
polymers for the formation  of nanoparticles is due to the dilution of the 
system with an excess of aqueous solution; at this point, the polymer phase 
added of water is emulsified with a stabilizer, leading to the diffusion of the 
solvent in the external water phase. At the end of the process solvent is 
removed by evaporation or filtration.144 
This method originally developed to formulate PLA nanoparticles,147 was 
adapted to the formation of chitosan nanoparticles. The modified process,  
involves the addition of an organic phase made by methylene chloride and 
acetone to an aqueous solution of chitosan in presence of lecithin as 
emulsifying agent. After formation of O/W emulsion, methylene chloride is 
removed and acetone spreads in the aqueous phase causing the precipitation 
of chitosan.148 Solvent diffusion enables also the formation of chitosan genipin 
crosslinked systems to deliver protein.114 
 Salting out  
This is another useful technique used to produce nanoparticles. The technique 
is a modified form of emulsification solvent diffusion method, and involves the 
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formation of an oil in water emulsion. The lipophilic polymer is dissolved in an 
organic phase usually acetone, and an active compound is added in a water 
miscible solvent. Water solution instead is a gel containing a stabilizer as PVP 
and a salting out agent (usually electrolytes or sucrose). The presence of an 
appropriate salting out agent is fundamental in the evaluation of encapsulation 
efficiency of a bioactive compound. The diffusion of the solvent in aqueous 
phase is inhibited by the presence of the salting out agent. Once emulsion is 
diluted with water to reduce the concentration of salting out agent, organic 
solvent starts to spread inducing the formation of nanospheres in the aqueous 
phase.149 
 Dialyses  
Dialyses is also a tool to produce nanoparticles. The method is similar to 
nanoprecipitation and involves solvent displacement mechanism, but unlike 
conventional nanoprecipitation, here, a dialysis tube with a determined cut off 
represents a physical barrier for polymer. The methodology  involves the use of 
a   miscible couple of solvent and non-solvent for the polymer. The polymer is 
dissolved in the solvent and dialyzed against the non-solvent leading to a 
reduction in polymer solubility and formation of nanoparticles.150 
 Emulsification and crosslinking  
The first application of emulsion in formation of nanoparticles of chitosan 
regards a preparation of chitosan nanoparticles in W/O emulsion (using toluene 
as continuous phase and Span 80 as emulsifier). Once system was emulsified, 
the glutaraldehyde acting as crosslinker agent was added.151 Different authors 
have then modified the continuous phase replacing toluene with liquid paraffin 
and petroleum ether.152 However, the use of glutaraldehyde as written above 
presents some drawbacks being responsible of toxicity and possible 
degradation of entrapped drug. The introduction of EDC as crosslinker was also 
explored, and in particular enables the formation of polymeric nanoparticles of 
controlled sizes by the control of  size of droplets. 
 Emulsification droplet coalescence 
This is an alternative methodology that includes the emulsion droplet 
coalescence as a mean to induce formation of chitosan nanoparticles. The 
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procedure uses paraffin and Span 83 as reagents to obtain W/O emulsion. The 
emulsion is then mixed with another emulsion of NaOH that causes the 
solidification of chitosan nanoparticles.153 The formation of nanoparticles is 
based on  random collision of the droplets when the emulsions are mixed and 
consequent coalescence.  
 
 All these different techniques open the door to little variations of the procedures to 
covalently attach chitosan to alginate polymer. In fact the above examples show that 
both alginate and chitosan are able to react in presence of EDC forming  covalent  
compounds, but there are very few studies on their ability to bind together. One of the 
most challenge is represented by the pH considering that solubilization of alginate 
suffers an acidic environment and EDC need slightly acidic condition to work. Recent 
advances in micro and nanoparticles formation from biodegradable polymers 
implemented the investigation of W/O emulsions method. In a typical procedure a 
certain amount of polysaccharide (as chitosan, alginate, starch) dissolved in water or 
other aqueous solvent is slowly dropped in a solution containing organic solvent. Once 
the emulsion was formed, another emulsion is formulated in the same way in presence 
of the counterpart component. Interactions based on random collision between 
droplets favor the reaction between the macromolecules.  
 
 
 
 
 
 
 
 
 
 
 
 
 
45 
 
1.5 Aim of this study 
 
This Thesis was developed at the Laboratory of Physical and  Macromolecular 
Chemistry  in the Department of Life Science in collaboration with the Department of 
Chemical and Pharmaceutical  Science.  
The growing interest in nutraceutics due to the  demonstrated beneficial effects of 
phytochemicals on human body is a driving force in the research field of new delivery 
systems. Actually the low solubility in water, the poor absorption in the gastro-
intestinal tract,  the low stability and the easy oxidation are  limiting factors  in the use 
of nutraceuticals. The possibility of an efficient entrapment, delivery and bioavailability 
of nutraceuticals represents a current relevant challenge for researchers. In this 
scenario biodegradable polymers as alginate and chitosan thanks to their 
characteristics of non toxicity, biocompatibility, mucoadhesion are very attracting for 
the formulation of new carriers for oral administration of nutraceuticals. 
The aim of my PhD project is the formulation and characterization of new delivery 
systems based on covalent interaction between alginate and chitosan. The possibility 
to form  a covalent linkage between the carboxyl units of alginate and the amine 
groups of chitosan using EDC/NHS as zero-length crosslinking agents will be 
investigated in order to obtain nanoparticles with improved stability and resistance. 
Moreover the covalent crosslinking should confer rigidity to the polymeric  network 
limiting the leakage  of  the entrapped nutraceuticals. In the Thesis different 
methodologies of nanoparticle preparation will be explored including reaction in 
water, reaction in food grade macroemulsion and reaction in nanoemulsion. In 
particular nanoemulsions are a promising technology because they allow to perform 
the reaction within the nano sized water droplets thus limiting the  interaction 
between polymers and giving the best result in terms of reduced sizes and stability of 
the nanoparticles. The systems will be fully characterized in size, stability, 
morphological shape, encapsulating properties and eventual toxicity. Inclusion of 
resveratrol and quercetin  will be critically discussed and the antioxidant activity after 
the entrapment will be evaluated.  
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2.1 Materials 
 
2.1.1 Polymers : 
 Alginate Ultrapure (NovaMatrix). Apparent viscosity : medium viscosity > 200 
mPa*sGuluronic content > 60%. 
 
 Chitosan Ultrapure (NovaMatrix). Apparent viscosity : low viscosity  20-200 
mPa*s Deacetylation 75-90 %. 
 
 
2.1.2 Components of food grade emulsions : 
 
 Sunflower oil. 
 Lecithin (Lecinova). 
 L- Phosphatidylcholine (PC): Sigma-Aldrich Co.(St Louis, Mo). 
 
 
2.1.3 Components of not food grade emulsions : 
  
 Cyclohexane: Sigma-Aldrich Co.(St Louis, Mo). 
 Hexanol: Sigma-Aldrich Co.(St Louis, Mo). 
 Triton X-100: Sigma-Aldrich Co.(St Louis, Mo). 
 Tween 80: Galeno, (Carmignano, PO, Italy). 
 Span 80:  Galeno, (Carmignano, PO, Italy). 
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2.1.4 Normal reagents: 
 
 (EDC) N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride: Sigma-
Aldrich Co.(St Louis, Mo). 
 NHS (N-Hydroxysuccinimide): Sigma-Aldrich Co.(St Louis, Mo). 
 Hydrochloric Acid (HCl) : Sigma-Aldrich Co.(St Louis, Mo). 
 Sodium Chloride ( NaCl), : Sigma-Aldrich Co.(St Louis, Mo). 
 Acetone: Sigma-Aldrich Co.(St Louis, Mo). 
 Methanol : Sigma-Aldrich Co.(St Louis, Mo). 
 
2.1.5 Other reagents: 
 
 DPPH (2,2-diphenyl-1-picrylhydrazyl radical): Sigma-Aldrich Co.(St Louis, Mo). 
 Amberlite AD2: Sigma-Aldrich Co.(St Louis, Mo). 
 MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide): Sigma-
Aldrich Co.(St Louis, Mo). 
 
 
 
2.1.6 Nutraceuticals : 
 Trans-Resveratrol, 3,4′,5-Trihydroxy-trans-stilbene: Acef (Fiorenzuola d'Arda 
PC), Italy 
 Quercetin, 3,3′,4′,5,6-Pentahydroxyflavone: Sigma-Aldrich Co.(St Louis, Mo). 
 Ascorbic acid:  Farmalabor  ( Canosa di Puglia, BT), Italy 
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2.2 Polymer characterization 
2.2.1 Alginate 
2.2.1.1 Viscometry 
 
Reduced capillary viscosity was measured using a Schott-Geräte AVS/G automatic 
apparatus mounting an Ubbelohde type viscometer. Measurement (see figure 2.1) was 
performed at 25°C on alginate salt solutions (0.1 M NaCl). The intrinsic viscosity [] 
value was determined by extrapolating the reduced specific viscosity (sp/c) values to 
zero concentration using the Huggins equation:  
 
                                                                                                            (5) 
 Where k' is  the Huggins constant. 
 
 
 
Fig.2.1 Extrapolation of [] in alginate NaCl 0.1 M solution. 
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Intrinsic viscosity [η] for a given polymer of molar mass M under fixed solvent 
conditions (i.e.: solvent type and temperature) follows a simple power law of MHS 
equation (3) where k and a are given parameters for a specific solute-solvent system. 
The <Mw>  of alginate calculated from viscosity measurements is 1,96x105 g/mol. The 
molar mass was estimated using the MHS parameters reported elsewhere.154 
 
2.2.1.2 Determination of Guluronic/Mannuronic ratio 
 
1H-NMR measurement was carried out at 80°C on a Varian spectrometer (11.74 T) 
operating at 500 MHz for 1H equipped with a model L650 Highland Technology pulsed 
field gradient (PFA) amplifier (10 A) and a standard 5 mm indirect detection PFG probe. 
Spectrum was recorded in D2O. The polymer was exchanged three times in the proper 
deuterated solvent before running the measurement. 
 
 
 
Fig.2.2 
1
H-NMR spectrum of alginate recorded at 80° C in D2O 
 
Signals recorded for alginate in the anomeric region (see figure 2.2) are located  at 5.43 
and at 5.06 ppm. The protons are assigned to the total guluronic (G) and mannuronic 
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(M) residues respectively. From the integrated area, a ratio  G/M content of 70/30 is 
obtained.155 
 
2.2.2 Chitosan 
2.2.2.1 Viscometry 
 
Reduced capillary viscosity was measured  using a Schott-Geräte AVS/G automatic 
apparatus mounting an Ubbelohde type (Schott)  viscometer. Temperature was 
maintained at 25 ± 0.1 OC using a thermostated water bath. Measurements were 
performed on chitosan solutions in 0.1 M NaCl at pH 4 (see figure 2.3). The intrinsic 
viscosity [] value was determined by extrapolating the reduced specific viscosity 
(sp/c) values to zero concentration by the use of the Huggins equation (5). 
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Fig 2.3 Extrapolation of [] in chitosan NaCl 0.1M solution. 
 
The <Mw> of chitosan calculated from viscosity measurements according to  MHS 
equation (3)156,157 is 2,61x105 g/mol in fair agreement with the value declared by the 
producer (2,6x105).   
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2.2.2.2 Determination of acetylation degree 
 
1H-NMR measurements were carried out at 80°C on a Varian spectrometer (11.74 T) 
operating at 500 MHz for 1H equipped with a model L650 Highland Technology pulsed 
field gradient (PFA) amplifier (10 A) and a standard 5 mm indirect detection PFG probe. 
Spectra were recorded in D2O/CD3COOD at pD =4. The polymer was exchanged three 
times in the proper deuterated solvent before running the measurements. 
 
 
 
Fig.2.4  
1
H-NMR spectrum of chitosan recorded at 80° C in D2O/CD3COOD (pD 4) 
 
 
1H-NMR spectrum of chitosan (see figure 2.4) shows signals located at 5.33 and 5.04 
ppm which are assigned to the anomeric proton resonances of the glucosamine 
residue (Glc-NH2) and to the undeacetylated residue (GlcNAc), respectively.
158 
Acetylation degree estimated from the ratio between the areas of the assigned peaks 
is 20%, in agreement with the technical data sheet. 
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2.3 Nanoparticles formation 
 
2.3.1 Alginate-chitosan nanoparticles: preparation in water  
 
The first approach for the synthesis of nanoparticles made of alginate and chitosan 
covalently crosslinked consists in the use of water as solvent for the reaction between 
the two polymers. In the formulation, the final total concentration of polymers was 
fixed at 0,2 % weight/volume (w/v). At first 2,5 ml of aqueous solution of chitosan 0,2 
% w/v was prepared and the pH was adjusted at 4,5 with 0,1 M HCl. In another becker, 
2,5 ml of water solution of alginate at a concentration of 0,2 % w/v  were  prepared. To 
this solution 18 l of a EDC solution in water at a concentration of  3,5*10-3 mol/ml 
and 5 l of a NHS solution in water at the concentration of 2,03 10-3 mol/ml were 
added. The final number of moles of EDC (6,3 10-5 mol) was calculated to be in little 
excess respect to the moles of chitosan repetitive units (2,3 10-5 mol), and final moles 
of NHS are calculated to be approximately 1/5 of final EDC moles (1,05 10-5). The 
alginate aqueous solution was then dropped slowly in the chitosan solution under 
stirring and cooling at 0 °C with a ice-bath. The reaction was stirred at 0 °C for 48 h. 
Finally the solution was filtered using Nitrocellulose filters with  decreasing  pore 
diameters (Millipore)  (0,8 m 0,4 m and 0,2 m) to remove insoluble material. 
 
 
2.3.2 Alginate-chitosan nanoparticles: preparation in food grade W/O 
macroemulsion 
 
The  aim of this study is to explore the possibility to obtain alginate-chitosan  
nanoparticles in macroemulsion. Macroemulsion-based systems can be fabricated 
using relatively simple processing operations and commercially available ingredients. 
They are currently used as delivery systems in many commercial applications. In our 
case the W/O emulsion was selected as a suitable system able to limit the reaction 
between alginate and chitosan at the internal aqueous droplets of the emulsion thus 
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enabling the formation of smaller nanoparticles and  reducing the aggregation of the 
formed particles. Being the nanoparticles conceived for application in food field, the 
emulsion was prepared  using food grade components. Water and polymers have been 
used as hydrophilic phase, sunflower oil as lipophilic phase and commercial lecithin or 
phosphatidylcholine (PC) as emulsifiers for W/O emulsions.  
 
 
2.3.2.1 Alginate-chitosan nanoparticles: preparation using lecithin as 
emulsifying agent for W/O macroemulsion 
 
At first, 2,5 ml of sunflower oil was poured in a becker and  heated at 70 oC, 0,8 g of 
lecithin were then added slowly  to reach a final concentration of 2% on the total 
volume of emulsion. Mixing was maintained at 70 oC until the complete dissolution of 
lecithin. In the meantime a water solution (0,75 ml) of chitosan at a concentration of 
0.2 % (w/v) was prepared and pH was adjusted to 4.5 with HCl. After cooling, the water 
solution of chitosan was introduced under stirring in the oil phase at room 
temperature. An aqueous solution of alginate (0,2% w/v, 0,75 ml) containing 100 L of 
crosslinker zero length EDC (3,5 10-3 mol/ml) and 20 L of NHS (2,03 10-3 mol/ml). was 
added and the total aqueous phase volume was adjusted with water to  a final volume 
fraction of 37,5% on the total emulsion volume. The final concentration of EDC is in 
great excess (10 times greater) respect  to the moles of chitosan present in the 
mixture. The shear rate was increased  and maintained for 24 h until a stable milky 
emulsion has formed. The emulsion was then diluted by adding a 5 time volume of 
water respect to the total emulsion volume. The addition of internal phase in excess 
causes a phase inversion and facilitates the following steps of filtration according to 
the demulsification process of surfactant-stabilized emulsions. 
Porous membrane (Nitrocellulose and Durapor Millipore) filters with decreasing  sizes 
of pores from 0,8 nm to 0,22 nm,  have been used to separate the emulsion, filtering 
one time for type and pore size of the filters. Sample was finally dialyzed with 
membranes with a small cut off (3 kDa) against  a solution of water. Totally 5 washing 
cycles of dialyses were made. 
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2.3.2.2 Alginate-chitosan nanoparticles: preparation using 
phosphatidylcholine (PC) as emulsifying agent for W/O macroemulsion 
 
The reaction in emulsion using food lecithin as a emulsifying agent revealed  some 
problems of analysis of the polymeric products. Being known that lecithin is a mixture 
of different components and analyzing its FT-IT spectrum we identified in PC the major 
component of our lecithin. So we decided to use pure PC as emulsifying agent instead 
of lecithin to avoid the presence of impurities in the final system. In particular being 
known from the lecithin technical data sheet the presence of 3g/100g of organic P we 
calculated that we need a percentage of 1,4% (w/v) of PC in the final emulsion volume 
to have the same emulsifying effect of lecithin considering a total volume of 4 ml of 
emulsion and a proportion of 6,25:3,75 oil:water. 
The emulsion was prepared using 2,5 ml of sunflower oil as continuous oil phase. The 
oil was heated at 70 oC and 0,056 g of PC was added to reach the the proportion 
calculated above. After cooling of the oil phase and emulsifying agent, the internal 
water phase (1,25 ml) made of chitosan at 0,2% w/v was dropped in the continuous 
phase, under rapid stirring. Then a water solution of alginate (1,25 ml) with a final 
concentration of 0,2% w/v containing 100 l  EDC 3,5 10-3 mol/ml and 20 l 2,03 10-3 
mol/ml was dropped in the emulsion. The emulsion was left to react for 24 h cooled in 
ice and under stirring. In this condition the emulsion seems to be instable as droplets 
of water were formed in the bottom of the becker. Nevertheless the preparation 
followed the same protocol described in the case of lecithin. The emulsion was diluted 
5 times with water and then filtered using durapor and nitrocellulose type filters with 
decreasing pore sizes. 
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2.3.3 Alginate-chitosan nanoparticles: preparation using not 
food grade W/O nanoemulsion 
 
The dimensions of the water droplet in the emulsion can have a pronounced influence 
on the functional properties and stability of the emulsion  and on the final sizes and 
stability of the nanoparticles.  Nanoemulsions can be produced with droplets of 
dimensions such as  small that they  do not scatter light appearing fully transparent. 
The advantage in using not food grade components in the preparation of the 
nanoemulsion is that they are pure and therefore they ensure an elevate control on 
the final composition of the emulsion. The drawback is  the necessity to remove 
completely the toxic solvents from the nanoparticles. 
 
2.3.3.1 Alginate-chitosan nanoparticles: preparation using Triton X-100 
as emulsifying agent for W/O nanoemulsion 
 
The protocol for the formation of the nanoemulsion consists of two steps: the first is 
the preparation of two separated emulsions, one containing chitosan and the other 
containing alginate and EDC/NHS. The second step involves the mixing of the two 
emulsions in a single emulsified phase. 
At first, 6,4 ml of cyclohexane were poured in a becker and 3,2 ml of hexanol were 
added slowly  under stirring. Then 2,4 ml of water and chitosan at a concentration of 
0,2% (w/v) were added dropwise to the oil phase and the stirring rate increased. 
Cyclohexane/hexanol/water  were  used in fixed ratios of 11:6:4 respectively in all the 
two emulsions prepared. 
The final step includes the addition of Triton X-100 drop by drop until to reach a 
transparent emulsion (2-2,5 ml for the volume considered here). The turning of the 
emulsion from milky to transparent is clearly visible. At this point the first emulsion is 
ready. 
For the preparation of the emulsion containing alginate the procedure is similar. A 
volume of 6,4 ml of cyclohexane was poured in a becker, 3,2 ml of hexanol were added 
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under stirring and 2,4 ml of water containing 0,2 % (w/v) alginate and 26 l of EDC at 
the concentration of 3,5 10-3 mol/ml and 10 l of NHS at the concentration of 2,03 10-3  
were  dropped slowly. After that,  Triton X-100 was dropped in the emulsion until the 
transparence was reached. 
The emulsions containing alginate and chitosan were finally mixed in a single emulsion 
phase and left at ambient temperature for 48 h under stirring, thus allowing enough 
time  for the mixing of the water droplets and for the coupling reaction to occur. 
After this time, a volume of acetone equal to that of the reaction mixture was added to 
precipitate the polymers. The sample was centrifuged at 3000 rpm for 10 minutes and 
the pellet recovered, suspended in water and precipitated with 5 ml of acetone for 4 
times. After the last precipitation step with acetone, the pellet was air-dried under a 
N2  flow. The dried pellet was resuspended in 15 ml of water and sonicated for 15 
minutes. The aqueous polymer suspension was then poured in a becker containing 
Amberlite XA2, preventively washed with methanol and water as reported in the 
technical data sheet. The resin has the capacity to remove traces of organic 
compounds and surfactants from the aqueous environment. In particular a dried 
weight of 1g of Amberlite AD2 is able to retain 0,37 g of Triton X-100. After 4 hours of  
slow stirring the resin was filtered off and the amount of Triton X-100 in the sample 
was analyzed by UV-Vis measuring the absorbance at 224 nm and calculating the 
concentration of surfactant using a  calibration curve obtained by known 
concentrations of Triton X-100. The washing steps were repeated until full removal of 
the surfactant (usually 2-3 washing cycles). At the end of the washing steps, the 
sample is ready to be characterized. To obtain a more concentrated water solution of 
nanoparticles and to avoid the presence of nanoparticle aggregates the sample was 
freeze-dried and the alg-chito pellet was hydrated in a lower volume of water and 
centrifuged at intermediate speed (10000 rpm) for 10 minutes after the Amberlite 
treatment. Specifically using 10 ml of water to suspend the pellet we obtained a 
solution of 390 g/ml of polymers. 
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2.3.3.2 Alginate-chitosan nanoparticles: preparation without crosslinkers 
using Triton X-100 as emulsifying agent for W/O nanoemulsion  
 
The system in emulsion formulated with Triton X-100 as emulsifying agent, 
cyclohexane as continuous phase and hexanol as cosurfactant was prepared with the 
procedure described above but in absence of the crossilinker agents (EDC, NHS). At 
first 6,4 ml of cyclohexane were poured in a becker, then 3,2 ml of cosurfactant 
hexanol were added and 2,4 ml of water containing chitosan at the concentration of 
0,2% (w/v) were  added to the organic solution under vigorous stirring. The ratio 
between water/oil/cosurfactant was maintained at a constant value of 4/11/6. A 
solution of Triton X-100 was finally dropped until to reach a transparent emulsion 
(usually 2-2,5 ml are needed). Another emulsion was prepared with the same modality 
and ratio between components, but using a water solution of alginate 0,2 % (w/v) 
instead of chitosan.  The alginate emulsion was then dropped into the chitosan 
emulsion. The final emulsion was kept under stirring for 48 h  at room temperature. 
The polymers matrix was then precipitated using a volume of acetone equal to that of 
the emulsion prepared. After a centrifugation of 10 minute at 3000 rpm the pellet was 
recovered, resuspended in water and reprecipited four times with 5 ml of acetone. At 
the end the pellet was dried using a nitrogen flow,  15 ml of water were added and the 
suspension was sonicated for 15 minute. After sonication the suspension was washed 
using Amberlite AD2 preventively washed with methanol and water.  The number of 
washing steps depends on the amounts of Triton X-100 present in suspension. Finally, 
to eliminate aggregates of nanoparticles the hydrated sample was centrifuged at an 
intermediate speed (10000 rpm) for 10 minutes. 
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2.3.3.3 Alginate-chitosan nanoparticles: preparation using Tween80-
Span80 as emulsifying agents for W/O nanoemulsion 
 
 
Crosslinked alginate chitosan nanoparticles were prepared also in a different  W/O 
nanoemulsion. The continuous phase is cyclohexane also in this case, but we used a 
mix of emulsifying agents that better stabilize the emulsion respect to a single one. In 
particular a mixture of Tween 80 and Span 80 in ratio 6,5:3,5 was used as emulsifying 
agents for the formulation of the nanoemulsion. The following procedure was 
optimized. At first Tween 80 and Span 80 were mixed in proportion of 6,5:3,5  under 
agitation. A volume of 8 ml of cyclohexane was poured in a becker and then 1 ml of the 
mixture of emulsifying agents was added drop by drop to the cyclohexane under 
stirring. In this case to have a stable emulsion we have reduced the total aqueous 
volume phase at 640 l thus to have a final ratio of cyclohexane/water of 8:0.64. 
Consequently, we have increased the final concentration of polymer in the water 
phase to 0,5 % w/v. 320 l of water were dropped very slowly in the 
cyclohexane/surfactant mixture followed by 320 l of water solution of alginate (1%, 
w/v) containing 26 l of EDC 3,5 10-3 mol/ml and 10 l of NHS 2,03 10-3 . A similar 
emulsion was prepared using chitosan (8 ml of cyclohexane, 1 ml of the mix Tween 
80:Span 80 ratio 6,5:3,5, 320 l of water and 320 l of chitosan 1% (w/v) in aqueous 
solution). Then the emulsion containing alginate was dropped into the emulsion 
formulated with chitosan under stirring. The final nanoemulsion  prepared was left 
under stirring for 48 h at room temperature. After this time, an identical volume 
(respect to the total volume of emulsion) of acetone was added to precipitate the 
polymers. The suspension was centrifuged at 3000 rpm for 10 minutes and the pellet 
was recovered. Then the precipitated polymers were resuspended in water and the 
precipitation-centrifugation cycle was repeated for further four times. After the last 
acetone washing the pellet was dried under a N2 flow. Water was finally added to 
resuspend the pellet and the solution was sonicated for 15 minutes. The sample was 
then washed several times with Amberlite AD2 resin to ensure the complete removal 
of  residues of cyclohexane, acetone and surfactants as described above. The progress 
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of surfactants removal was monitored at the UV-Vis. Spectra were registered in the 
range of 200-500 and the decreasing in absorbance at 230  nm was followed after each 
washing cycle. Finally, to eliminate aggregates of nanoparticles the hydrated sample 
was centrifuged at an intermediate speed (10000 rpm) for 10 minutes. 
 
 
2.3.3.4 Alginate-chitosan nanoparticles: preparation without crosslinkers 
using Tween80-Span80 as emulsifying agents for W/O nanoemulsion 
 
To compare results obtained from emulsion in which the crosslinkers EDC and NHS are 
present, a similar emulsion in absence of crosslinkers  was formulated. The procedure 
adopted for the formulation of the emulsion includes the same steps described above, 
but alginate is not preventively activated with EDC and NHS. Briefly,  1 ml of Tween80-
Span80 mixed in proportion 6,5:3,5 is added to a solution of 8 ml of cyclohexane, then 
320 l of water were added under stirring to the organic solution followed by  320 l 
of alginate 1% (w/v). A second emulsion of chitosan was prepared  following the same 
procedure. At the end the alginate emulsion was dropped in the chitosan emulsion, 
and the resulting final emulsion was kept under vigorous stirring for 48 h. Then, 
acetone in ratio 1:1 respect the final volume of emulsion was added to precipitate the 
polymer matrix. The mixture was centrifuged at 3000 rpm for 10 min. The pellet was 
suspended in water and the precipitation-centrifugation cycle was repeated for further 
four times. After the last acetone washing the pellet was dried under a N2 flow. Water 
was finally added to resuspend the pellet and the solution was sonicated for 15 
minutes. To remove organic contaminants the suspension was washed using Amberlite 
AD2 resin for many times checking the elimination of tween80-span80 at the UV-Vis at 
the wavelength of 230 nm, as described above.  
Finally, to eliminate aggregates of nanoparticles the hydrated sample was centrifuged 
at intermediate speed (10000 rpm) for 10 minutes. 
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2.4 Nanoparticles characterization 
 
2.4.1 Determination of particle size 
 
The sizes of the nanoparticles were evaluated using the Nanoparticle Tracking Analysis 
(NTA) HaloTM LM10 of NanoSight Ltd Lysaner Way, UK, recently acquired by Malvern 
instruments. The instrument has a laser device that contains a solid state single-mode 
laser diode (635 nm). The technique provides that small particles in a liquid sample 
which pass through the beam pat are directly visualized from the operator as small 
points of light moving under Brownian motion. 
 
Fig.2.5 Image of the NTA LM10 instrument. 
 
 
 
Diffused light scattered by the particles could be processed according to the Mie 
theory analyzing the light scattering intensities for the determination of particles sizes. 
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A similar theorization involves considerable information about optical properties of 
sample, solvent and so on.  A valid option is to analyze trajectories of nanoparticles 
moving under Brownian motion for  an appropriate period of time exploiting the 
capacity of NTA to visualize the sample in real time. In fact the NTA software has the 
capacity to recognize and track individual nanoparticles and to relate the Brownian 
movements with the particle size according to the Stokes-Einstein equation: 
 
   
   
            
                                                                                                                                         (6)    
 
 
Where KB is Boltzmann’s constant, T is temperature,  is solvent viscosity, Dt is the 
diffusion coefficient, rh the hydrodynamic radius. 
The results obtained from NTA have been also compared to data obtained from DLS, a 
widespread technique used for determination of nanoparticle sizes. The instrument 
used was a Malvern Zetasizer  nano ZS (Malvern Instruments, Worcestershire U.K).  
DLS analysis is based on dynamic laser light scattering. A monochromatic light 
generated by a laser hit the sample causing the scattering of light in all directions. The 
scattered light is collected and the resulting optical signals shows random changes due 
to the random movements of nanoparticles in and out of the laser beam, thus the  
scattered light fluctuates, and the frequency of this fluctuation is correlated to the size 
of the nanoparticles. Signals are then interpreted in term of autocorrelation function 
(data are processed with a correlator that  enables to obtain the autocorrelation 
function as a function of delay time). Although DLS is a very useful and accessible 
device, it presents several drawbacks strictly correlated to the  methodology used. 
Indeed, deriving the determination of particle sizes from fluctuation  in scattered light 
and being the scattered light proportional to the sixth power of the particle diameter, 
the presence of large particles strongly influences the measurement. This event can 
affect the accuracy of size determination.159 Nanoparticles analyzed from NTA are 
tracked and visualized separately for the generation of the particle size distribution. 
This represents an important advantage respect to the distribution profile analyzed 
from DLS. In fact, DLS analyzes particles simultaneously and this can generate an error 
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in the measurement if a small number of  highly scattering large nanoparticles is 
present.  
 
 
2.4.5 Determination of particle stability  
 
Nanoparticles solutions in water have been stored at ambient temperature and the 
NTA measurement of stability were conducted every week for a total of 14 day to 
check any variations in size due to destabilization or aggregation processes as a 
consequence of aging. Stability of nanoparticles solutions was also verified subjecting 
the sample to centrifugation at a low  speed of rotation (3000 rpm) and at a  
intermediate speed of rotation (10000 rpm) for 10 minutes. Centrifugal force 
accelerates sedimentation of aggregates. All the samples were then analyzed using 
NTA.   
 
 
2.4.2 Spectroscopic analysis (FT-IR) 
 
 
FT-IR spectra were recorded using a Thermo Scientific IS50 Nicolet FT-IR 550 Avatar 
320 on the range of 4000-600 cm-1. The samples were prepared mixing the lyophilized 
powder with finely powdered potassium bromide (KBr). The pellet is then pressed and 
air dried, finally it is located in the holding for the analysis. Spectra of raw materials 
and powder of samples have been acquired.  
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2.4.3 Determination of particle morphology: transmission electron 
microscopy (TEM) and scanning electron microscopy (SEM) 
 
Alginate chitosan nanoparticles were examined by transmission electron microscopy 
(TEM). All the measurements were carried out using an EM 208-Philips TEM 
(Eindhoven, Netherland) equipped with a Quemesa camera (Olympus Soft Imaging 
Solution, Munster, Germany). The analysis were performed at Electronic Microscopy 
Center (Department of Life Science of University of Trieste).  The samples for the 
analysis were prepared following a negative staining: 10 l of sample were deposited 
on a carbon coated copper grid, then 10 l of uranyl acetate (1% in water) were added  
as contrasting agent. After 10 minutes, the  time needed for deposition of the uranyl 
acetate, the excess uranyl acetate was absorbed with filter paper and the sample was 
kept 20 minutes to dry completely. 
Further information about nanoparticles morphology has been acquired from SEM 
after an air drying process of the sample. The dry powder was examined by scanning 
electron microscopy  (SEM) Leica Stereocan 430i (Leica Cambridge Ltd, Cambridge, 
UK). The sample is mounted on a stub of metal coated with gold and observed with the 
microscope. The analysis were performed at Electronic Microscopy Center 
(Department of Life Science of University of Trieste). The sample was metalized using 
S150A Sputter Coater metallizer. 
 
 
 
2.4.4 Spectroscopic analysis (UV-Vis) 
 
UV-Vis spectra were acquired with a  Perkin Elmer Lambda 35 UV-Vis. Spectroscopic 
analysis was carried out in solutions inserted in quartz cuvettes with  1 cm of optical 
path.  
 
 
 
65 
 
2.4.5 In vitro toxicity test: MTT assay 
 
The viability of Caco-2 cells (human epithelial colorectal adenoma carcinoma  cells, 
employed as model of intestinal epithelium) in the presence of alginate chitosan 
nanoparticles was evaluated using a standard test. Specifically, MTT assay was used as 
test for the measurement of cell viability and proliferation. The technique is based on 
the evaluation of mitochondrial reductase enzyme activity after incubation of 
nanoparticles with  cells. Tetrazolium salt (MTT) a water soluble yellowish probe, in 
fact is reduced to insoluble MTT –formazan (see figure 2.6) of dark purple color, during 
normal metabolic activity . 
 
 
Fig.2.6  Reduction of MTT to MTT formazan by the mitochondrial reductase. 
 
 
The resulting MTT formazan can be dissolved and quantified spectrophotometrically at 
the  wavelength of 540 nm. In case of apoptosis or necrosis or in general in case of 
mortality processes due to a toxic action of external compounds (alginate-chitosan 
npts resulting from Triton X-100 nanoemulsion and alginate-chitosan npts deriving 
from Tween80-Span80 nanoemulsion in this case) the mitochondrial activity is 
reduced. This  leads to a reduction of MTT- formazan formation and consequently a 
reduction of UV-Vis  absorbance. 
Cells were plated in a sterile 96-well tissue culture plate (20000 cells/well), in 100 l of 
complete Eagle’s MEM (Minimum Essential Medium). Water suspension of 
nanoparticles were filtered using 0,2m sterile filters to ensure the  sterility of the 
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sample before the contact with cells. The wells with 10 l of diverse concentrations of 
nanoparticles were incubated  in triplicate for 24 h. In particular the concentrations 
tested were 0,75 g/ml, 3,75 g/ml, 7,5 g/ml for nanoparticles formulated using 
Triton X-100 as emulsifying agent and 2 g/ml, 10 g /ml, 20 g/ml for alginate-
chitosan nanoparticles obtained from emulsion with Tween80-Span80. In parallel in 
the same plate a positive reference of 10 l of water was incubated with cells too. 
After 24 h, MTT was dissolved in water  at a concentration of 5 mg/ml and  10 l were 
incubated for 4 hours with cells (added of nanoparticles). After 4 h when a purple 
precipitate is visible, medium is removed and 50 ml of DMSO were added in every well. 
The 96 well plate is inserted in a microplates readers and absorbance at 540 nm read 
and recorded. 
 
 
2.4.6 Loading of nutraceuticals in the nanoparticles 
 
2.4.6.1 Loading of resveratrol 
 
The loading ability of the nanoparticles was determined on samples prepared by 
resuspension of the nanoparticles in water.  The established protocol is described 
below. At first a stock solution of resveratrol (10 mg/ml in ethanol) was prepared. Then 
the solubility limit of resveratrol in water was determined. At this purpose, 50 l of 
stock solution  (excess resveratrol) were added to 1 ml of water. The sample was 
stored for 24 h at ambient temperature, time necessary for the precipitation of 
insoluble components. Then the sample was centrifuged at 3000 rpm for 10 minutes to 
complete the precipitation process. Supernatant was collected and resveratrol 
quantified spectrophotometrically, adding 40 l of the supernatant to 3 ml of water, 
and recording the UV-Vis spectrum in the interval of 200-500 nm. Absorbance at 307 
nm (maximum absorbance value of resveratrol) was read  and the concentration of 
resveratrol calculated using a calibration curve determined in ethanol. To verify the 
validity of the method, samples were  centrifuged at higher rotation speed (20000 rpm 
for 10 minutes). The output value was the same of that obtained at lower speed 
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rotation and, therefore, the lower speed rotation was selected to avoid precipitation 
of nanoparticles. In this condition the maximum solubility of resveratrol in water is 1,3 
g/ml. For the determination of the amount of loaded resveratrol in alginate-chitosan 
nanoparticles obtained from emulsion in presence of Triton X-100 as emulsifying 
agent, 50 l of resveratrol stock solution were added to different concentrations (52, 
36, 26, 16, 5 g/ml) of nanoparticles suspended in a final volume of 1 ml of water. 
The same procedure was used in the case of alginate-chitosan nanoparticles obtained 
from emulsion in presence of Tween80-Span80 as emulsifying agents but using the 
following concentrations of nanoparticles: 73, 51, 36, 22, 7 g/ml. 
The samples were left  to stabilize for  a night enabling the excess of resveratrol to 
precipitate on the bottom of the vial. Samples were then centrifuged at 3000 rpm or 
10000 rpm for 10 min as described above. 40 l of supernatant were taken and added 
to 3 ml of water. Finally the UV-Vis spectrum was recorded and the absorbance was 
read at 307 nm to calculate the amount of resveratrol present in the samples (values 
were subtracted of the  resveratrol absorbance  in water solution). 
 
 
 
2.4.6.2 Loading of quercetin 
 
The loading ability of the nanoparticles was determined on samples prepared by 
resuspension of the nanoparticles in water. The procedure adopted to encapsulate and 
measure the amount of encapsulated quercetin is slightly different. The established 
protocol is described below. At first a stock solution of quercetin (10 mg/ml in DMSO) 
was prepared. Then the solubility limit of quercetin in water was determined (5g/ml). 
At this purpose, 65 l of stock solution  (excess quercetin) were added to 1,3 ml of 
water. The sample was stored for 24 h at ambient temperature, time necessary for the 
precipitation of insoluble components. Then the sample was centrifuged at 3000 rpm 
for 10 minutes to complete the precipitation process. Supernatant was collected and 
quercetin quantified spectrophotometrically, without further dilution, recording the 
UV-Vis spectrum in the interval of 200-500 nm. Absorbance at 372 nm (maximum 
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absorbance value of quercetin) was read  and the concentration of quercetin 
calculated using a calibration curve determined in ethanol. The resulting absorbance 
was then compared with the  absorbance of the same sample centrifuged at higher 
rotational speed (20000 rpm for ten minutes) to exclude any possible interference of 
small crystals still present in solution. In this conditions the solubility of quercetin in 
water is 5 g/ml. After having verified the total accordance between the results 
obtained we proceeded with the analysis on the samples containing the nanoparticles. 
Five aqueous dilutions of nanoparticles in a final volume of 1,3 ml were added of 65 g 
of the quercetin stock solution. Specifically for alginate-chitosan nanoparticles deriving 
from  emulsion in which Triton X-100  was used as emulsifying agent the 
concentrations of nanoparticles used are 68, 52, 36, 21, 5 g/ml, instead for alginate-
chitosan nanoparticles deriving from  emulsion in which tween80-span80 were used as 
emulsifying agent the concentrations used are 95, 73, 51, 29, 7,3 g/ml. The samples 
were left  to stabilize for  a night enabling the excess of quercetin to precipitate on the 
bottom of the vial. Samples were then centrifuged at 3000 rpm or 10000 rpm for 10 
min as described above and the supernatant was analyzed. The UV-Vis spectrum was 
recorded in the interval 0f 200-500 nm and the absorbance was read at 372 nm to 
calculate the amount of resveratrol present in the samples and values were subtracted 
of the  resveratrol absorbance  in water solution. 
 
 
2.4.7 Radical scavenger activity: DPPH assay 
 
Then antioxidant activity of nanoparticles loaded with resveratrol was evaluated by the 
diphenylpicryl-hydrazyl (DPPH) assay. This methodology is commonly used for the 
estimation of the antioxidant properties of several substances. DPPH is in fact a stable 
free radical, thanks to the delocalization of the unpaired electron (see figure 2.7)  on  
the all structure. This peculiar electronic configuration confers to DPPH dissolved in 
ethanol a deep violet color with an absorption maximum at 522 nm. When DPPH is 
reduced it loses the violet coloration. 
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Fig.2.7 Left: structure of DPPH. Right: structure of reduced form of DPPH. 
 
The method is a useful way to determine if alg-chito resveratrol-loaded npts have the 
ability to reduce DPPH and thus a potential scavenging activity. If resveratrol acts as a 
scavenger, DPPH loses its color and the absorbance at 522 nm decreases. A stock 
solution (1 mg/ml) of DPPH in ethanol was prepared  and 24 l of the stock solution 
were added to different volumes of loaded resveratrol npts suspension (30 l, 40 l, 
50 l) diluted in a final volume of 1 ml of water:ethanol 1:1 thus realizing different 
concentration of resveratrol-npts. (1,6 2,1, 2,6 g/ml of npts). The  absorbance at the 
fixed wavelength of 522 nm was then  measured every 5 minutes for 25 minutes until 
the discoloration process was complete. 
 
 
2.4.8 Protection of quercetin from oxidation 
 
A procedure usually adopted to protect quercetin from oxidation is the use of the 
water soluble ascorbic acid. The protocol provides the addition of quercetin (as 
described in paragraph relative to quercetin loading) to the highest concentrated 
sample of nanoparticles. Two different concentrations (3 and 7,4 g/ml) of ascorbic 
acid were added to samples. Samples were then stored for 5 days checking the 
stability of the peak at 372 nm and compared to  samples prepared in absence of 
ascorbic acid. Experiments were conducted in triplicate. 
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Premise 
 
This chapter is constructed following  the evolution of the different protocols and 
experimental conditions which have been tested and optimized in order to obtain 
alginate-chitosan nanoparticles. Indeed, different procedures for the synthesis of 
stable nanoparticles, formed by covalently crosslinked alginate and chitosan have been 
examined, the most relevant of  which will be presented and described in the next 
pages. Therefore, the architecture of the chapter follows  the temporal succession of 
the modifications of the synthetic protocol aimed to reach the final goal.  
Every formulation attempted and the relative results obtained, represented an 
important  link to develop the subsequent system. So all the improvements and 
modifications  derive from a critical evaluation of the previous systems. The chapter 
starts describing the first attempts of reaction between alginate and chitosan in water 
in presence of the crosslinking agents; results relative to this method will be briefly 
summarized. The instability of the system obtained in this conditions has prompted 
the investigation of new procedures. So  the attention has moved  towards the 
formulation of alginate-chitosan nanoparticles in emulsion  exploiting two different 
food grade W/O macroemulsion as a microreactor to obtain nanoparticles. Results will 
be presented with  a short  description and discussion. 
Finally the chapter focuses on a further optimization of the process represented by the  
optimization of two different types of stable W/O nanoemulsions. These systems 
present the best characteristics if compared to the previous ones. A depth description 
of the results obtained and of the experimental conditions optimized regarding the last 
two systems will be presented and discussed. The   properties and characteristics of 
the obtained crosslinked alginate-chitosan nanoparticles will be examined and 
illustrated critically. This last part  is in fact the fulcrum of the Thesis, but for a full 
comprehension is important to present all the steps that led us to the final process 
optimization. 
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3.1 Alginate-chitosan nanoparticles: preparation in water  
 
 
The first attempt to couple alginate carboxyl units with chitosan amine functions  was 
performed in aqueous environment. As explained in the Introduction, in fact, the 
electrostatic interaction occurring between carboxylates alginate and amines of 
chitosan is responsible of the process of polyelectrolyte complexation named complex 
coacervation. The interaction is strongly influenced by the pH, molecular weight and 
concentration of the polymers. If the interaction is strong, the possible effect is the 
formation of a macrogel. Controlling the parameters mentioned above it is possible to 
obtain micro or nano structures, but the formed network is usually weak and loses its 
integrity rapidly.102 So we thought that the use of EDC/NHS as covalent crosslinker 
agents may reinforce the weak  ionic network resulting in stable nanoparticles. At first, 
an aqueous solution of chitosan (0,2%w/v) was prepared. The pH of the water solution 
was preventively acidified at a value of 4.5- 5 with HCl 0,1 M. Then a water solution of 
alginate (0,2% w/v) previously added of EDC and NHS  was added. EDC belongs to the 
family of carbodiimides which  are commonly used as condensing agent in peptide 
synthesis. Carbodiimide is a generic term referring to unsaturated molecules having 
the following structure RN=C=NR’.  
 
 
Fig.3.1 Schematic reaction of EDC and NHS in presence of carboxylic  acid and amine. 
 
The reaction scheme (see figure 3.1) involves the attack of the nucleophilic carboxylate 
ion (carried by alginate) to the electrophilic carbon atom of the carbodiimide. The 
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resulting activated O-acylisourea adduct is then attacked by the primary amine 
(chitosan in our case) forming an amide derivative. EDC is the most frequently used 
carbodiimide for amide bond formation. It is a water soluble molecule very reactive 
especially in a pH range of about 3,5-4,5. One of the main problem during the reaction 
is the possible formation of the N-Acylurea adduct. In our procedure the pH was fixed 
at 5 and in these conditions the hydrolysis of the O-acylisourea is fast, leading to a 
lower yield of coupling. The addition of N-Hydroxysulfosuccinimide (NHS) reduces the 
deactivation improving coupling efficiency and reducing the possibility of 
rearrangement to N-acylurea derivative. In our preparation, EDC and NHS are firstly 
incubated with alginate (the molecule bearing the carboxyl groups)  and then water 
solution containing the polymer and the crosslinking agents were finally added to 
chitosan. In the final mixture the amount in weight of the two polymers was the same. 
The reaction vessel was kept in ice under stirring for 48 h.  After that time, the mixture 
presented some macro-gel aggregates probably due to the strong interaction between 
alginate and chitosan. Macro-gel were removed by filtering the suspension using 
nitrocellulose filters with  a decreasing  pore diameters from 0,8 m to 0,4 m and 0,2 
m. 
 
 
3.1.1 Determination of particle size 
 
 The sizes of nanoparticles have been determined using Nanoparticles Tracking 
Analysis (NTA). The formulation suspended in water, obtained as described above, was 
loaded into the sample chamber using a syringe. The sample was fluxed slowly 
avoiding formation of bubbles. Once the sample was equilibrated in the chamber it is 
possible to proceed with the measurements of the nanoparticle size. The instrument is 
able to measure and calculate the mean diameter of a nanoparticle solution with a 
concentration between106- 109 nanoparticles per ml. The size distribution profile (see 
figure 3.2) of the system shows an average diameter of the nanoparticles of 200 nm 
(standard deviation (= ± 63 nm. The size distribution is, however broad and shows  
the tendency of the nanoparticles to form aggregates  with size in the range of 500 nm. 
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In addition we have to consider that the larger particles have been removed during the 
filtering procedure. 
 
 
 
 Fig.3.2 Size distribution of nanoparticles resulting from NTA analysis. 
 
3.1.2 Determination of particle morphology 
 
The shape and morphology of the material obtained from the reaction in water was 
investigated by TEM.  One drop of the filtered sample was deposited on a carbon 
coated copper grid, stained with uranyl acetate and, after evaporation of water, 
examined by TEM. The TEM image presented in figure 3.3 shows a not well defined 
aspect of the matrix and the presence of raw material. Probably the ionic interaction 
between alginate and chitosan is the predominant force of interaction in the system 
thus impeding the covalent reaction between polymers  and the formation of stable 
and well defined nanoparticles. Alternatively, a too high degree of covalent 
crosslinking between the polymers generates a rigid linear structure. In addition the 
high vacuum required by TEM favors the aggregation within the matrix. 
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Fig.3.3 TEM image of alginate-chitosan matrix deriving from reaction in water. 
 
The sample was also investigated performing a  SEM analysis on the filtered material. 
The image (see figure 3.4) confirms the data obtained by TEM showing the 
predominance of aggregated non-structured material. 
 
 
Fig.3.4 SEM image of alginate-chitosan matrix deriving from reaction in water. 
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Overall the results obtained from NTA and electronic microscopy show that the 
reaction between alginate and chitosan in water leads to the formation of aggregated 
polymeric materials and not of nanoparticles.   
 
3.2 Alginate-chitosan nanoparticles: preparation using lecithin as 
emulsifying agent for W/O macroemulsion 
 
To prevent the aggregation phenomena observed  in the samples obtained from the 
reaction in water, we decided to perform the reaction between alginate and chitosan 
in a different system. In particular we explored conditions in which the interaction 
between the polymers can be limited. Emulsions for instance represent an interesting 
strategy to confine a limited amount of reactants in a small and insulated 
environment. In our  case, the reaction  between the polymers occurs in an aqueous 
medium and, therefore, using W/O macroemulsion the reaction is confined in the 
water droplets of the emulsion which contain a limited amount of polymers although 
an equilibrium within droplets with exchange of material is present. Being the final use 
of the nanoparticles conceived for food application, the components of the emulsion 
were selected within food grade components. The first step is the selection of the 
emulsifying agent and of  the continuous phase. Generally vegetable oils can represent 
a good choice for formation of both W/O and O/W emulsion systems. Among this class 
numerous articles have explored the use of sunflower oil, olive oil, castor oil, soybean 
oil and peanuts oil as continuous or internal phase.160,161 In this work after a first 
attempt using castor oil, sunflower oil was selected as external phase of the emulsion. 
Regarding the emulsifying agent, relevant articles show the use of polyglycerol 
polyricinoleate (PGPR)162 or lecithin163 as active surface agents. Lecithin is usually 
applied in food industry as emulsifier and as agent to regulate viscosity and thus was  
selected as potential emulsifying agent. Lecithin is a combination of different 
phospholipids mixed to other components such as triglycerides and fatty acids and can 
be used to obtain both W/O and O/W emulsions depending on the ratio between 
external and internal phase. Although the HLB of commercial lecithin is not declared, it 
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is  known164 that this value depends on the composition of lecithin but usually has an 
intermediate value between that required for O/W and W/O. Different concentrations 
and ratios between oil and water and emulsifying agent have been tested, in according 
to the diagram phase, before to set the right conditions and ratio between internal and 
continuous phase. At the end a ratio of 6,25:3,75 oil: water and a 2% concentration of 
lecithin were set as the best condition. The procedure for the formation of emulsion is 
briefly described below. 
The chitosan aqueous phase was prepared by dispersing 0,2% (w/v)  polymer in water 
at pH 5-5,5 under stirring. The oil phase was prepared by mixing lecithin at the 
concentration of 2% (on the total volume of emulsion) with sunflower oil. Mixing was 
performed at 70 oC until a complete dissolution of lecithin. After cooling,  the water 
phase was introduced under shear in the oil phase at room temperature. Then, pH was 
adjusted to 5,5 with HCl. 
A solution of alginate (0,2% (w/v)) in water preventively activated with EDC and NHS 
was then added to the emulsion  to obtain a volume fraction of dispersed water phase 
of the 37,5 % respect to oil phase. In the final water phase the amount of the two 
polymers was the same expressed in weight. 
The shear rate was increased  and maintained for one day until a stable milky emulsion 
has formed. After this time which should allow the reaction between the two polymers 
and the formation of the nanoparticles,  the emulsion must be broken to recover the 
nanoparticles. Several techniques are described in literature to destabilize and break 
emulsion as micro-wave radiation165 or demulsification based on freeze and thaw 
method166, but these procedures seemed do not work on our system. 
After different attempts, the separation of phases was achieved  combining two 
different procedures: phase inversion of emulsion and filtration. In fact the phase 
inversion can represent a strategy to destabilize the emulsion. Filtration seems to 
produce the same effect, in particular it seems that hydrophobic membranes produce  
demulsification of oil in water emulsion due to the coalescence of oil droplets in the 
membrane pores.167 So we first inverted the emulsion  from W/O to O/W by diluting 
with a five times volume of water and then the emulsion was filtered using 
hydrophobic and hydrophilic membranes of decreasing sizes pores. In particular, the 
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filtration was performed using filters with pore size of 0.8 m, 0,4 m and 0.22 m,  
filtering one time for type of filter and for pore size.  
 
3.2.1 Spectroscopic analysis (FT-IR)  
 
Initially FT-IR spectra were performed directly on the matrix obtained by lyophilization 
of the solution after  filtration. However, filtration was not able to completely remove 
lecithin and crosslinkers. in fact the FT-IR spectrum of the sample not purified shows a 
very complex pattern. An Attempt to purify the samples was did using pre packed 
column of Sephadex G 25 but this led to  a further dilution of the polymer suspension 
and, moreover, aggregated matrix of alginate and chitosan had the tendency to 
obstruct  the pores of the column. Finally we have selected dialyses as a possible 
approach for purification. Dialysis was performed in dialyses bag with a small cut off (3 
kDa ) against  a solution of water. After 5 washing cycles of dialyses, the sample was 
freeze-dried and analyzed. 
The Infrared spectra were performed on lecithin powder, on the pure polymers and on 
the final alginate-chitosan matrix deriving from the reaction in emulsion. All the 
samples for analysis have been prepared in KBr tablets. 
 
 
Fig.3.5 FTIR spectra of pure polymers, lecithin and alginate-chitosan after reaction. 
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The FT-IR spectrum (see figure 3.5) of  lecithin (purple track) shows the typical 
absorption bands of this surfactant. In particular the peak at 3282.61 cm-1 is due to the 
stretching OH and the peaks at 3010, cm-1,  2958 cm-1 and 2924 cm-1  are due to the 
asymmetric stretching of the  =CH-,  and to the asymmetric and symmetric stretching 
of the CH groups respectively. At 1739 cm-1  there is the typical band of the stretching 
of the carbonyl groups of the fatty acids, the signals at 1624 cm-1 and 1464 cm-1  
correspond to the CH scissoring, while the peak at 1380 cm-1  is due to the CH3
 
symmetric bending, finally the absorption bands at 1234-1065 cm-1 are  the typical 
asymmetric and symmetric stretching of the phosphate group. 
The FT-IR spectrum of the alginate-chitosan matrix (blue track) deriving from the 
reaction in emulsion is essentially dominated by the resonances of the lecithin which is 
still present in the sample. The clear identification of the polymers and in particular of 
the eventual characteristics bands of the amide bond  is not possible.  
Indeed, the peak at 1649 cm-1 could be identified as the amide bands (bands ) but the 
attribution is ambiguous because alginate and chitosan present also peaks close to this 
value (alginate at 1613 cm-1 and chitosan at 1639 cm-1 ). The band at 1554 cm-1 instead 
can be interpreted as the amide band and it is certainly a new band, but being 
lecithin still present is not possible to attribute the eventual covalent bond to alginate 
and chitosan interaction. In fact as underlined, lecithin includes different substances 
potentially bearing carboxyl and amine functions that can also react forming amides. 
An important observation is the absence of the characteristic and  intense peaks of 
EDC in the range of 2700-2000 cm-1, meaning that the purification steps were able to 
completely remove the crosslinking agent. 
 
 
3.2.2 Determination of particle size 
 
Nanoparticles prepared in emulsion and purified by dialysis were characterized in 
terms of size and size distribution with NTA.   Figure 3.6 presents  the results obtained. 
 
 
80 
 
 
Fig.3.6 Sizes distribution of alginate-chitosan nanoparticles from W/O macroemulsion resulting from NTA analysis. 
 
The average size distribution of the nanoparticle is centered at 200 nm (= ± 46) and 
the curve is simmetrically distributed around the average value.  
 
 
3.2.3 Determination of particle morphology 
 
Samples were analyzed in form and shape using transmission electron microscopy 
(TEM). The image (see figure 3.7) obtained reveals the presence of some 
nanoparticles. The major amount of material, however, does not present a well 
defined structural arrangement, but it is aggregated in non uniform way.  
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Fig.3.7 TEM image of alginate-chitosan matrix deriving from W/O macroemulsion. 
 
Overall, also with this system we were not able to obtain nanoparticle.  In addition we 
have to consider that from FT-IR spectra is visible the presence of lecithin. Dialysis in 
fact is not able to remove completely lecithin and this can influence the final 
composition and also the type of interactions within the sample. Indeed, examples of 
chitosan-lecithin interactions are well  described in literature. Sonvico et al. first 168 and 
other groups then 169 developed a method to produce chitosan-lecithin nanoparticles 
for encapsulation of drugs. The formation of nanoparticles is based on electrostatic 
interaction between the negatively charged lecithin and the positively charged 
chitosan. Considering this further element we cannot exclude that the particles 
observed with NTA and partly with TEM may derive from a chitosan/lecithin 
interaction.  
The fact that lecithin is a mixture of different components represents also a problem 
for the reaction between alginate and chitosan. In fact, substances present in lecithin 
and bearing amine functions can act as competitor of chitosan in the coupling reaction. 
In general, too many variables complicates the comprehension of the processes 
involved in this type of emulsion. To better understand the system it is, therefore, 
necessary a selection of pure components  in order to simplify the systems. 
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3.3 Alginate-chitosan nanoparticles: preparation using PC as emulsifying 
agent for W/O macroemulsion 
 
The use of lecithin, despite the formation of a stable macroemulsion, revealed some 
critical issues deriving from a possible involvement in a ionic interaction with chitosan. 
As referred above, lecithin consists of a complex mix of components. In particular the 
70 % is made of phospholipids170 and among these,  phosphatidylcholine (PC) is the 
greater component. A comparison of the FT-IR spectrum of lecithin with the PC and 
phosphatdylethanolamine (PE) ones, revealed that our lecithin is mostly composed 
from PC. To understand if the PC alone  has the capacity to stabilize the emulsion, we 
prepared an emulsion in the same condition of the previous one using PC instead of 
lecithin as emulsifier agent. The attempt was made with the identical ratios between 
emulsion components used in the case of lecithin. We only calculated the amounts of 
PC  from the percentage of phosphoric group present in lecithin. In  the final 
composition of emulsion a 1,4 % of PC is present. 
Unfortunately the resulting emulsion is not stable and the water droplets coalesce 
forming a precipitate. In any case sample was diluted five times with water and then 
the emulsion was filtered using hydrophobic and hydrophilic membranes of decreasing 
sizes pores. In particular, the filtration was performed using filters with pore size of 0.8 
m, 0,4 m and 0.22 m,  filtering one time for type of filter and for pore size. The FT-
IR spectrum performed on the filtered matrix is not well resolved and identification of 
the components is not possible. 
 
3.3.1 Determination of particle size 
 
NTA analysis (see figure 3.8) of the sample obtained shows a broad distribution of sizes 
and low concentration of particles in the sample. Probably the high hydrophobic 
behavior of PC has negative effects on the stability of emulsion destabilizing the 
system.  
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Fig.3.8 Sizes distribution of nanoparticles resulting from NTA analysis in presence of PC. 
 
As a conclusion of this part, the results obtained from food grade emulsion have been 
useful to  design the characteristics of the next emulsion. In particular it will be 
desirable 
o A reduction of the water droplet size in the emulsion to form smaller 
nanoparticles. 
o The use of more pure components (organic solvents) in order to avoid 
complications deriving from impurities. 
o The definition of a relatively simple and efficient purification process. 
o The use of non ionic emulsifying agent to avoid direct interactions with the 
polymers. 
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3.4 Alginate-chitosan nanoparticles: preparation using Triton X-100 as 
emulsifying agent for W/O nanoemulsion 
 
The procedure developed for the formation of alginate-chitosan nanoparticles in the 
internal droplets of the W/O nanoemulsion was conceived to obtain a stable system  
using not food grade components, and in particular the behavior of pure organic 
components was explored. This choice was motivated by the problems encountered in 
the analysis and characterization  of systems formulated with food grade components, 
due to the presence of large amounts of impurities. Organic solvents and reagents give 
the possibility to work with pure components without any contamination of raw 
materials. In literature several articles report the possibility to use cyclohexane as 
continuous phase.171 As underlined in the introduction in the formulation of a stable 
emulsion it is important to know the required HLB of the continuous phase. 
Cyclohexane, for example needs a value of HLB close to 10. Triton X-100 is a common 
emulsifying agent, frequently used as emulsifier in presence of cyclohexane as 
continuous oil phase. Triton X-100 is a polyoxyethylene derivative (see figure 3.9) 
belonging to the non ionic surfactant family.  
 
Fig.3.9 Structure of Triton X-100  
 
The choice of a non charged surfactant is justified by the presence of two charged 
polymers (alginate and chitosan); a further charged component in the emulsion can 
complicate the reaction interacting with the polymers. Triton X-100 has a HLB of 13, a 
value too high for cyclohexane, and an hypothetic emulsion formulated in such a way 
can undergo phase inversion. To obtain a stable emulsion it is, therefore, necessary to 
add a further component lowering the HLB to a value close to 10. To this aim, usually, 
a blend of Triton X-100 and hexanol172 is used. The co-surfactant, in this case a linear 
alcohol like hexanol  with an HLB of 6, acts as a HLB lowering agent. Selected the 
components to be used for the formulation of the emulsion and calculated the single 
volume fractions to obtain a value of HLB close to 10, the final composition may be 
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fine-tuned to set the best condition. In particular, the optimization of component ratio 
was achieved referring to the phase diagram reporting the three components (oil, 
water, surfactant). The region explored was the part of the diagram in which 
cyclohexane is present in large amount being the continuous phase, hexanol is the 
second component respect to the total volume fraction, the surfactant  is present in a 
relative high amount to stabilize the emulsion, and, finally, the aqueous phase is 
present in small amount to avoid phase inversion of the emulsion. 
 
  
Fig.3.10 Left: phase diagram showing the components ratios tested (red points) before to select the best one (black 
point). Right: final aspect of emulsion. 
 
Figure 3.10 shows the phase diagram used to optimized the composition of the 
emulsion and the mixtures tested (red and black points). All the points tested fall in the 
W/O nanoemulsion region and the final composition chosen is very close to that 
reported by J. Zhi and al..173 This work describes the in situ preparation of 
chitosan/Fe3O4 magnetic nanoparticles in W/O nanoemulsion with a good control of 
nanoparticle size and homogeneity thanks to the use of the internal water droplets of 
the nanoemulsion as nanosized reactors. In particular, a solution of chitosan and 
ferrous salt was prepared in water and then mixed with cyclohexane and  hexanol in a 
fixed  W/O ratio of 4/17.  In the final step of nanoemulsion formulation, Triton X-100 
was added under a vigorous stirring until the system became transparent. Then, 
magnetic chitosan nanoparticles were precipitated with a rapid change of pH adding 
NaOH to the emulsion and were crosslinked with glutaraldehyde. An article of the 
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same authors174 describes the formation of chitosan nanoparticles using a slightly 
different procedure. At first, two emulsions, one containing chitosan and the other 
glutaraldehyde, were independently formulated in the same condition as above. Then 
the emulsion containing glutaraldehyde was added dropwise in the emulsion 
containing chitosan and kept under stirring enabling to the water droplets of the two 
different emulsions to collide and to exchange their components putting in contact the 
polymer with the glutaraldehyde. This process allows the formation of crosslinked 
chitosan-glutaraldehyde nanoparticles. The article reports also that the crosslinked 
chitosan nanoparticles are able to absorb and concentrate furosemide from a water 
solution, thanks to the hydrophobic interactions established between chitosan and 
furosemide. Inspired by  these works we decided to explore a similar methodology for 
the preparation of alginate-chitosan crosslinked nanoparticles exploiting the water 
pool of nanoemulsion as nanoreactors. Two emulsions have been formulated using the 
following cyclohexane/hexanol/water ratios: 11/6/4 and titrating with Triton X-100 
under stirring until a clear solution was obtained. In this condition and in the absence 
of polymers, measurement of aqueous droplets of the emulsion recorded by DLS 
shows a mean diameter of 58 nm with a low polydispersity index (0,25). The final 
Triton X-100 ratio was about 1/3 respect to cyclohexane. The first emulsion was 
prepared using a water solution (pH= 5) of chitosan at a 0,2 w/v concentration and the 
second one  was prepared using a water solution of alginate at a 0,2 w/v concentration 
added of  the zero length crosslinkers EDC (26 l at the concentration of 3,5 10-3 
mol/ml) and NHS (10 l at the concentration of 2,03 10-3). 
In our preparation EDC and NHS are firstly incubated with alginate (the molecule 
bearing the carboxyl groups)  and the water solution containing the polymer and the 
crosslinking agents was used to form the emulsion which was finally added to the 
emulsion containing chitosan (see figure 3.11). After coalescence of the water droplets 
of the two emulsions the reaction takes place probably between the mannuronic (M) 
functions of alginate, being less rigid than G blocks, and  the amine functions of 
chitosan. The emulsion containing alginate and EDC/NHS was then added dropwise in 
the emulsion containing chitosan and the system was maintained under stirring for 48 
hours to ensure efficient collision between the drops of alginate and  chitosan and to 
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let the crosslinking reaction to occur thus forming crosslinked alginate-chitosan 
nanoparticles.  
 
Fig.3.11 Schematic representation of the protocol used to form alginate-chitosan nanoparticles in w/o 
nanoemulsion using Triton X-100 as emulsifying agent. 
 
The step  following the reaction between the two polymers in the nanoemulsion was 
the recovery and purification of the nanoparticles. This step was problematic and took 
several time and attempts to find a convenient procedure. In the first attempt the 
emulsion was broken by addition of water and the organic solvent was evaporated 
under reduced pressure leaving a water solution of nanoparticles containing also 
hexanol and Triton X-100. Removal of these two components was then attempted by 
repeated dialysis against water or water/ethanol mixtures and by treatment with 
Amberlite AD2 (see below). However, with these methods the full removal of Triton X-
100 was not obtained. At the end, the most convenient procedure was found to be the 
precipitation of the polymeric fraction from the emulsion with acetone which being 
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miscible with water can penetrate in the water droplets causing the precipitation of 
alginate-chitosan nanoparticles.175 Acetone is also useful because it dissolves all the 
organic components included emulsifying agent, determining the formation of two 
well distinguished phases: the precipitated polymer matrix and the organic solution. 
Therefore, the emulsion was treated with acetone and centrifuged. The liquid phase 
was discharged and the pellet was resuspended in water and precipitated again with 
acetone for five times. After the last precipitation the pellet of polymers was dried 
with a N2 flow and resuspended in water. Totally about 70% (6,5 mg) of initial 
polymers is recovered. To remove completely the traces of organic solvents and Triton 
X-100, Amberlite AD2, was used. As stated in the technical data sheet, Amberlite AD2 
is a polystyrene  resin which is used in “very sensitive analytical procedures to detect 
organics in the environment or to concentrate them from a water solution”. In fact this 
resin is very efficient in adsorbing hydrophobic molecules on the polystyrene surface 
thanks to van der Waals forces. The resin is also able to remove traces of Triton X-100 
still present in the nanoparticles water suspension with an adsorbing capacity of 0,37 g 
of surfactant per g of dry resin: 
 
 
Fig.3.12 UV-Vis spectra of water solution of Triton X-100, acetone and nanoparticles suspension before and after 
treatment with Amberlite AD2. 
The purification step was followed by UV-Vis spectroscopy. As is possible to see in 
figure 3.12, Triton X-100 has a UV-Vis spectrum with two absorbance maxima (green 
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track) at 273 nm and 224 nm (the most intense peak). The water suspension of 
nanoparticles (blue track) before to be washed with Amberlite AD2 still  contains 
traces of acetone and Triton X-100. The signal relative to Triton X-100 at 273 nm is  
covered by the broad peak due to acetone still present in little amount in the water 
suspension, but the presence of Triton X-100 is clearly deducible from the peak at 224 
nm. Using a calibration curve, obtained by measuring the absorbance at 224 nm of 
solution at known concentration of Triton X-100, it also possible to calculate the 
amount of Triton X-100 still present in the water suspension of nanoparticles and to 
proceed with the washing steps until all the Triton X-100 is removed. Usually the total 
removal of the surfactant requires 2 or 3 steps of washing with the resin and the UV-
Vis spectrum obtained at the end of the treatment showing the absence of Triton X-
100 is reported in figure 3.12 (violet track). 
After the nanoparticles sample was completely purified from organic solvents and 
emulsifying agent, it was possible to proceed with further analysis. 
 
3.4.1 Determination of particle size 
 
In all the applications  related to nanoparticles, the particle size is the most important 
parameter to know. One popular method widespread in the last period is the NTA, a 
versatile technology that enables a direct visualization of the sample thanks to a 
camera connected to the sample chamber. The measurements were performed at 
ambient temperature and represent the medium  value of  three different 
measurements of three different batches. Figure 3.13 shows the results obtained. The 
mean diameter of the nanoparticles is 215 nm (= ±49 nm). The curve appears 
simmetrically distributed around this central value. A little amount of nanoparticles 
seems to be present at very low diameter values, between 10-60 nm, but this region is 
in the proximity of the detection limit of the instrument (40 nm for polymers) so the 
signal can be due to background noise as also suggested from the low concentration 
reported. 
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Fig.3.13 Particle size of nanoparticles obtained from NTA. 
 
The size distribution of the nanoparticles obtained is comparable to those reported in 
the literature for similar polymeric formulation.176 The sizes appear acceptable and 
well reproducible from different batches.  
 
3.4.2 Determination of particle stability  
To verify the stability of the nanoparticle suspension the mean nanoparticle diameter 
was measured (by NTA) on the same samples over 1 week and 2 weeks in order to  
understand if any structural change or degradation process occur in the system. In 
particular we measured the mean diameter maintaining the same dilution of the 
sample which was conserved at room temperature during all the experiment. Figure 
3.14 reports the result obtained.  
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Fig.3.14 Diameter distribution curves measured for the same sample after 1 and 2 weeks of aging. Each curve is the 
average of three independent measurements.   
From the curve obtained (see figure 3.14) it is possible to observe a clear reduction of 
the particle size after one week even more evident after two weeks from preparation. 
This phenomenon could be the result of a partial disruption of the nanoparticles or, 
more likely, an event of aggregation and consequent precipitation of the biggest 
nanoparticles. In this case, indeed, the removal due to aggregation/precipitation of the 
larger nanoparticles will result in a shift of the mean diameter toward lower values. 
This hypothesis is also supported by an analogous size decrease observed after a 
centrifugation step of the sample, carried out on the same day in which the batch is 
prepared. Indeed, centrifugation of a freshly prepared sample at 10000 rpm for 10 
minutes precipitates the aggregated particles separating them from the smallest ones 
which remain suspended in water. The results are shown in figure 3.15 and comparing 
the size distribution curve (green track) resulting from centrifugation with the one 
measured after two weeks of aging (see red track in figure 3.14) there is a good 
correspondence in term of mean diameter and  shape of the curves. This suggests that 
the centrifugal force accelerates the sedimentation process of aggregated 
nanoparticles present in suspension, thus representing a useful approach to detect and 
remove the presence aggregated nanoparticles from the suspension. Moreover, the 
centrifuged sample is stable at room temperature during time not showing appreciable 
modification of the nanoparticle man diameter after 14 days of aging.  
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Fig.3.15 Average size of nanoparticles measured using NTA before and after centrifugation 
 
3.4.3 Spectroscopic analysis (FT-IR)   
 
From the FT-IR spectra is possible to found a confirmation about the presence of both 
alginate and chitosan in the final composition of the nanoparticles and to formulate 
some hypotheses about an eventual interaction. In particular comparing the spectra of 
the final alginate-chitosan matrix with alginate and chitosan powder, some 
considerations can reinforce the hypothesis of an interaction without, however, a real 
evidence confirming the formation of the amide bond. Figure 3.16 reports the FT-IR 
spectra obtained in KBr pellet for chitosan, alginate and the alginate-chitosan 
nanoparticles and tables 3.1 and 3.2 show the assignments of the bands to chitosan 
and alginate respectively. 
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Tab.3.1 FT-IR bands of chitosan                                     Tab.3.2 FT-IR bands of alginate 
 
The Infrared spectrum of the chitosan reveals the typical chitosan absorbance peaks: 
the bands appearing from 3750 to 3000 cm-1 are due to the stretching vibrations of O-
H groups overlapped to stretching vibration of N-H. Absorption in the range of 1680-
1470 cm-1 indicates vibrations of carbonyl groups, in this specific  case the secondary 
amide due to the partial acetylation of chitosan  has a frequency of 1631 cm-1.177 The 
peak at 1515 cm-1 instead can be attributed to the protonated amine group 
overlapped to the amide signal. The absorptions at 1380 cm-1  and 1415 cm-1 are 
relative to the bending vibrations of CH3 and CH2 respectively. The band at 1249 cm
-1  
is the absorption peak of the stretching vibration of the C-O-H group. The bands 
located at 1153-1026 cm-1  are related to C-O-C vibrations. The alginate  FT-IR 
spectrum shows a broad peak around 3500 cm-1 relative to the O-H stretching and H 
bonded, the peaks at 2923 cm-1  and 2858 cm-1 instead are due to the C-H asymmetric 
and symmetric stretching. At 1610 cm-1 and 1415 cm-1 there are the characteristic 
bands of alginate (COO-  asymmetric and symmetric stretching). The peak at 1320 cm-1  
corresponds to C-O stretching, peaks at 1166 cm-1  and 1126 cm-1 are due to the C-C-O 
stretching. The last peak at  944  cm-1  is due to the O-H bending. In the spectrum of the 
lyophilized matrix after reaction between alginate and chitosan it is evident the 
presence of the characteristic peaks of the polymers. 
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Fig.3.16 Comparison of FT-IR spectra obtained from alginate and chitosan powder, and alginate-chitosan covalent  
matrix after reaction. 
 
In particular the presence of an intense peak at 1635 cm-1 can be the result of the 
addition of alginate and chitosan characteristic peaks (1631 cm-1 for chitosan and 1610 
cm-1 for alginate)  or it can be considered as the amide  band. The absence of a peak 
at 1530 cm-1 suggests the absence of the protonated amine of chitosan possibly due to 
a  large involvement of the amine in the reaction of amidation. In conclusion the 
analysis of the FT-IR spectrum of the polymer nanoparticles confirms the presence of 
the two polymers but cannot give a clear-cut demonstration of the formation of the 
amide bond. Regrettably, attempts to characterize the nanoparticles using NMR failed 
due to a too low solubility in water and other NMR solvents (MeOH, DMSO, etc.) 
 
3.4.4 Determination of particle morphology 
 
The morphology, shape and size of the nanoparticles were investigated using TEM and 
SEM microscopy. To perform TEM a droplet of water suspension of nanoparticles was  
poured on a copper grid and contrasted with uranyl acetate. After complete 
evaporation of water, the sample is ready to be introduced in the chamber for the 
analysis. 
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Fig.3.17 TEM images of covalent alginate-chitosan nanoparticles at different magnification. 
 
Nanoparticles appear with a spherical shape (see figure 3.17) and the image reveals a 
good distribution of the mean diameter with the particles being quite homogenous in 
sizes. The mean diameter measured by analyzing 70 nanoparticles  using a digital 
micrograph program is 96 nm (= ± 27 nm (see figure 3.18). 
 
 
Fig.3.18 Size distribution of particles measured with Micrograph program. 
The average diameter is smaller when compared with that obtained from NTA. 
However, this is likely the effect of the measurement conditions. Indeed, TEM analysis 
is performed under high vacuum and the drying of the sample results is a general 
shrinkage of the nanoparticles.178 This shrinkage effect underlines the swelling 
properties in water environment for the crosslinked nanoparticles. The TEM image 
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recorded at higher magnification (see figure 3.17, right) shows well shaped spherical 
nanoparticles. In this case it is possible to observe some clusters of nanoparticles that 
probably reflect the agglomeration process observed with NTA. 
The topology of nanoparticles has been explored using SEM microscopy which shows 
the tridimensional structure of the nanoparticles. The resulting figures for the system 
composed of alginate-chitosan nanoparticles show a clear aggregative process of the 
nanoparticles. The sample presents a large amorphous structure made by fused 
nanoparticles as is clearly seen on the surface where the spherical shape of the 
nanoparticles is maintained (see figure 3.19, left). 
 
Fig.3.19 SEM images of covalent alginate-chitosan nanoparticles. 
 
3.4.5 In vitro toxicity test: MTT assay 
 
In order to evaluate the possible toxicity of the nanoparticles prepared with the 
protocol described above the MTT toxicological assay was set on Caco-2 cells. The MTT 
assay is a valid method to check the proliferation of cells and therefore an eventual 
mortality in case of toxic action of external agents, the nanoparticle suspensions in this 
case. This study represents a preliminary information about toxicity of the polymeric 
matrix forming the nanoparticles in se or on the toxic action due to organic residues of 
solvent or surfactant. In fact these factors may potentially have a key role in the 
mortality of cells. In particular three dilutions of alginate-chitosan nanoparticles have 
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been tested with Caco-2 cell line in order to  highlight  possible effects of the sample 
concentration. 
 
 
Fig.3.20 Histogram relative to % viability of Caco-2 cells after exposition to different concentrations of alginate-
chitosan nanoparticles. 
The results of the toxicity test is shown in figure 3.20. Comparison of the cell viability 
after exposure to the 3 different concentration of nanoparticle sample (blue) with the 
control experiment (red) does not manifest evident changes in proliferation of cells. 
Therefore, a toxic action of the nanoparticles can be excluded at least at the 
concentrations tested. The nanoparticles (also considering the standard deviation) 
show a value of cell vitality comparable with compounds normally referred as non 
toxic for cells.179 However, a slightly lower value of cell viability, although within the 
experimental error, observed at the highest concentration tested suggests that some 
toxicity may manifest at higher concentration. This opens the way to further studies  
aimed to test a wider concentration range of nanoparticles. 
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3.4.6 Encapsulating properties of the nanoparticles 
 
The design of polymer nanoparticles manifesting encapsulation ability is of 
fundamental importance in drug delivery. Several reviews and articles have explored 
the possibility of alginate and chitosan derivatives to encapsulate and retain bioactive 
drugs or peptides.180 In general hydrophilic biopolymers are investigated for the ability 
to load a water soluble drug. The encapsulation of a hydrophilic charged drug is based 
on ionic interactions occurring among  opposite charges carried by the biopolymer and 
the drug. However, preparation of the polymeric carrier directly in water in the 
presence of the drug  usually results in a low encapsulation. So many efforts were 
addressed on the preparation of nanoparticles using emulsification techniques. In the 
case of  alginate nanoparticles, for example, emulsification followed by gelation with 
Ca2+ ions showed a low encapsulation efficiency and a fast release for the high porosity 
of alginate matrix.  The coating of the alginate nanoparticles with chitosan improves 
the encapsulation efficiency by modifying the surface properties of the 
nanoparticles.181 However, in some cases the loading ability remains low probably for 
the several stages usually included in the protocol for the preparation of the 
nanoparticles that determine a loss of loaded molecules. Our purpose is to explore the 
ability of alginate-chitosan crosslinked nanoparticles to encapsulate hydrophobic 
drugs. It’s well recognized the ability of chitosan to establish hydrophobic interactions 
with lipophilic molecules, thanks to the presence of a little amounts of acetylated 
functions, and this property seems to be strictly  related with the molecular weight 
with hydrophobic interactions increasing with the molecular weight.182 In the protocol 
developed to evaluate the encapsulating properties of alginate-chitosan nanoparticles, 
the bioactive compounds are not loaded in the initial step of emulsion formulation. In 
fact being the lipophilic compounds, the possibility to lose the drug in the continuous 
phase of the nanoemulsion during nanoparticles formation is very high. To avoid this 
problem and also the risk of bioactive molecules loss during the purification procedure, 
the bioactive molecules were added directly to the water suspension of nanoparticles 
in the final step, after nanoparticles have been purified from organic solvent, taking 
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advantage of chitosan hydrophobicity.183 Being the final system not a rigid matrix, the 
chitosan hydrophobic moieties have a certain tendency to place themselves in the core 
of the structure if exposed in aqueous environment. Resveratrol and quercetin in 
particular, are the lipophilic compounds selected to investigate the entrapping 
properties of the nanoparticles. Literature reports 20,38,50,101 describe several carriers 
explored for the encapsulation of these polyphenols, but researches on alginate-
chitosan covalent carriers are lacking. 
 
3.4.6.1 Loading of resveratrol 
 
Resveratrol represents a molecule of great interest in nutraceuticals for its antioxidant 
properties. It belongs to the class of the stilbenes and specifically is a 3,4’,5 –
Trihydroxystilbene (see figure 3.21). The antioxidant  activity is reported only for the 
trans form of the compound. Different authors have described the positive beneficial 
effect of a daily consumption of resveratrol and several carriers were explored  with 
encapsulation purpose.10  
 
Fig 3.21 Structure of resveratrol. 
Recently the technologies related to encapsulation of bioactive molecules into 
different polymer matrices to enhance stability have been developing rapidly. Chitosan 
and alginate being safe polymers can represent potential carriers for resveratrol. In 
particular literature reports recent investigation on resveratrol-loaded chitosan-TPP 
microspheres184 and alginate sub-micro-spheres.184 Yield in encapsulation is highly 
variable and depends from different parameters. 
 In this Thesis the experiments to verify the encapsulating properties of alginate-
chitosan nanoparticles were conducted spectrophotometrically because resveratrol 
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presents an easily detectable absorbance band  in the UV range with a maximum at 
307 nm. Before to proceed with the measure of the encapsulation capacity of the 
nanoparticles it was necessary to develop a procedure to determine the solubility limit 
of resveratrol in water. At this purpose, an aqueous suspension was prepared in which 
resveratrol was added in excess (0,5 mg/ml). After 24 h of equilibration time, 
necessary to permit to the excess resveratrol to precipitate, the sample  was 
centrifuged at 3000 rpm for 10 min, and a small volume of supernatant  was diluted in 
water and inserted in the couvette for the UV-Vis measurements (see figure 3.22, blue 
track). It is important to highlight that the system needs a given time (before 
centrifugation) to ensure nucleation and growth of  the crystals in accordance with the 
Ostwald ripening process. In fact at first many small crystals having a higher solubility 
respect to larger ones are formed. Hand to hand these small crystals grow forming 
larger crystals which precipitates out of solution. Control experiments in our conditions 
showed that 24 h of aging are sufficient to ensure a complete precipitation of the 
insoluble material giving a saturated water solution of resveratrol. 
 
 
Fig.3.22 Validation of the procedure to measure the solubility limit of resveratrol. 
After this first centrifugation step, the speed of rotation was increased to confirm the 
complete precipitation of the insoluble portion of resveratrol, avoiding possible false 
positive results due to small crystals of resveratrol still present in suspension. The 
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absorbance of resveratrol at 307 nm after centrifugation at 20000 rpm (red track) was 
the same as in the case of centrifugation at lower speed indicating that centrifugation 
at 3000 rpm is sufficient to ensure complete precipitation of the insoluble portion of 
resveratrol. This absorbance value corresponds to a solubility limit of 1,3 g/ml 
calculated using a calibration curve measured in ethanol. For the experiment with the 
nanoparticles a similar protocol was used. An excess of resveratrol (0,5 mg/ml) was 
added to the nanoparticle suspension and, after 24 h of aging, the water suspension 
was centrifuged at 3000 rpm and the UV-Vis spectrum was recorded.  In this way the 
trapping ability of the nanoparticles can be easily evaluated from the absorbance value 
at 307 nm respect to that obtained in water. 
The results of these experiments carried out at different concentration of 
nanoparticles are shown in figure 3.23. As expected increasing the concentration of 
nanoparticles the measured absorbance at 307 nm increases indicating that the 
nanoparticles are able to entrap resveratrol increasing its concentration above its 
solubility limit in water. The correlation between resveratrol absorbance and 
nanoparticle concentration is almost linear for the first four points and departs from 
linearity in the most concentrated sample (black point). Considering the linear part of 
the curve we can calculate an entrapping efficiency of  1,4 g of resveratrol  per 1 g 
of nanoparticles. Instead if we consider the black point (the most concentrated 
sample) the value of entrapped resveratrol is of 2,35 g per 1 g of nanoparticles. As 
discussed before in occasion of the analysis of nanoparticles stability during time, 
probably the deviation from linearity in the trapping ability of the nanoparticles can be 
ascribed to  the presence of aggregates at high concentration of nanoparticles in which 
resveratrol remains “entangled”. Indeed, following the evolution of the most 
concentrated sample (black point of figure 3.23) during a period of days (see figure 
3.24), a decrease of resveratrol absorbance during the time is observed until a plateau 
is reached. This decrease is likely due to the precipitation of the aggregated 
nanoparticles present at the relatively high concentration of the sample. This is also 
confirmed by the fact that  the samples obtained at lower concentration are stable 
over time.  
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Fig 3.23 Absorbance of resveratrol at different concentrations of alginate-chitosan nanoparticles. 
 
Fig 3.24 Evolution of the highest concentrated sample (black point figure 3.23) during the time. 
 
 
 
3.4.6.2 Radical scavenger activity: DPPH assay 
 
Having demonstrated the ability of alginate-chitosan nanoparticles to entrap 
resveratrol, we investigated if the antioxidant ability of the molecule is retained in the 
nanoparticles formulation. A common test used to evaluate the ability of resveratrol to 
act as a scavenger is the DPPH assay. DPPH is a stable radical (thanks to a good 
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delocalization of the unpaired electron in the structure) with an oxidant ability. In a 
typical reaction with an antioxidant molecule, DPPH is reduced from the antioxidant 
molecule, which in turn is oxidized. This behavior mimics what occurs in our body 
between radicals and radical-scavengers as polyphenols.  
 
Fig.3.25 Reduction of DPPH at different concentrations of resveratrol. 
 
Reduction of DPPH is followed by the loss of the typical violet color detectable in the 
visible spectra at 530 nm. If resveratrol encapsulated in the alginate-chitosan 
nanoparticles is able to act as scavenger (how normally in the body does) thus 
reducing DPPH, the absorbance at 530 nm should decrease. The graph of figure 3.25 
shows the results obtained in the experiment performed for 25 minutes, the time 
necessary to reach a plateau value for the absorbance of DPPH. Resveratrol, at the 
solubility limit in water (violet track) and resveratrol in nanoparticles  prepared at 
different concentrations show a similar trend of decay. Nanoparticles having a 
concentration of resveratrol above the solubility limit  have a lower plateau value of 
absorbance compared to resveratrol in water thus indicating that resveratrol 
entrapped in the nanoparticles preserves its antioxidant action. 
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3.4.6.3 Loading of quercetin  
 
Quercetin (3,3',4',5,7-Pentahydroxy-flavone) is a relevant polyphenols in the field of  
nutraceutics (see figure 3.26) belonging to the family of flavones. It is a  potent 
antioxidant molecule, and as reported from many works has an interesting activity 
against cancer.185 However its use is limited by its extreme insolubility in water.  
 
 
Fig.3.26 Structure of quercetin. 
 
Different materials and conditions have been studied to overcome this drawback and  
to improve water solubility of quercetin. The inclusion in nano carriers seems to 
represent a possible strategy. Entrapment in carrier in fact can also stabilize the 
molecule against rapid oxidation and degradation. The scope of this part of the project 
is to study encapsulation ability of synthesized alginate-chitosan nanoparticles and 
their capacity  to retain and protect quercetin. A protocol similar to that of resveratrol 
was used to evaluate the encapsulation of  quercetin. In brief quercetin was dissolved 
in DMSO at a concentration of 10 mg/ml and then added to water to reach a  final 
concentration of 0,5 mg/ml. This oversaturated solution was incubated for 24 h and 
then centrifuged at increasing centrifuged forces to eliminate the insoluble portion of 
quercetin (see figure 3.27). As in the previous case centrifugation at 3000 rpm is 
sufficient to eliminate the suspended quercetin. In this condition the solubility limit of 
quercetin is 5 g/ml, calculated using a calibration curve obtained in ethanol. 
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Fig.3.27 UV-Vis spectra of quercetin solution in water after centrifugation at different centrifugal speeds. 
 
 Then, five samples with increasing concentrations of nanoparticles were incubated 
with the oversaturated concentration of quercetin. After the aging for 24h the 
suspensions were centrifuged at 10000 rpm to overcome the problems due to the 
possible presence of aggregated nanoparticles observed in the experiments with 
resveratrol at high concentration of nanoparticles. Figure 3.28 shows the dependence 
of the measured absorbance of quercetin in the nanoparticle suspensions after 
centrifugation which, in this case, is linear for all the concentrations investigated. From 
the data of figure it is clear that the nanoparticles are able to increase the amount of 
quercetin solubilized in water reasonably by entrapping the bioactive molecule thanks 
to hydrophobic interaction and hydrogen bonding. In these conditions the amount of 
quercetin entrapped is 346 ng per 1 g of nanoparticles 
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Fig.3.28 Increasing concentration of quercetin at increasing amount of alginate-chitosan (Triton X-100) 
nanoparticles. 
 
 
3.4.6.4 Stability of quercetin in nanoparticles and protection from 
oxidation 
 
As a further characterization of the quercetin loaded nanoparticles and considering 
that quercetin is easily oxidized we monitored the stability of the bioactive molecule 
during time following the evolution of its UV-Vis spectra. Figure 3.29 shows that the 
absorbance of a quercetin solution at  its solubility limit in water at 372 nm, in 
correspondence of its maximum absorbance, measured after three days of aging is 
unchanged indicating that the molecule in this condition is stable.  
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Fig.3.29 Stability of quercetin in water. 
 
On the other hand, the UV-Vis spectrum of  quercetin loaded in alginate-chitosan 
nanoparticles (conc 68 g/ml) during time shows a drastic evolution with the decrease 
of the absorbance at 372 nm and the appearance of a new peak at 330 nm (see figure 
3.30). The time course of the absorbance at 330 and 372 nm over a period of five days 
is shown in figure 3.31 (left and right respectively) and shows that this phenomenon 
reaches a plateau after about 4 four days.  
 
 
Fig.3.30 Time evolution of the UV-Vis spectra of quercetin entrapped in alginate-chitosan nanoparticles (68 g/ml).  
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Analysis of the literature suggests that the spectral modifications observed are 
probably related to an oxidation process of quercetin.186 Indeed,  quercetin is a 
polyphenolic compound known to act as antioxidant with scavenging activity toward 
oxygen reactive species in human body. This scavenging process leads to a two 
electron oxidation of quercetin which is converted in an ortho-quinone derivative, 
named QQ (see figure 3.32). 
 
 
Fig.3.31 A time course of the absorbance at 372 nm (left) and 330 nm (right) for quercetin entrapped in alginate-
chitosan nanoparticles (68g/ml). 
 
Fig .3.32 Different oxidation states of quercetin. 
The quinone (QQ) derivative yields from the oxidation of the two hydroxyl groups 
present in the B ring (catechol group). This oxidized molecule is present in different 
isomeric forms (orto quinone and many para quinone methides). This process is 
described186 to lead to a spectral change of quercetin very similar to that observed in 
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our case and in particular to the disappearing of the peak at 372 nm and its 
replacement with a new absorbance peak at 330 nm. Contemporary the peak at 268 
nm and a near shoulder decrease in absorbance. Therefore, we can conclude that 
quercetin is not stable when trapped in the nanoparticles and this is probably related 
to the high local concentration of the molecules in the relatively small volume of the 
nanoparticles. Indeed it is known  that at high concentration, antioxidants molecules 
can undergo an auto-oxidation process.187 Clearly, the instability of the bioactive 
molecule in the nanoparticles is a undesired effect also because the quinone form of 
quercetin is toxic being able to arylate cellular proteins and to react with the biological 
occurring thiols. However, the oxidation process of quercetin can be suppressed by 
addition of a other water soluble oxidant such as ascorbic acid which can act as 
protective agent toward quercetin.188 Figure 3.33 shows the percentage of oxidation of 
quercetin loaded in the nanoparticles in the condition of figure 3.30 after five days in 
water and in the presence of a 3 g/ml and 7,4 g/ml of ascorbic acid. Increasing the 
amount of ascorbic acid the amount of oxidized quercetin decreases and at a 7,4 
g/ml it is reduced to a value close to zero. Therefore, ascorbic acid can represent a 
valid protecting agent for quercetin entrapped in our nanoparticles. 
 
 
Fig.3.33 Prevention of quercetin oxidation, adding different concentration of ascorbic acid in quercetin loaded 
alginate-chitosan nanoparticles. 
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3.5 Alginate-chitosan nanoparticles: preparation without crosslinkers 
using Triton X-100 as emulsifying agent for W/O nanoemulsion 
 
To investigate the effect of the crosslinkers EDC and NHS on the preparation of 
alginate-chitosan nanoparticles an analogous set of experiments was performed in the 
same conditions used for the preparation of the nanoparticles in the emulsion with 
Triton X-100 but in the absence of EDC/NHS. Briefly a W/O nanoemulsion using 
cyclohexane as continuous phase, hexanol as cosurfactant and aqueous phase 
containing 0,2% (w/v) chitosan was prepared in ratio 17/4 of oil /water. Emulsion was 
then titrated with Triton X-100 until to reach a transparent nanoemulsion. At the same 
time and with the same procedure a similar nanoemulsion was prepared in presence 
of 0,2% (w/v) alginate in the aqueous phase (without the addition of EDC and NHS). 
The emulsion containing alginate was then added dropwise in the emulsion containing 
chitosan. At the end of the mixing step, the resultant emulsion was maintained under 
stirring for 48 h to favor spontaneous collision between droplets. The process of 
purification was the same adopted for the emulsion in presence of EDC and NHS. The 
particles were precipitated five times using acetone  and then resuspended in water 
and washed with the polystyrene resin Amberlite AD2 for many times checking the 
complete removal of organic solvents and surfactant at the UV-Vis. At the end of the 
purification, the water suspension of nanoparticles is ready to be analyzed. Following 
this procedure the total polymer recovery was 70 % of which we were able to 
resuspend in water a 20% while the rest remains as insoluble pellet. 
 
3.5.1 Determination of particle size 
 
The ionic interaction between the opposite charges of alginate and chitosan is 
responsible of a process known as  complex coacervation. The complexation between 
the two polyelectrolytes represents an advantage in the case of exposition of the final 
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matrix to sudden change of pH as after an oral administration. In fact, alginate is 
soluble at high pH and shrinks at low pH whereas chitosan dissolves at low pH and is 
insoluble at high pH. Moreover, the bonding with chitosan solves the problem of the 
porosity of the alginate network mitigating the possible leakage of drugs.73 The 
complexation between the polymers usually involves a first step of a ionic gelation in 
which alginate is crosslinked with calcium, followed by the complex coacervation 
occurring between ca-alginate and chitosan. In fact calcium is essential to obtain good 
results in term of mechanical properties thanks to an increase of structure stability of 
the complex.189 Chitosan-alginate interaction (in absence of calcium) is reported to be 
weak.190 During the complexation, the acetylation degree (of chitosan) and the control 
of pH are key factors to maintain the chitosan dissolved: amine groups have to be 
charged and at high pH the number of charged amines decreases. Increasing pH, 
protonation also depends from the molecular weight of the polymers: the higher is the 
molecular weight the lower is the maximum value of pH at which chitosan is soluble. 
The network deriving  from alginate-chitosan interaction can be described as a 
sequence of ionic interchain bonds alternating to  regions constituted from uncoupled 
units of both polymers. The consideration discussed above may have a crucial role 
during coacervation between the polymers. In fact in the set-up of our experiments 
calcium is not present. However, the interaction between opposite charges carried by 
alginate and chitosan in emulsion is limited to the internal water droplets and the 
compartmentalization of the aqueous phase containing the polymers can help the 
formation of small size coacervates. Once the suspension was purified from the 
organic material, the sizes of the nanoparticles were analyzed using NTA. A 
comparison of the properties and the results obtained with alginate-chitosan covalent 
cross-linked nanoparticles with the system obtained from ionic interactions can 
elucidate the importance of the crosslinkers in the formulation of the nanoparticles. 
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Fig.3.34 Particle size of alginate-chitosan nanoparticles measured with NTA. 
 
The plotted graph showing the size distribution of ionic alginate-chitosan nanoparticles 
(see figure 3.34), shows a broad curve if compared with the result for nanoparticles 
obtained in the presence of the crosslinkers (see figure 3.15). In particular, the 
distribution of sizes is not homogeneous with the presence of large nanoparticles or 
aggregates of polymers. Centrifugation of the suspension at 10000 rpm has little effect 
on the shape of the size distribution which, unexpectedly, moves toward a larger mean 
diameter. A possible explanation for this observation is that the centrifugal action can 
force polymers to approach each other thanks to the free charges present on the 
chain, determining an increment of volume of the aggregates. Despite this, the 
average particle size is in the range of 200-300 nm denoting the preferred formation of 
small particles respect to large aggregates.  
 
3.5.2 Spectroscopic analysis (FT-IR) 
 
FT-IR spectra were acquired to study the final composition of the matrix and in 
particular to know if alginate and chitosan are still present in the final composition 
despite the several washes and treatments they are exposed. Analysis by Fourier 
0 
0,1 
0,2 
0,3 
0,4 
0,5 
0,6 
0 200 400 600 800 1000 
C
O
N
C
 E
6  
p
ar
ti
cl
e
s/
m
L 
size (nm) 
A-C  triton  no 
EDC/NHS 
A-C triton no 
EDC/NHS centr 
10000 rpm 
113 
 
transform infrared (FT-IR) was performed on the final ionic alginate-chitosan system 
and on pure alginate and chitosan polymers. Considerations about the characteristic 
peaks of pure alginate and chitosan have been discussed in the previous paragraph. 
Here are reported only the results concerning the presence of characteristic peaks in 
the polymeric matrix obtained by ionic interactions (see figure 3.35). Pure alginate 
presents characteristic vibration peaks at 1610 cm-1 and 1415 cm-1 due to  the 
carboxylate group (asymmetric and symmetric CO2
-
 stretching respectively). Other 
important bands are present at the wavenumber of 1322 cm-1 due to the skeletal 
vibration of the saccharide structure and at 1091-1027 cm-1 relative to asymmetric 
stretching of the C-O-C system. Pure chitosan instead displays characteristic strong 
peaks at 1631 cm-1 and 1515 cm-1: the band at 1631 cm-1 due to the stretching C=O 
(amide  band) and band at 1515 cm-1 probably due to N-H peak of amine overlapped 
to the amide  vibration. The spectrum of ionic alginate-chitosan system has the same 
appearance with only few differences. The peaks of alginate (1610 cm-1 ) and of 
chitosan ( 1631 cm-1) appear overlapped in an intense peak at 1630 cm-1. In addition it 
is possible to see the formation of a new peak a 1739 cm-1 due to carboxylic acid, 
suggesting that a little amount of alginate is present in a protonated state. The  peak  
of pure chitosan at 1515 cm-1 and of pure alginate at 1415 cm-1 compare in a single 
peak at 1428 cm-1. The addition of the two bands in fact explains the increment in 
intensity of the peak at 1428 cm-1 respect to peak at 1631 cm-1 (if we compare the 
intensity of peaks in pure polymers). 
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Fig.3.35 FT-IR spectrum of alginate-chitosan ionic matrix after reaction.  
 
 
3.5.3 Determination of particle morphology 
 
The shape and morphology of the polymeric matrix were also studied with TEM and 
the images were compared with those obtained from covalent interaction in the 
nanoparticles described in the previous paragraph (see figure 3.17). The sample for 
analysis was prepared in the same condition used for the sample in presence of 
crosslinkers: uranyl acetate was used as contrasting  agent. After air drying the sample 
was examined at the transmission electron microscope (TEM). The images obtained 
suggest that the polymeric matrix is not arranged in well shaped structures but at a 
first approach it appears as raw material. The presence of nanoparticles cannot be 
excluded, but, if present, they  are entrapped in a continuous material so it is difficult 
to individuate them from the images (see figures 3.36, 3.37). 
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Fig.3.36 TEM images performed on ionic alginate-chitosan sample. 
 
 
 
Fig.3.37 TEM images performed on ionic alginate-chitosan sample. 
 
At high magnification (see figure 3.37) of a restricted field, structures similar to 
nanoparticles with an irregular form, entrapped in the matrix can be identified. As 
discussed before, it is possible that electrostatic attraction between the oppositely 
charged groups in the polymers is limited to some portions of the polymer chains and 
other parts remain as loops of the single polymer giving less structured nanosystems. 
Moreover, the evaporation of the solvent can improve the tendency of material to 
shrink facilitating the formation of collapsed structures. So the first important 
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difference emerging between the two systems (covalent and ionic ones) is the lacking 
of well shaped and separated nanoparticles in the matrix.  
 
  
Fig.3.38 SEM images of ionic alginate-chitosan nanoparticles. 
 
The morphology  of the system was investigated also with the scanning electron 
microscopy (SEM). SEM analysis of the sample validates the morphological aspect 
resulting from TEM.  In the image (see figure 3.38) nanoparticles of 200-300 nm are 
visible as decoration of a filamentous network. Nanoparticles appear in a bunching 
state among polymer fibers. The average sizes of particles resulting from NTA is 
confirmed from the sizes of particles visible from SEM  taking into account that these 
tools cause a general shrinking of the polymer material due to water evaporation.  
 
3.5.4 Encapsulation properties of the nanoparticles: loading of 
resveratrol 
  
Purified samples of ionic alginate-chitosan system were investigated for their ability to 
encapsulate hydrophobic nutraceutical resveratrol. The process of encapsulation 
followed the same procedure adopted for covalent cross-linked alginate-chitosan 
nanoparticles. The samples were prepared in triplicates at five dilutions in a fixed 
volume of 1 ml of final sample. Resveratrol was added in a fixed concentration of 0,5 
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mg/ml and after precipitation of the excess of resveratrol, the samples were 
centrifuged. Taking in account the problems of the relative high sizes of the 
nanoparticles, the samples were subjected to a intermediated speed of rotation of 
10000 rpm. Then the supernatant was collected and analyzed at UV–Vis measuring the 
characteristic absorbance peak of resveratrol at 307 nm. For comparison a similar set 
of experiments using centrifugation at 10000 rpm was performed with the covalent 
crosslinked alginate-chitosan nanoparticles and the results are reported in figure 3.39.   
 
Fig.3.39 Comparison of resveratrol absorbance between covalent and ionic alginate-chitosan samples (centrifuged 
at 10000 rpm). 
 
In the case of the covalent crosslinked nanoparticles (red points) the amount of 
encapsulated resveratrol increases linearly with the concentration of nanoparticles in 
all the concentration range explored. If we compare these results with those reported 
in figure 3.23, which were obtained at a lower centrifugation speed (3000 rpm), it is 
evident that in this conditions the positive deviation from the linearity observed at 
high concentration disappears. This confirms the hypothesis that the observed higher 
encapsulation capacity was due to formation of nanoparticles aggregates which are 
removed by centrifugation at higher speed. On the other hand, in the case of the 
nanoparticles ionically bonded (blue points) a strong positive deviation from linearity 
at the highest nanoparticle concentration is still present, despite the centrifugation at 
10000 rpm. Probably, in this case the amount of agglomerated material is much higher 
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respect to the covalent cross-linked nanoparticles as confirmed from the results of 
NTA, TEM and SEM and  the centrifugation step is not sufficient to completely remove 
this material. As hypothesized for the crosslinked alginate-chitosan system, the 
aggregated nanoparticles are able to solubilize a higher amount of resveratrol thanks 
to chain entanglements between polymers and resveratrol. This phenomenon was also 
evidenced in studies about physical interaction between resveratrol and PLA.191 On the 
other hand this system was not stable and loses resveratrol during time. The same 
phenomenon is observed also in our case. Figure 3.40 shows the evolution in time of 
the resveratrol content in the two systems under study measured at the highest 
concentration of polymers. While in the case of the covalent crosslinked nanoparticles 
the decrease of the concentration of resveratrol in five days is very small, the ionic 
system loses very quickly a high amount of resveratrol reaching after six day a plateau 
value smaller than that observed with covalent crosslinked nanoparticles. This rapid 
loss of resveratrol  is indicative of a fast precipitation of the matrix and of the 
entangled resveratrol or of a weaker interaction of resveratrol with the network 
possibly due to the high porosity of alginate and to the presence of single polymer 
chains.  In any case, however the trapping efficiency of the two systems are not very 
different. 
 
 
Fig.3.40 Evolution of the absorbance at 307 nm for the highest concentrated  sample (centrifuged at 10000 rpm)  of 
covalent and ionic nanoparticles during the time. 
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3.5.5 Effect of salt concentration on the size of alginate-chitosan 
nanoparticles 
 
The last aspect we have investigated to evaluate differences between ionic and 
covalent crosslinked manufactured nanoparticles, regards their behavior if exposed to 
an increasing concentration of salt. The experimental setup was optimized in presence 
of NaCl.  A low concentration range of salt was explored to individuate possible 
differences in a little interval of concentration. The effect deriving from the addition of 
salt to a polymer solution is an aspect largely studied for  the determination of the 
physico-chemical properties of a polyelectrolyte solution. In fact as referred in the 
chapter describing alginate and chitosan, the addition of salt reduces the intrinsic 
viscosity of polyelectrolytes.  The presence of charges of the same type on the polymer 
chain determines an expansion of the chain due to the repulsion between nearby 
charges. Increasing the ionic strength, repulsion is screened, leading to a reduction of 
the volume occupied by polymer. Some reports suggest that the addition of salt such 
as NaCl on alginate and chitosan ionic complexes has a low influence on the interaction 
between polymers.192 The effect on particle size (see figure 3.41) after addition of 
different concentrations (10, 20, 50 mM) of NaCl to ionic and covalent crosslinked 
systems is different.  In ionic alginate-chitosan nanoparticles (green track), the addition 
of salt seems initially to increase the attraction between polymers thanks to a 
screening effect that reduces the expansion of the chains, but after a “critical” 
concentration value the interaction between polymers became weaker and particle 
size increases. This may be due to a competition of the salt  for the available binding 
sites on the two polymers which decreases their interaction leading to the formation 
of  larger particles. On the other hand, the covalent crosslinked nanoparticles (violet 
track) show a small gradual increment of sizes with the concentration of added salt. 
This suggests that the covalent crosslinking reinforces the network making the 
nanoparticles less sensitive to the added salt. 
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Fig.3.41 Change in particle size after addition of NaCl on covalent and ionic alginate-chitosan nanoparticles. The 
sizes have been calculated considering as mean diameter the value referring to the 90% of the total particle 
population. 
 
3.6 Alginate-chitosan nanoparticles: preparation using Tween 80-Span80 
as emulsifying agents for W/O nanoemulsion 
 
 
The difficulty met in purification of  the nanoparticle suspension from the residues of 
Triton X-100 and the need to found a stable formulation for alginate-chitosan 
nanoparticles, led us to an examination of other possible emulsifying agents. At first, 
different attempts were made using Span 60 in vaseline, but the resulting solution was 
viscous and difficult to process. Other attempts were addressed in formulation of 
systems in presence of paraffin oil and Span 80 but the emulsions were milky and not 
transparent meaning that the water droplets were very large. After many efforts failed 
for the viscous behavior of mineral oil we decided to maintain cyclohexane as 
continuous phase. In fact, despite problems related to toxicity, cyclohexane is easily 
removed and forms stable W/O nanoemulsions. The emulsifying agent was instead 
changed. Generally a blend of emulsifying agents has the advantage respect to a single 
one to an easy tuning of the final HLB by modulating  the proportion between the 
blend components.  Moreover a blend of emulsifiers provides a better solubilization of 
water and a prolonged stability 193 of the emulsion.  So the investigation was 
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addressed toward series of Span and Tween. After several attempts  a blend between 
Tween 80 and Span 80 was selected. These emulsifying agents are well known for their  
characteristics of biocompatibility, good stability and poor toxicity. They are approved 
for pharmaceutical and food use and found application in several fields. Span 80 (see 
figure 3.42, left) is a sorbitan mono-oleate which behaves as a viscous emulsifier able 
to form W/O emulsion with an HLB of 4,3.  
 
 
Fig.3.42 Left: structure of Span 80. Right: structure of Tween 80. 
 
 
 
Tween 80 instead, is a polyoxyethylene derivative of sorbitan functionalized with an 
oleic acid chain. The number of the oxyethylene moieties in the different chains may 
vary but the sum x+y+w+z = 20 (see figure 3.42, right). Tween 80 has an HLB of 15 and 
thus an hydrophilic behavior favoring the formation of O/W emulsions.  
A blend of these two emulsifying agents is generally used to form both O/W and W/O 
emulsions. In particular we are interested in the formulation of a stable W/O 
nanoemulsion. We, therefore, started to explore the behavior of emulsifiers, using  
different ratios of emulsifying agents and observing the type and stability of the 
emulsion formed. To investigate the dispersion of water in the system, the aqueous 
phase was added slowly to oil phase containing the blend of surfactants according to 
the titration method.194 The selected ratios tested between Tween 80 and Span 80 
were  5:5, 1:9, 3:7, 7:3 and 6,5:3,5. In these conditions different phenomena have been 
observed: formation of gel, creaming, instability of emulsion, milky aspect. In 
particular, during the optimization of the emulsion composition we investigated the 
region of W/O nanoemulsion in proximity to a low value of emulsifying agent to 
simplify the consequent step  of purification from surfactant. After many attempts the 
final ratio chosen was  Tween 80/Span 80  6,5:3,5 which ensures the formation of a 
stable clear  emulsion. The HLB of Tween 80 is 15 and so it gives a contribute of 9,7 to 
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the total HLB. Instead  Span 80 has a HLB of 4,3 meaning that its contribute to the final 
HLB is 1,5. The relative high amount of Tween 80 needed to formulate the emulsion 
can be explained with the high solubilization capacity of this emulsifying agent that is 
classified as a strong solubilizer for water.193 The final 11,3 HLB value is close to that 
required for cyclohexane (HLB= 10). Indeed, a good match between the HLB of the 
continuous phase (cyclohexane in our case) with the HLB of the emulsifying agents 
increases the possibility to formulate a stable emulsion. 
The final composition between oil/emulsifiers/water  emerging after titration and 
optimization using the phase diagram is 83/10/7 which corresponds to the black point 
in the nanoemulsion region (see figure 3.43, left).  
 
 
Fig.3.43 Left: best ratio of components selected (black point).  Right:  final aspect of emulsion prepared referring to 
the phase diagram. 
  
 
The established protocol for the formation of the emulsion (see figure 3.44 ) is slightly 
different respect to the one used for the emulsion with Triton X-100. In particular the 
process starts with the  addition of the external phase in a becker. Then the  
emulsifying agent is added in the proportion indicated. The aqueous phase at  pH 5 
containing the polymer (chitosan) in a concentration of 0,5 (w/v) is finally added 
dropwise and the system was left under stirring for 48 h. A transparent  yellowish 
solution is observed at the end of the process (see figure 3.43, right). If the solution 
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shows still opalescence some droplets of emulsifiers blend may help to turn the 
emulsion towards the transparency.  
 
 
 
Fig.3.44 Schematic representation of the protocol used to form alginate-chitosan nanoparticles in w/o 
nanoemulsion using Tween80-Span80 as emulsifying agents. 
 
The same procedure was followed for the preparation of the emulsion containing 
alginate and the crosslinkers EDC/NHS preventively mixed to activate the carboxyl 
groups of alginate. Briefly after addition of the blend of Tween 80-Span 80 to the 
continuous phase, the aqueous phase containing  alginate at the concentration of 0,5 
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(w/v), 26 l of EDC at the concentration of 3,5 10-3 mol/ml and 10 l of NHS at the 
concentration of 2,03 10-3 was added dropwise. Once the two emulsions were 
prepared, the alginate emulsion was poured drop by drop in the chitosan emulsion 
and the final system left to react under stirring for 48 h. During this time the droplets  
of the emulsions have sufficient time to collide and merge thus enabling the reaction 
between alginate and chitosan to occur. In the final emulsion the concentration of the 
two polymers in the water phase was 0,25 w/v and EDC/NHS were in large excess 
respect to the concentration of carboxylate groups of alginate. 
Elapsed the reaction time, the emulsion was treated with acetone to precipitate the 
polymers. The polymeric pellet was suspended in water and re-precipitated for 5 times 
to ensure the complete removal of the organic solvent and surfactants. After the last 
wash, the polymer matrix was dried under N2 flux to remove residues of acetone  and 
then resuspended in water and treated with Amberlite AD2 resin to remove 
completely any  traces of organic components and surfactants still present.  During the 
purification we discovered that the resin has a better capability to adsorb Triton X-100 
rather than Tween80 –Span80 , so the sample needed more washing steps (4-5) before 
to be purified. In any case the emulsifying agents used in this preparation are not toxic 
and approved in food products. Also in this case the removal of emulsifiers and 
acetone was checked by UV-Vis spectrometry (see figure 3.45).  
 
 
Fig.3.45 UV-Vis spectra of water solution of Tween80-Span80 mixture, acetone and nanoparticles suspension before 
and after treatment with Amberlite AD2. 
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The graph displays the proceeding of the purification of the sample. Tween80-Span80 
blend present a maximum absorption at 230 nm (red track) and acetone has a broad 
band at 265 nm (violet track). The sample before the washing with Amberlite AD2 
(blue track) displays both the peaks relative to surfactants and acetone. After two 
washing steps the  amount of impurities decreases (green track) and after five washing 
steps (orange track) the sample is completely purified and ready for further 
investigation and characterization. 
 
3.6.1 Determination of particle size and stability 
 
Sizes of the purified sample suspended in water were measured with NTA directly after 
loading the sample in the chamber. All the measurements were performed at ambient 
temperature. The nanoparticle diameter distribution profile of the sample is shown in 
the figure 3.46. All the curves are the averages of three independent measurements. 
 
 
Fig.3.46 Diameter distribution curves measured for the same sample after 1 and 2 week of aging. Each curve is the 
average of three independent measurements. 
 
The curve recorded on fresh nanoparticle sample (red track) shows a monodisperse 
nanoparticle population  with a mean diameter of about 180 nm (= ± 54). As in the 
case of the sample prepared with Triton X-100, the stability of the preparation was 
analyzed investigating the size changes over the time. In fact, changes in particle size 
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can be a valid method to detect instability of the sample (aggregation, degradation). 
The sample stored at ambient temperature, and analyzed after one week (blue track) 
shows slight changes in particle distribution while a small reduction of size becomes 
apparent after two weeks of aging (green track). The evident higher concentration of 
the sample aged two weeks is due to a different dilution of the suspension but the 
shape of the curve is almost the same as the other ones. As a conclusion, the sample 
appears stable when stored for 14 days without relevant changes in the nanoparticle 
size distribution. The stability and homogeneity of the sample was also investigated 
after centrifugation. In fact if aggregated nanoparticles are present, the centrifugal 
force accelerates their precipitation. So freshly prepared sample was centrifuged at 
10000 rpm for 10 minutes and the supernatant was examined with NTA (see figure 
3.47). 
 
 
Fig.3.47 Average size of nanoparticle measured using NTA before and after centrifugation. 
 
Figure 3.47 shows the diameter distribution for the nanoparticle population before 
(red curve) and after centrifugation (green track). Apart from the different absolute 
intensity due to different dilution of the samples, the shape of the two curves are very 
similar. This confirms the good stability  of the sample prepared with Tween80-Span80 
and indicates that only a little amount of aggregated nanoparticles is present. 
The nanoparticle samples prepared using Tween80-Span80 were also investigated 
using DLS, another useful tool very popular in sizes characterization, in order to 
validate the results  gained from NTA.  
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Fig.3.48 DLS measurements on alginate-chitosan nanoparticles obtained from w/o nanoemulsion. 
 
 
The results of DLS analysis (see figure 3.48) when compared with those of NTA show a 
similar trend of diameter distribution with a slightly broader distribution and a larger 
polydispersity. Also the mean diameter is slightly shifted to higher value (300 nm).  
 
 
3.6.2 Spectroscopic analysis (FT-IR) 
 
FTIR analysis represents a valid spectroscopic aid to evaluate possible interactions 
between pure alginate and chitosan after the reaction and to confirm the presence of 
both the polymers in the final composition of the nanoparticles. Sample was analyzed 
in form of pellet prepared mixing the lyophilized sample with KBr salt. The recorded 
spectrum (see figure 3.49) was then compared with spectra of pure alginate and 
chitosan. The tables 3.1 and 3.2 reported in the previous paragraph show the typical 
bands and relative attributions of pure chitosan and alginate.  
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Fig.3.49 Comparison of FT-IR spectra obtained from alginate and chitosan powder and alginate-chitosan covalent 
matrix after reaction using tween80- span80 as emulsifying agents. 
 
 
Alginate-chitosan sample (blue track) presents a broad peak relative to O-H and N-H  in 
the interval of 3500-3100 cm-1. Bands due to CH stretching are also present in the 
range 3000-2800 cm1.  The typical bands of chitosan (red track) and alginate (green 
track) at 1631 cm-1 and 1610 cm.1 respectively appear in a single splitted peak. Also in 
this case the peak relative to the amine functions (1515 cm-1) of chitosan is not present 
possibly for its involvement in the reaction with alginate. The peaks related to the 
skeleton of ring at 1160-1020 cm.1 are instead present in the final polymeric 
nanoparticles. The analysis confirms that alginate and chitosan are both present but 
doesn’t give direct information about the possible formation of the amide bond 
between the carboxyl groups of alginate and the amine functions of chitosan. Further 
attempts to obtain the desired information from NMR analysis failed due to the low 
solubility of the sample in the different solvents tested. 
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3.6.3 Determination of particle morphology 
 
Further information about sizes and shape of the nanoparticle samples has been 
acquired from TEM analysis. TEM is a tool  enabling  a direct imaging of nanomaterial  
offering the possibility to obtain quantitative information on the size and  morphology 
of the nanoparticles. A good image quality depends on the contrast of the sample 
related to the background. In our case  sample has been contrasted using uranyl 
acetate, after that a droplet of the sample has been deposited on a copper grid coated 
with a thin carbon layer and allowed to evaporate. 
 
 
 
 Fig.3.50 TEM images of covalent alginate-chitosan nanoparticles at high magnification. 
 
 
Digital images of the sample (see figure 3.50) show spherical nanoparticles, with a 
regular shape. Particles analysis is not complicated by the presence of aggregated 
material and the mean diameter was measured for all the particles in the image.  The 
distribution profile of nanoparticles  was obtained measuring each particle diameter 
using Digital Micrograph analyzer and the data were processed to obtain  histogram of 
particle size distribution. 
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Fig.3.51 Size distribution of particle measured with Digital Micrograph program  
 
The resulting data (see figure 3.51) show a monodisperse profile of particle diameters 
with a maximum at 40 nm and a mean diameter value of 48 nm (= ± 11 nm). The 
mean diameter shows a large difference compared to the value of 200-300 nm 
resulting from NTA and DLS. However, in general, sizes measured by TEM are smaller 
than those obtained from NTA and DLS. This difference is due to the fact that DLS and 
NTA measure the hydrodynamic radius of the nanoparticles while TEM measures the 
projected area diameter of particles in a dry state. Results presented by other 
investigators on alginate-chitosan nanoparticles report similar discrepancy between 
data acquired with these techniques.195 
 
3.6.4 In vitro toxicity test: MTT assay 
 
Alginate and Chitosan are safe and biocompatible polymers largely employed in food 
and pharmaceutical fields. However, during the manipulation they can undergo 
modification respect to native state and the presence of residual reactants can cause 
toxicity. To evaluate an eventual toxic action, several technique are reported from 
literature thus generating a great variability of parameters to analyze. MTT assay is a 
popular method adopted at this purpose. MTT is a useful assay for the measurement 
of cell proliferation. As model cells to perform MTT assay we have selected  Caco-2 
cells (human epithelial colorectal adenocarcinoma cells, as a model of intestinal 
epithelium). 
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MTT is a yellowish probe converted to water-insoluble MTT-formazan of dark purple 
color by mitochondrial dehydrogenases of living cells. The intensity of purple color is 
measured colorimetrically at a wavelength of 570 nm.  
 
 
 
Fig.3.52 Histogram relative to % viability of Caco-2 cells after exposition to different concentration of alginate-
chitosan nanoparticles 
 
If nanoparticles show toxicity, they interfere with the normal metabolic process of the 
cell, thus the conversion of MTT in MTT formazan decreases. Before the experiment, 
nanoparticles were filtered with 0,2 m sterile filters to ensure sterility and 1 ml of 
filtered suspension was lyophilized and the residue weighed to know the amounts of 
polymer (20 g/ml). Then three different dilutions of the sample (see figure 3.52) were 
introduced on a 96 well plate in presence of Caco-2 cell and after one day of 
incubation MTT was added to estimate the activity of the cell.  All samples (blue) were 
evaluate in triplicate including a positive control (red). No evidence of citotoxicity is 
visible from the plotted results and a viability of about 100% of cells is reported for all 
the concentrations analyzed.  
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3.6.5 Encapsulating properties of nanoparticles 
 
The investigation of encapsulating properties of alginate-chitosan covalent carriers 
represents part of the scope of this Thesis. The growing interest in nanotechnology is 
justified from the high advantages offered by nano sized carriers. The primary 
milestone during the manufacturing of nano carriers is the demonstration of their 
ability to retain and release bioactive drugs. The main interest in our case is to 
demonstrate the  entrapment of  nutraceuticals of interest in cardiovascular related 
diseases. 
 
3.6.5.1 Loading of resveratrol 
 
 
As in the case of the nanoparticles described in the previous paragraph we 
investigated the encapsulation of resveratrol in our carriers once the nanoparticles 
have been purified from organic residues. This reduces an eventual loss of the 
bioactive molecule during purification. Resveratrol can establish several hydrogen 
bonds (for the presence of the phenolic hydroxyl groups) and thus it can form H-
bonded complexes with alginate and chitosan. Moreover chitosan bears an acetylated 
portion that offers a hydrophobic site for the binding of lipophilic molecules. Following 
the protocol described in the previous chapter, in the experimental quantification of 
resveratrol in nanoparticles at the beginning a lower speed of rotation in the 
centrifugation of the samples was selected to avoid precipitation of polymers. In 
particular five concentrations of nanoparticles were prepared in a fixed volume of 1 ml 
and the same amount of resveratrol was added to each sample (final concentration 0,5 
mg/ml) and after centrifugation the amount of resveratrol remained in the 
supernatant was determined spectrophotometrically. The results are reported in figure 
3.53 where each point represents the average value of three independent 
measurements with relative standard deviation. From the graph is possible to observe 
that increasing the concentration of nanoparticles the amount of solubilized 
resveratrol increases well above the solubility limit in water. As in the case before, the 
correlation between concentration of nanoparticles and solubilized resveratrol is linear 
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for the first part of the graph (four points) and deviates positively at the highest 
concentration explored (black point). This higher value of entrapped resveratrol, is 
probably due to an increased interaction between resveratrol and polymers matrices 
which at the highest concentration form some kind of aggregates. However, this  
resulting entangled network of resveratrol-matrices is not stable and collapses during 
time as can be seen from the decrease in resveratrol concentration observed during 
time (see figure 3.54). The estimated value of resveratrol entrapped in nanoparticles 
corrected of the value deriving from the water soluble fraction of resveratrol is of 1,87 
g per 1 g of nanoparticles. 
 
 
Fig.3.53 Absorbance of resveratrol at different concentrations of alginate chitosan nanoparticles. 
 
 
Fig.3.54 Evolution of the highest concentrated sample (black point figure 3.53) during time. 
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If the samples are centrifuged at an intermediate speed value (10000 rpm) the 
correlation between concentration of nanoparticles and solubilized resveratrol 
becomes linear for all the concentration investigated (see figure 3.55, left) and the 
samples are stable for at least 10 days as shown in the right panel of figure 3.55 for the 
sample at the highest concentration of nanoparticles.  
 
 
Fig.3.55 Left: linear trend for all concentrations of A-C nanoparticles entrapping resveratrol (centrifuged at 10000 
rpm). Right: stability during time of the highest concentrated sample (black point). 
 
The described results underline the capability of alginate-chitosan nanoparticles 
manufactured from W/O emulsion in presence of Tween 80-Span 80 to encapsulate 
resveratrol.  
 
 
3.6.5.2 Loading of quercetin 
 
 
To study the encapsulation of quercetin with the alginate-chitosan nanoparticles  the 
procedure optimized and described in the previous chapter was used. In brief, five 
concentrations of alginate-chitosan nanoparticles were prepared in 1,3 ml of water 
solution. Then an excess quercetin at a fixed concentration (0,5 mg/ml) was added to 
all the samples. Samples were left at ambient temperature for 24 h to enable the  total 
precipitation of quercetin and centrifuged at an intermediate speed rotation (10000 
rpm). Then the concentration of quercetin solubilized in the supernatant was 
determined using UV-Vis spectroscopy. The resulting data are plotted in figure 3.56.   
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Fig.3.56 Increasing concentration of quercetin at increasing concentration of alginate-chitosan nanoparticles. 
 
The graph shows a linear trend between concentration of nanoparticles and solubilized 
quercetin for all the samples prepared with a good R value. Moreover all the 
concentrations of nanoparticles are able to dissolve quercetin over its solubility limit 
thus improving its water solubility.  
 
 
3.6.5.3 Stability of quercetin in nanoparticles and protection from 
oxidation 
 
The above samples were observed during time and a variation of the quercetin 
spectrum was observed. Indeed, the characteristic peak of quercetin decreases 
gradually until to disappear while a new peak appears at a maximum wavelength of 
330 nm. As described before, the phenomenon is associated with the oxidative process  
of quercetin to quinone form (process and structures involved are reported in figure 
3.32). 
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Fig.3.57 Evolution of absorbance of the highest concentration (95 g/ml) of alginate-chitosan nanoparticles during 
time. 
 
 
Figure 3.57 shows the disappearing of the characteristic peak of a quercetin loaded 
sample (95 g/ml of alginate-chitosan nanoparticles) at 372 nm (orange track) and the 
increment of intensity of the peak at 330 nm relative to an oxidized state of quercetin 
(blue track). The progress of the conversion of the reduced form into an oxidized state 
is  reported in  figure 3.58 showing the decay of the signal at 372 nm (left) and the 
increasing absorbance of the peak at 330 nm (right). As observed before, this oxidation 
process is not observed in quercetin stored in water ad ambient temperature (see 
figure 3.29).  
 
      
Fig.3.58 Left: decay of absorbance peak at 372 nm during time of the highest concentrated sample (95 g/ml). 
Right: increase of absorbance at 330 nm during time of the same sample. 
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Quercetin in the quinone form loses its antioxidant activity and therefore this process 
is unfavorable for a potential use of the nanoparticles as nutraceutical carriers. 
However, also in this case addition of ascorbic acid protects quercetin from the 
spontaneous oxidation as shown in figure3.59. 
 
 
Fig.3.59 Prevention of quercetin oxidation, adding different concentration of ascorbic acid. 
 
 
Addition of ascorbic acid to alginate-chitosan nanoparticles (concentration 95 g/ml) 
revealed a very useful approach  to prevent the oxidation of the encapsulated 
quercetin. In fact as is possible to see from the graph, the percentage of oxidized 
quercetin decreases  substantially in presence of ascorbic acid. The two concentrations 
of ascorbic acid explored (3 g/ml and 7,4 g/ml) show a similar capacity to prevent 
oxidation. 
 
 
3.7 Alginate-chitosan nanoparticles: preparation without crosslinkers 
using Tween80-Span 80 as emulsifying agent for W/O nanoemulsion 
 
Ionic alginate-chitosan nanoparticles were prepared also in emulsion with Tween 80-
Span 80 following the protocol reported above but for the absence of the crosslinkers 
EDC/NHS. The procedure adopted for the preparation of the nanoemulsion (in 
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presence of Tween 80-Span 80) is identical both with and without crosslinkers. Briefly 
a W/O nanoemulsion was prepared adding drop by drop 2 ml of Tween 80-Span 80 
mixed in proportion 6,5:3,5 to 8 ml of cyclohexane followed by 0,32 ml of a 0,5 % 
water solution of chitosan. In the meantime an identical emulsion was prepared using 
a 0,5 % aqueous solution of alginate. Finally the alginate emulsion was added to the 
chitosan emulsion. The resulting mixed emulsion was kept  under stirring at ambient 
temperature for 48 h. The polymers were then precipitated by addition of a volume of 
acetone equal to the final volume of emulsion followed by centrifugation at 10000 rpm 
for 10 minutes. The pellet was resuspended in water and precipitated with 5 ml of 
acetone for  further 4 times. After the last precipitation, the pellet was hydrated in 
water and sonicated for 15 minutes. The nanoparticles suspension was then washed 
with Amberlite AD2 for several times checking the complete removal of organic 
solvents and surfactant at the UV Vis.  At the end of the washing procedure, the 
sample is ready to be analyzed.  
 
3.7.1 Determination of particle size  
 
Particle size was analyzed by NTA (see figure 3.60). The size distribution profile of the 
ionic alginate-chitosan nanoparticles is similar respect to that obtained for the sample 
prepared using  the crosslinkers (see figure 3.47). Centrifugation of the sample at 
10000 rpm has not a strong effect on the size distribution although there is a small 
increment in the number of larger particles (400-500 nm) compensated by an 
analogous increment of the particles with diameters within 100-200 nm. Therefore at 
difference to what observed in the case of Triton X-100  (see above) in this case the 
samples obtained with or without using EDC/NHS behaves very similarly suggesting 
that the nanoparticles formed by simple ionic interaction are relatively stable. 
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Fig.3.60 Average size of nanoparticle measured using NTA before and after centrifugation. 
 
 
3.7.2 Spectroscopic analysis (FT-IR) 
 
Final composition of the ionic coacervate was spectrophotometrically studied with FT-
IR to determine if both alginate and chitosan are still present after the several 
treatments to which the sample was subjected. The attribution and relative 
consideration about the characteristic peaks of pure polymers are reported in the 
previous paragraph. The spectrum obtained (see figure 3.61) is very broad. However, 
some typical resonances can be identified: the splitted vibrational band presenting two 
peaks at 1630 and 1610 cm-1 is due to the characteristic bands of chitosan and 
alginate, and the same band is present in the spectrum of the covalently crosslinked 
alginate-chitosan system (see figure 3.49). Another splitted band includes the typical 
absorption band of asymmetric COO- of alginate at 1415 cm-1. Peaks related to the 
skeleton of the rings at 1160-1020 cm-1 are also present in the spectra. All together  
the spectrum is very similar to that studied for the alginate-chitosan covalent system.  
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Fig.3.61 FT-IR spectrum of alginate-chitosan ionic bonded matrix obtained in nanoemulsion in presence of tween80-
span80 as emulsifying agent. 
 
3.7.3 Determination of particle morphology 
 
The morphology of the material obtained in the absence of EDC/NHS was analyzed by 
TEM after staining with uranyl acetate. 
 
Fig.3.62 Left: TEM images of alginate-chitosan ionic sample obtained using tween80-span80 as emulsifying agents. 
Right: sample at high magnification. 
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Figure 3.62  shows the presence of nanoparticles with an approximate diameter of 50-
60 nm over a layer of non-structured material. Image at high magnification (right) 
confirms the presence of spherical partly fused nanoparticles. However, respect to the 
sample obtained using EDC/NHS (see figure 3.50), the number of nanoparticles is 
lower. In any case, the results obtained from TEM depict a different situation respect 
to the case of ionic coacervate obtained with Triton X-100. Indeed, with the Tween 80-
Span 80 emulsion some nanoparticles are obtained while with the Triton X-100 
emulsion only amorphous material was observed. This observation suggests that this 
type of nanoemulsion is able to stabilize the ionic interaction between alginate and 
chitosan respect to the nanoemulsion in which Triton X-100 was used. This result is in 
accordance with the data obtained from NTA and FT-IR underlying that covalent and 
ionic nanoparticles obtained using Tween 80-Span 80 emulsion show several similar 
properties.  
 
3.7.4 Encapsulating properties of nanoparticles: loading of resveratrol 
 
Ionic alginate-chitosan nanoparticles were investigated for their ability to encapsulate 
the hydrophobic nutraceutical resveratrol. The process of encapsulation followed the 
same procedure adopted for crosslinked alginate-chitosan nanoparticles. The samples 
were prepared in triplicates at five dilutions in a fixed volume of 1 ml of final sample. 
Resveratrol was added in a fixed concentration of 0,5 mg/ml and after precipitation of 
the excess of resveratrol, the samples were centrifuged. Taking in account the 
problems of the relative large sizes of the nanoparticles, the samples were subjected 
to a intermediate speed of rotation of 10000 rpm. Then the supernatant was collected 
and analyzed by UV–Vis measuring the characteristic absorbance peak of resveratrol at 
307 nm. Also in this case, EDC/NHS crosslinked nanoparticles and ionic coacervates 
behave very similarly being able to entrap similar amounts of resveratrol and showing 
a similar dependence of the trapped efficiency from the concentration of polymers 
(data not shown). However, and in analogy with the case of Triton X-100 the ionic 
coacervate is less stable and resveratrol escapes more quickly from the nanoparticles 
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respect to the EDC/NHS crosslinked system which is stable for several days (see figure 
3.63).      
 
 
Fig.3.63 Evolution of the absorbance at 307 nm for the highest concentrated sample (centrifuged at 10000 rpm) of 
covalent and ionic nanoparticles during the time. 
 
3.7.5 Effect of salt concentration on the size of alginate-chitosan 
nanoparticles 
 
Finally the effect of the ionic strength on the size of the two types of nanoparticles was 
examined by NTA (see figure 3.64). Increasing the concentration of NaCl the average 
diameter of the EDC/NHS crosslinked nanoparticles remains almost constant while that 
of the ionic coacervates suddenly increases at a 50 mM concentration of salt. Overall 
the behavior is very similar to that observed in the case of the preparation with Triton 
X-100 (see figure 3.41) and confirms that the ionic nanoparticles are less stable respect 
to the covalent ones. 
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Fig.3.64 Change in particle size after addition of NaCl on covalent and ionic alginate-chitosan nanoparticles. The 
sizes have been calculated considering as mean diameter the value referring to the 90% of the total particle 
population. 
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Conclusions 
 
In this Thesis we have explored the possibility to form nanoparticles of alginate and 
chitosan covalently crosslinked thanks to the formation of amide bonds between the 
amino groups of alginate and the carboxyl groups of chitosan promoted by the zero-
length EDC/NHS crosslinking reagents. The final aim was the development of suitable 
carriers for water insoluble nutraceuticals. 
The results have shown that the reaction between alginate and chitosan in W/O 
emulsion leads to more stable systems compared to the reaction in water. The 
optimization of  the emulsion represented a milestone for the aim of the project. 
Reactions in nanoemulsion, in particular, are an applicable strategy to obtain 
nanoparticles from carbohydrate polymers. In fact, the use of water nanodroplets as 
nanoreactors may prove to be a winner  strategy for the  stabilization of complex 
polymer matrices. 
The FTIR analysis of the obtained nanoparticles, although does not give  a definitive 
evidence about the  formation of the covalent bonds between the polymers, 
demonstrates the presence of both alginate and chitosan polymers in the final 
composition of the nanoparticles. Moreover, a direct comparison between covalent 
and ionic nanoparticles reveal important structural differences thus supporting the 
effective formation of a covalently linked polymeric matrix. 
NTA analysis shows that the nanoparticles are relatively small with an average size of 
180 nm and are stable in time. The performed morphological investigation (TEM, SEM) 
also confirms the formation of spherical uniform nanoparticles. Preliminary toxicity 
studies  performed on Caco-2 cells (MTT assay) exclude a toxic action of the 
nanoparticles. 
Finally the capacity of the nanoparticles to entrap resveratrol and quercetin, molecules 
of high interest in food, was experimented. Results show  a good ability of the systems 
to encapsulate  those molecules. Aqueous solubility of bioactive molecules results 
improved when nanoparticles are present and nutraceuticals preserve their 
antioxidant activity after being loaded in the nanoparticles. In conclusion the 
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nanocarriers developed in this Thesis may represent an important alternative delivery 
system for uses both in food and pharmaceutical field. 
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